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SUMMARY.
A distinctive feature of herpes simplex virus (HSV) is 
the ability to establish latency in the neuronal cells of 
the sensory ganglia. The current working model for the 
organization of the latent HSV type 1 (HSV-1) genome is that 
it persists as a circular episome associated with 
nucleosomes in a chromatin-like arrangement. Thus, latent 
HSV-1 genomes in vivo are in a physical state that differs 
from the characteristic unit length molecules found in 
virion DNA. During latency HSV-1 gene expression is 
restricted to a family of latency associated transcripts 
(LAT) detectable in the sensory ganglia of experimental 
animals and humans. An in vitro latency system has been 
utilized to investigate the molecular biology of HSV 
latency. The main objectives of the research were the 
examination of the process of reactivation, particularly the 
role of the HSV-1 polypeptide VmwllO and the elucidation of 
the properties of mutant inl814 during latency in vitro.
The HSV-1 deletion mutant dll403 was previously shown 
to be unable to reactivate latent HSV type 2 (HSV-2) in the 
in vitro latency system. The failure of dll403 to 
reactivate latent HSV-2 suggested a role for VmwllO in the 
reactivation process but did not exclude the possiblity of a 
role for LAT or that VmwllO acted in conjunction with other 
immediate early (IE) polypeptides. These aspects of 
reactivation were investigated using a combination of hybrid 
adenoviruses and inframe deletion mutants of HSV-1. 
Superinfection of latently infected monolayers with these 
viruses revealed that during reactivation in vitro there was 
no requirement for LAT and that the only prerequisite was a 
functional VmwllO. Specific features intrinsic to VmwllO 
that were important for the ability of VmwllO to activate 
gene expression in the absence of Vmwl75 in transient 
transfection assays were essential for reactivation.
Mutant inl814 contains a 12 base pair (bp) inframe 
insertion in the gene encoding Vmw65 such that the 
polypeptide it encodes is unable to interact with cellular 
proteins and thereby transinduce IE gene expression.
Southern hybridization analysis demonstrated that in!814 
reactivates latent HSV-2, although less efficiently than
wild type (wt) HSV-1 or the rescuent 1814R. Infection of 
human foetal lung (HFL) cells at low multiplicity (0.1 
particle/cell) with inl814 resulted in the efficient 
establishment of latency from which the majority of input 
particles could be recovered by superinfection with tsK at 
38.5°C. By exploiting the reduction in gene expression and 
growth of inl814 on HFL cells, a high multiplicity latency 
system was developed. Importantly, mutant inl814 permitted 
the establishment of a latent infection directly at the 
physiological temperature provided the growth medium was 
supplemented with arabinofuranosyl cytosine (Ara-C). 
Infection at high multiplicity suggested that the effects of 
mild heat shock and the mutation were not additive, implying 
that they exert their effects through the same pathway 
involving IE gene expresssion.
The responsiveness of the latent inl814 genome to the 
transactivators VmwllO and Vmw65, was determined after 
establishment of latency at 42°C or 3 7°C by superinfection 
of cultures with either tsK or tsK irradiated with 
ultraviolet light. As latency was established, the IE 
promoters were rapidly modified and became insensitive to 
transinduction by Vmw65. In analogy with the HSV-2 latency 
system, a functional VmwllO supplied by the superinfecting 
virus was necessary for reactivation of inl814 in either the 
42°C or 37°C system.
The HSV-1 terminal fragments BamHI q and s were 
undetectable in the nuclei of HFL cells infected with 5 
particles/cell in!814 following incubation for 4 days at 
42°C and 37°C in the presence of Ara-C or aphidicolin 
despite the detection of the HSV-1 joint spanning fragment 
BamHI k. Therefore, the predominant form of inl814 DNA 
during latency in cultured cells is non-linear. By 
comparison with reconstruction experiments the inl814 joint 
fragment was estimated to be present in quantities of 0.1-
0.5 copies/cell at 37°C and 0.2-1.0 copies/cell at 42°C in a 
monolayer of 106 cells. This is the first evidence that 
latent HSV-1 is "endless" in vitro and is in agreement with 
a previous observation that under similar conditions the 
latent HSV-2 genome is in a non-linear configuration.
The status of gene expression of the latent inl814 
genome was examined using a variety of methodologies. In
particular, expression of HSV-1 genes in total cell RNA 
extracts was investigated by the polymerase chain reaction 
using primers unique to LAT and thymidine kinase. In 
latently infected HFL cells HSV-1 gene expression, including 
that of LAT, was not detected at 42°C or 37°C.
It has been speculated that the specific inhibition of 
HSV-1 replication by interferon (IFN) is mediated at the 
level of IE gene transactivation. Results presented in this 
thesis utilizing human lymphoblastoid IFN-a and the Vmw65 
mutant, inl814, suggest that the antiviral effect of IFN was 
not brought about by direct interference with the 
trails inducing function of Vmw65, and that uptake of viral 
DNA to the nucleus was not affected.
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1. INTRODUCTION.
The research presented in this thesis concerns the 
investigation of the molecular mechanisms involved in 
herpes simplex virus (HSV) latency in cultured cells. The 
Introduction focuses on the current understanding of HSV 
latent infection (Section 1.3.), control of immediate early 
(IE) gene expression (Section 1.2.3.1.), and the properties 
and functions of the IE polypeptides (Section 1.2.4.).
Space restrictions necessitate that cellular transformation 
by the human herpesviruses and lytic phase replication of 
HSV DNA are not discussed.
1.1. The Herpesviruses.
1.1.1. The Architectural Components of KSV Virions.
Mature HSV particles have a highly characteristic 
appearance. The large extracellular virions measure about 
100-180nm in diameter and are composed of four major 
elements: the core, capsid, tegument and envelope (Wildy et 
al. , 1960; Epstein, 1962b). The core consists of an 
electron dense torotclal structure, placed eccentrically 
within the capsid, which contains DNA that may be arranged 
in spools around the cylindrical mass (Epstein, 1962b; 
Furlong et al., 1972). The capsid measures approximately 
lOOnm in diameter and exhibits 5:3:2 axial symmetry (Wildy 
et al., 1960). The capsid is composed of 150 hexameric and 
12 pentameric prismatic capsomeres which are arranged in the 
form of an icosahedron (Wildy et al., 1960). Recent 
evidence suggests that all capsomeres may be composed of 
multiple copies of a single protein, the major capsid 
protein (Schrag et al., 1989). Cryo-electron microscopy and 
computer image analysis has provided the first three 
dimensional structure of full and empty capsids of herpes 
simplex virus type 1 (HSV-1) (Schrag et al., 1989). In the 
study by Schrag et al. (1989) the nucleocapsid was 
determined to be organized into three distinct layers: i) an 
outer shell of capsomeres, ii) an intermediate proteinaceous 
layer in T=4 icosahedral lattice and iii) an inner layer
- 2 -
containing the HSV genome. The tegument is defined as the 
structure located between the capsid and the envelope. In 
thin section, the tegument appears as an amorphous matrix 
(Epstein, 1962b; Roizman and Furlong, 1974). The amount of 
tegument material is variable even within the same infected 
cell (Fong et al. , 1973) and is genetically determined by 
the virus (McCombs et al., 1971). The outermost structure 
of the herpes virion is the envelope, which is probably 
derived from the host nuclear membrane (Morgan et al. , 1959; 
Epstein, 1962a). The envelope is a triple layered structure 
covered with periodic projections composed of HSV 
glycoprotein molecules (Morgan et al., 1959; Wildy et al., 
1960; Epstein, 1962b; Stannard et al., 1987).
The family Herpesviridae has been classified into three 
subfamilies, namely Alpha, Beta and Gammaherpesvirinae, by 
the Herpes Study Group appointed by the International 
Committee on Taxonomy of Viruses, based on the criteria of 
host range, length of reproductive cycle, cytopathology and 
characteristics of latent infection (Roizman et al., 1981). 
The characteristics of the human herpes viruses and the 
subfamilies assigned to them are summarized in Table 1.1.
1.1.2. Human Herpesviruses and Disease.
In humans, infection with HSV-1 typically occurs early 
in life. The disease is often inapparent and frequently 
undifferentiated from other childhood illnesses. Despite 
recovery from the primary oropharyngeal infection, the virus 
establishes a long term latent infection during which 
clinically overt symptoms are not apparent. The latent 
infection serves as a reservoir for periodic recurrent 
attacks of herpes labialis. In addition, HSV-1 recurrences 
involving the epithelium of the cornea (herpes keratitis) 
may have severe sequelae including blindness. Herpes 
genitalis is usually a sexually transmitted disease seen 
mainly in adults, although herpes simplex virus type 2 (HSV- 
2) infection can also occur at birth (Whitley et al. , 1985). 
Most genital herpes infections are caused by HSV-2 but a 
minority can be attributed to HSV—1. Like HSV—1, HSV—2 
establishes a latent infection in the sensory ganglia with
Table 1.1. CLASSIFICATION OF HUMAN HERPESVIRUSES ACCORDING
TO THEIR BIOLOGICAL PROPERTIES, AND SUBDIVISION 
INTO SUBFAMILIES.
Alphaherpesvirinae.
Variable host range in tissue culture.
Short reproductive cycle.
Cytolytic infection.
Latent infection established primarily in ganglia.
EXAMPLES Herpes Simplex Virus 1 (Human Herpes Virus 1)
Betaherpesvirinae.
Restricted host range.
Relatively short reproductive cycle; slow progressing 
infection in cell culture.
Cytomegalic infection.
EXAMPLES Human Cytomegalovirus (Human Herpes Virus 5)
Host range limited to family or order of natural host.
In vitro replication in lymphoblastoid cells; some also 
cause lytic infections in some types of epithelioid and 
fibroblastoid cells.
Latent virus is frequently demonstrated in lymphoid tissue. 
EXAMPLE Epstein-Barr Virus. (Human Herpes Virus 4)
Herpes Simplex Virus 2 
Varicella Zoster Virus
(Human Herpes Virus 2) 
(Human Herpes Virus 3)
Human Herpes Virus 6
Gammaherpesvirinae.
\
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occasional recurrence of disease at the periphery.
The pathogenesis of varicella (chicken pox) involves a 
primary subclinical infection of the oropharynx or 
conjunctiva, followed by viraemia and the development of 
generalized systemic epithelial eruptions (Weller, 1983; 
Gelb, 1985). Herpes zoster (shingles) is the consequence of 
endogenous reactivation of latent varicella zoster virus 
(VZV) from sensory ganglia (Vafai et al., 1988) and it is 
thought that immunosuppression combined with increasing age 
predisposes individuals to recurrences (Schimpff et al., 
1972) . In rare cases, both HSV and VZV may spread to the 
central nervous system (CNS) during the primary or possibly 
recurrent infection causing encephalitis and meningitis 
(Kennedy, 1987). The fatalities are high and many survivors 
suffer permanent neurological damage.
Productive Epstein barr virus (EBV) infections in 
humans are often asymptomatic but clinically apparent 
infection is manifest as infectious mononucleosis, typically 
amongst adolescents. EBV is also associated with the 
development of Burkitts lymphoma and nasopharyngeal 
carcinoma (Neiderman et al., 1976; Miller, 1985).
Transplacental human cytomegalovirus (HCMV) infection 
is a major viral cause of congenital abnormalities in 
newborns (Alford and Britt, 1984). However, most HCMV 
infections acquired after birth are benign and subclinical, 
and when apparent a syndrome resembling EBV mononucleosis 
with atypical lymphocytes is observed. HCMV infection has 
been reported in immunocompromised patients, particularly 
recipients of organ transplants (Ho, 1982) and AIDS 
sufferers.
Salahuddin et al. (1986) described the isolation of a 
novel herpesvirus, human herpes virus type 6 (HHV-6), from 
the lymphocytes of patients with AIDS and
l y m p h o p r o literative disorders. Recent surveys indicate that 
80—90% of humans develop antibodies to HHV-6 early in life 
(Saxinger et al., 1988; Okuno et al., 1989) and there is 
evidence to suggest that HHV-6 is the causo-tive agent of 
childhood exanthum subitum (roseola infantum) (Yamanishi et 
al., 1988). It is unclear whether this virus is responsible 
for any other human disease(s).
- 4 -
The Structure of the Human Herpesvirus Genomes.
Herpesviruses may be defined on the basis of their 
nucleic acid characteristics (Roizman, 1982) , and are 
diverse in terms of their biological properties (Section
1.1.2.) and the size, structure and base composition of 
their genomes (Honess, 1984). The structures of the six 
human herpesvirus genomes are illustrated in Figure 1.1.
The base composition of herpes virus DNA varies from 
relatively low % G+C, eg. VZV has a G+C content of 46% 
(Ludwig et al., 1972; Davison and Scott, 1986), to 
classified viruses with a mean G+C% composition >60%, eg. 
HSV-1, HSV-2 and EBV strain B95-8 have G+C contents of 
68.3%, 69%, and 59.9% respectively (McGeoch et al. , 1988; 
Kieff et al. , 1971; Baer et al. , 1984). Betaherpesviruses 
occupy the middle of the range of observed compositions, eg. 
HCMV has a G+C content of 57-58% (Crawford and Lee, 1964; 
Plummer et al. , 1969). The complete nucleotide sequence is 
available for HSV-1 (McGeoch et al. , 1985,1986,1988; Perry 
and McGeoch, 1988) , EBV (Baer et al. , 1984) and VZV (Davison 
and Scott, 1986) . Chee et al. (1990) determined the 
sequence of HCMV strain AD169 and presented an analysis of 
the potential protein coding content of the genome. For 
HSV-2 strain HG52 most of the unique short (Ug) region has 
been sequenced (McGeoch et al. , 1987) . Recently, 
approximately 22 kilobases (kb) of sequence from the genome 
of HHV-6 strain U1102 was obtained (Lawrence et al., 1990) 
that included sequences previously recognized as having 
significant homology with a region of the HCMV genome 
(Efstathiou et al., 1988).
The HSV genome is a linear duplex molecule of 
approximately lOOxlO3 kilodaltons (kd) in the native state 
(Becker et al., 1968; Kieff et al. , 1971). Electron 
microscopic studies showed that the HSV-1 genome is a 
complex molecule divided into two covalently linked regions 
long (L) and short (S) . Both the L and S components consist 
of unique sequences, unique long (Ul ) and Ug, flanked by 
large terminal repeats [terminal repeat long (TRL ) and 
terminal repeat short (TRS)] (Sheldrick and Berthelot, 1974; 
Figure 1.1.). The position that separates the L and S
Figure 1.1. GROSS STRUCTURES OF THE HUMAN HERPESVIRUS GENOMES.
The genome structures of the six known human herpesviruses are 
presented as linear molecules. Bold lines represent unique 
sequences and repeat elements are shown as open boxes with 
arrows indicating the relative sequence orientation.
Abbreviations used in the diagram :
UL unique long
Us unique short
i /t r l internal/terminal repeat long
I/TRS internal/terminal repeat short
UL direct repeat left
d r direct repeat right
MIR major internal repeat
ori origin of DNA replication
This figure was reproduced from McGeoch (1989).
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segments is termed the joint [internal repeat long (IRl ),
internal repeat short (IRg)] and is identical to but
inverted with respect to the terminal repeats (Sheldrick and
Berthelot, 1974). The redundant repeat regions bracketing
the L and S segments were designated ab/b'al and a'c',ca
respectively (Wadsworth et al., 1975; Figure 1.2.). The . , ,
repeats are not identical except that they share an 400 base
pair (bp) a sequence that is defined as the minimum terminal
repetitive sequence required for optimal circularization
(Wadsworth et al. , 1976) . The a sequence can vary in length
and it has been reported that many junctions between L and S
contain only a single a sequence (Wagner and Summers, 1978).
HSV DNA extracted from plaque purified virions is
heterogeneous and consists of equimolar amounts of four
isomeric molecules differing from each other in the relative
orientation of the Ul and Ug segments with respect to the
joint (Sheldrick and Berthelot, 1974; Hayward et al., 1975;
Delius and Clements 1976; Wilkie and Cortini 1976; Clements
et al., 1976; Roizman, 1979). Amongst this population of
molecules a prototype arrangement was chosen for mapping
C\'<.§ cK tU
purposes (Roizman, 1979;*Figure 1.3.). The internal 
recombination events that generate all four isomers are 
directed by the a sequence (Mocarski and Roizman, 1982).
There is evidence to suggest that each isomer is able to 
take part in the production of infectious progeny (Davison 
and Wilkie, 1983a) and participate in a latent infection 
(Efstathiou et al., 1986). HSV-1 and HSV-2 have closely 
related genome sequences that are esentially colinear 
(Davison and Wilkie, 1983b) and share a high degree of 
homology (70-80%) in coding sequences (McGeoch et al.,
1987). The greatest differences occur in the major repeat 
elements and in Us (Davison and Wilkie, 1981; McGeoch et 
al., 1987).
1.2. Lytic Infection.
1.2.1. Initial Cell-Virus Interactions.
The earliest steps in HSV replication are viral 
attachment and penetration. The initial step in the
Figure 1.2. THE POSITIONS OF THE a, b AND c SEQUENCES IN THE 
REPEAT REGIONS OF THE HSV GENOME.
The locations of the a, b and c sequences in the HSV genome are 
indicated. The a 1, b' and c 1 sequences are identical to a, b 
and c in inverted orientation. The copy number of a sequences 
present at the junction between the L and S components of the 
genome is variable but often equal to one.
0)
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infection of cells by both HSV serotypes is thought to be 
the binding of virus particles to a heparan sulphate moiety 
on the surface of the cell (WuDunn and Spear, 1989). 
Subsequent additional interactions are required between 
other cell receptors and the virus envelope for complete 
adsorption (Addison et al., 1984). Penetration into the 
target cell has been observed by fusion and endocytosis 
(Smith and De Harren, 1974), although the principle mode of 
entry is via a membrane fusion route (Morgan et al., 1968; 
Para et al. , 1980; Johnson et al., 1984). It was shown that 
mild acidic conditions can reversibly inhibit penetration of 
HSV and that the extent of pH dependence was determined by 
the HSV strain (Rosenthal et al., 1989) . The adsorption and 
penetration of HSV are probably mediated by multiple 
interactions between envelope glycoproteins encoded by the 
viral genome and cell surface components. Genetic evidence 
has demonstrated that the glycoproteins designated gB, gD 
and gH are essential for virus infectivity and entry into 
the cell (Little et al. , 1981; Ligas and Johnson, 1988; Cai 
et al., 1988; Desai et al., 1988). Neutralizing monoclonal 
antibodies specific for each of these glycoproteins blocked 
viral penetration with minimal effect on virion adsorption 
(Fuller and Spear, 1987; Highlander et a l . , 1987, 1988; 
Fuller et al. , 1989). An in vitro binding assay has 
indicated that gC may be involved in complex formation with 
cellular surface structures (Kuhn et al., 1990).
1.2.2. Alteration of Host Macromolecule Synthesis.
The inhibition of host macromolecule synthesis is a 
multistage process (Fenwick, 1984). A primary phase of host 
shutoff of protein synthesis is mediated by one or more 
components of the virion (Fenwick and Walker, 1978; Fenwick 
et al., 1979; Hill et al., 1985), designated virion host 
shutoff (vhs), that is accompanied by degradation of 
cellular mRNAs (Fenwick and McMenamin, 1984; Schek and 
Bachenheimer, 1985). A late (secondary) shutoff function 
reduces the remaining levels of host protein synthesis and 
requires expression of viral early (B) and late (7) genes 
(Fenwick and Clark, 1982; Read and Frenkel, 1983). Several
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viable vhs mutants have been isolated that were defective in 
the inhibition of host protein synthesis (Read and Frenkel, 
1983; Kwong and Frenkel, 1987). Mapping of the vhs mutation 
in HSV-1 (KOS) to position 0.6 map units (mu) on the genome 
suggested that the virion-mediated shutoff function was 
encoded by 11^41 (Kwong et al. , 1988) . Inactivation of the 
vhs gene is associated with increased stability of viral 
transcripts (Read and Frenkel, 1983; Kwong and Frenkel,
1987) and recent studies indicate that mutations in vhs 
lengthen the cytoplasmic half-life of many HSV-1 mRNAs 
representing all kinetic classes (Oroskar and Read, 1989). 
Therefore, the vhs protein may play a role, in conjunction 
with transcriptional controls, in determining the abundance 
and kinetics of expression of several viral mRNAs.
The vhs product has not been characterized, but it is 
postulated that the vhs protein may be a virus-encoded RNase 
or may function by activating a pre-existing cellular enzyme 
(Oroskar and Read, 1989). The degree of virion-mediated 
suppression of host protein synthesis varies amongst 
different strains of HSV. A hybrid virus, 17G41, derived 
from HSV-1 strain 17+ (weak vhs activity) with the HSV-2 
strain G (strong vhs activity) Ul 41 homologue recombined 
into the thymidine kinase (TK) gene was used to determine if 
instability of IE mRNA in the presence of cycloheximide was 
co-inherited with strong host shutoff function (Fenwick and 
Everett, 1990a). In the diploid 17G41 recombinant the HSV-2 
(G) characteristic dominated and controlled both functions. 
However, in a mixed infection the weak shutoff function of 
HSV-1 (17+) was dominant. To account for these 
observations, Fenwick and Everett (1990a) hypothesised that 
in the infected cell UL41 must activate a cellular nuclease 
and function as a dimeric molecule.
The protein product of gene UL41 does not have an 
essential secondary role as a structural component of the 
virion, since deletion mutants within this gene can be 
isolated (Fenwick and Everett, 1990b).
In contrast to HSV induced host shutoff, the synthesis 
of some cellular proteins is stimulated during HSV infection 
(LaThangue et al. , 1984; Macnab et al. , 1985; Kemp et al. , 
1986; Patel et al., 1986). Recent results have indicated
- 8 -
that a HSV-1 IE protein (Vmw63) is obligately required for 
the accumulation of a 40kd cellular protein, in 
combination with an additional factor present in infected 
cells (Estridge et al., 1989). Overexpression of an 
abnormal form of Vmwl75 is responsible for induction of 
cellular stress proteins (Notarianni and Preston, 1982; 
Russell et al., 1987). Human fibroblast cell lines infected 
at the non-permissive temperature (NPT) with a temperature 
sensitive (ts) mutant defective for virus entry induced the 
expression of a 56kd cellular protein (Preston, 1990).
1.2.3. Transcription of HSV Genes.
The transcription of viral DNA occurs in the cell nucleus 
and is directed by an unmodified host RNA polymerase II 
(Ben-Zeev and Becker, 1977; Costanzo et al . , 1977). Viral 
mRNAs are processed in a similar manner to cellular messages 
by 5' capping, 3' polyadenylation and internal methylation 
(Bachenheimer and Roizman, 1976; Silverstein et al., 1973,
1976). The sequence YGTGTTYY (where Y is a pyrimidine) 
located 30bp downstream of the polyadenylation signal AATAAA 
is thought to be involved in the efficient -J>r*cxjsj aj of 
HSV transcripts (McLauchlan et al. , 1985) . Only a small 
proportion of HSV mRNAs are derived by splicing, notably 
those of IE-1 (Perry et al., 1986), IE-4/5 (Watson et al., 
1981; Rixon and Clements, 1982), UL15 (Costa et al., 1985; 
McGeoch et al. , 1988) and the latency associated transcripts 
(LAT) (Wagner et al., 1988b; Weschler et al. , 1988a). 
Colinear mRNA families from several regions of the HSV-1 
genome that possess individual promoters and 5' termini but 
which share 3' terminal sequences have been described 
(McLauchlan and Clements, 1983; Watson et al. , 1983; Rixon 
and McGeoch, 1984; Draper et al., 1986).
Productive infection of cells with HSV involves the 
coordinated temporal control of viral transcripts that is 
ordered into three phases referred to as IE (a) , B and 7 
(Swanstrom and Wagner, 1974; Jones and Roizman, 1979; 
Clements et al., 1977). During the replicative cycle five 
IE genes are initially transcribed in the absence of de novo 
protein synthesis (Kpzak and Roizman, 1974; Clements et al.,
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1977) . Expression of early genes is dependent on the 
synthesis of functional IE proteins (Honess and Roizman, 
1974; Preston, 1979b; Everett, 1984a; O'Hare and Hayward, 
1985a). Maximum expression of late (7^) and "true" late 
(72) genes requires the activities of IE and early gene 
products as well as viral DNA synthesis (Honess and Roizman, 
1974) . However, transcription of 7^ genes can be detected 
at moderately high levels before the onset of DNA 
replication whereas 72 gene expression is strictly dependent 
upon DNA synthesis (Holland et al., 1980; Johnson and 
Everett, 1986a) . McLauchlan et al. (1989) demonstrated the
presence of a virus-induced heat labile factor in infected 
cells, which selectively increased cleavage at a late HSV 
polyadenylation site, that functioned in an in vitro 
cleavage assay and in the context of the viral genome. 
Polyadenylation site selection may be involved in the 
regulation of HSV gene expression, although examination of 
polyadenylation sequences employed at IE, early and late 
times does not suggest a correlation between stimulation of 
processing activity and temporal class (McLauchlan et al., 
1989).
On the basis of open reading frame (ORF) predictions 
the HSV-1 genome was estimated to encode 70 unique 
polypeptides (McGeoch et al., 1988; Figure 1.3.). The 
properties of the five IE proteins induced by HSV infection 
are described in detail in Section 1.2.4. Many early genes 
have been identified as coding for proteins that are 
essential for viral origin-dependent DNA synthesis and 
enzymes involved in nucleotide metabolism that are largely 
non-essential (TK, ribonuclease reductase, dUTPase, uracil- 
DNA glycosylase and alkaline exonuclease; Table 1.2.). Late 
genes consist of those that encode structural proteins and 
proteins involved in virion assembly (Table 1.2.)
1.2.3.1. Regulation of HSV IE Genes.
Biochemical transformation of cells with a TK gene 
controlled by the IE-3 promoter revealed that enhancement of 
IE-TK gene expression required a factor associated with a 
superinfecting TK~ virus (Post et al., 1981). Mutant tsB7
Figure 1.3. ORGANIZATION OF THE GENES ENCODED BY HSV-1.
The prototype arrangement of the HSV-1 genome is illustrated 
over four consecutive lines relative to the indicated scales 
(upper and lower scales are map units and kilobases 
respectively). The locations of predicted ORFs are shown as 
arrows and the proposed polyadenylation sites of each transcript 
are indicated with a vertical bar. The positions of the DNA 
origins of replication are represented as an X (Stow, 1982; 
Spaete and Frenkel, 1982; Stow and McMonagle, 1983; Weller et 
al., 1985). Many HSV-1 ORFs have been assigned functions and 
are listed in Table 1.2.
This figure was reproduced from McGeoch et al. (1988).
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Table 1.2. PROPERTIES OF HSV-1-ENCODED PROTEINS.
GENE
IE110: 
UL2 :
UL5 :
UL6 : 
UL8 :
UL9 :
UL10 : 
UL12 : 
UL13 :
UL18 :
UL19 : 
UL20 : 
UL22 : 
UL23 : 
UL25 : 
UL26 :
UL27 : 
Ul28 :
UL29 :
UL30 : 
UL34 : 
Ul36 : 
UL37 :
UL38 :
FUNCTION OR PROPERTIES
IE transcriptional regulator 
uracil-DNA glycosylase
DNA helicase-primase component
virion protein
DNA-helicase-primase component
DNA replication origin binding 
protein
possible membrane insertion protein
deoxyribonuclease
protein kinase
capsid protein
major capsid protein 
possible membrane insertion protein 
virion glycoprotein H 
thymidine kinase
probable virion structural protein 
DNA packaging protein
virion glycoprotein B 
capsid protein
single stranded DNA binding protein
required for replication
replicative DNA polymerase
virion protein
very large tegument protein
DNA binding protein, possible role
in packaging
capsid protein essential for
ADDDITIONAL KEY 
REFERENCES
Mullaney et al. 
1990
Crute et al., 
1989
Crute et al., 
1989
Olivo et al., 
1988
Smith and Smith
1989
Rixon et al.,
1990
Rixon et al., 
1988
Addison et al., 
1990
Shelton et al., 
1990
Pertuiset et
assembly
Ul 39 : large subunit of ribonucleotide 
reductase
Ul 40 : small subunit of ribonucleotide 
reductase 
Ul 41 : virion host shutoff function
Ul 42 : ds DNA binding protein, subunit of 
DNA polymerase that increases the 
efficiency of polymerization 
Ul 44 : virion glycoprotein C 
Ul 47 : tegument protein
Ul 48 : tegument protein, activator of IE 
gene expression 
Ul 50 : deoxyuridine triphosphatase 
Ul 52 : helicase-primase component
Ul 53 : possible membrane protein
Ul 54 : Vmw63, IE transcriptional regulator
IE175: Vmwl75, IE transcriptional regulator
Ugl : Vmw68, IE protein
Ug3 : protein kinase
Ug4 : virion glycoprotein G
Ug5 : putative glycoprotein
Ug6 : virion glycoprotein D
Ug7 : virion glycoprotein I
Ug8 : virion glycoprotein E
Ug9 : tegument phosphoprotein
UglO : virion protein
Us12 : Vmwl2, IE protein
al., 1989; Rixon 
et al., 1990
Kwong et al., 
1988
Gottleib et al., 
1990
McLean et al., 
1990
Crute et al., 
1990
Many HSV-1 ORFs have been assigned functions and are listed 
above. References are cited in the original paper (McGeoch 
et al., 1988) and where appropriate additional references 
are quoted to update the table. Unmentioned ORFs have no 
assigned property/function.
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that is defective for capsid uncoating could stimulate IE 
gene expression at the NPT indicating that the component 
mediating IE induction was located external to the 
nucleocapsid (Knipe et al./ 1981; Batterson and Roizman,
1983). The identity of the transinducing factor was 
determined by cotransfection assays using HSV restriction 
fragments and chimeric constructs in which TK gene 
expression was directed by an IE-specific promoter (Campbell 
et al. , 1984). TK activity was stimulated by a 2.7xl03bp 
subclone of the BamHI f fragment (Campbell et al., 1984). 
This region was shown by analysis of HSV-1 x HSV-2 
recombinants to encode a major virion phosphoprotein present 
in the tegument at approximately 400-600 molecules per 
particle (Marsden et al., 1978; Heine et al., 1974).
Sequence data indicated the presence of a single ORF (Ul 48) 
in BamHI f predicted to encode a polypeptide of molecular 
weight (mwt) 50,342 (Dalrymple et al., 1985). Hybrid- 
arrested translation and immunoprecipitation studies 
demonstrated that Ul 48 encoded a 65kd protein termed Vmw65 
(Campbell et al., 1984).
The signals responsible for the regulation of IE genes 
were first identified using a recombinant virus in which the 
TK early promoter was replaced with the 5' upstream 
sequences of an IE gene (Post et al. , 1981) . In cells 
infected with the recombinant virus TK was transcribed and 
processed under IE conditions (Post et al., 1981). 
Examination of sequence data and deletion analysis of the 
far upstream region of HSV IE genes revealed a conserved 
cis-acting homology, the TAATGARAT motif (where R represents 
a purine), distinct from the promoter and TATA box elements, 
that was essential for IE gene expression in response to 
Vmw65 (Mackem and Roizman, 1982a,b,c; Cordingley et al., 
1983; Kristie and Roizman, 1984; Lang et al., 1984; Preston 
et al., 1984; Gaffney et al., 1985; Bzik and Preston 1986). 
DNA sequences flanking the TAATGARAT motif contribute to the 
positive stimulatory effect of Vmw65 (Kirstie and Roizman, 
1984; Preston et al. , 1984; Bzik and Preston, 1986; 
Triezenberg et al. , 1988a; Figure 1.4.). The GA-rich 
sequences are found in close proximity to at least one 
TAATGARAT consensus (Kristie and Roizman, 1984) and increase
Figure 1.4. DNA SEQUENCES REQUIRED FOR EFFICIENT REGULATION OF 
HSV-1 GENES.
The control regions of IE genes contain a far-upstream 
consensus TATAGARATTC necessary for stimulation of IE gene 
expression by Vmw65. Distal elements found upstream of IE and 
early promoters include a CAAT box homology, and GC- or GA-rich 
motifs. Late promoters consist of a TATA box, capsite region 
and an active origin of replication.
This figure was reproduced from Johnson and Everett (1986a).
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the TAATGARAT mediated responsiveness to Vmw65 (Bzik and 
Preston, 1986; Triezenberg et al., 1988a). The regulatory 
region of Vmwl75 contains several copies of a GC-rich tract 
which is the binding site for the eukaryotic transcription 
factor Spl (Jones and Tjian, 1985). In addition to these 
regulatory elements, the upstream region between IE-3 and 
IE4/5 contains an enhancer-like sequence (Lang et al., 1984; 
Preston and Tannahill, 1984). In the absence of Vmw65, the 
enhancer can stimulate expression from fused genes in an 
orientation independent manner and at a considerable 
distance from a heterologous promoter (Lang et al., 1984; 
Preston and Tannahill, 1984). However, unlike prototype 
enhancers, this HSV enhancer is not functional when inserted 
downstream of a gene (Preston and Tannahill, 1984).
While the function of Vmw65 correlates with its ability 
to interact with cis-acting target sequences, Vmw65 does not 
itself have any intrinsic DNA binding properties either for 
DNA containing the TAATGARAT motif or non-specifically for 
double stranded DNA (Marsden et al., 1987; Preston et al.,
1988). A combination of DNasel footprinting and gel 
retardation assays indicated that a physical association of 
Vmw65 with cellular components was required for specific 
binding to TAATGARAT elements (McKnight et al. , 1987; O'Hare 
and Goding, 1988; Preston et al., 1988; Gerster and Roeder,
1988). Gel retardation assays demonstrated the presence of 
cellular factors in uninfected HeLa cell nuclear extracts 
which had the capacity to interact with a short DNA fragment 
containing the TAATGARAT element, that resulted in the 
formation of a specific complex (Preston et al., 1988; 
O'Hare and Goding, 1988). Importantly, analysis of infected 
cell nuclear extracts detected the presence of a novel 
complex with very low electrophoretic mobility termed an 
immediate early complex (IEC) (Preston et al., 1988). 
Addition of a NP40 treated virion preparation to uninfected 
nuclear extracts also directed the formation of a DNA- 
protein complex that was indistinguishable from the IEC 
(Preston et al., 1988). Therefore, IEC formation is 
dependent upon both cellular and viral factors.
Evidence that Vmw65 is a component of IEC is derived 
from several experiments: i) incorporation of a monoclonal
-  1 2  -
antibody specific for Vmw65 in gel retardation assays 
further decreased the migration of the IEC complex (Preston 
et al., 1988) and ii) addition of affinity purified or in 
vitro translated Vmw65 to uninfected cell extracts induced 
complex formation (McKnight et al., 1987; Preston et al.f 
1988; O'Hare and Goding, 1988).
The identity of cellular factors involved in the co­
operation with Vmw65 in IEC formation was suggested by 
comparison of the TAATGARAT motif with the sequence elements 
known to be recognized by other transcription factors. The 
TAATGARAT consensus is homologous to the octamer binding 
site for a cellular protein, nuclear factor III, located in 
the adenovirus DNA replication origin (Pruijin et al.,
1986). Also, the nuclear factor III binding sequence is 
similar to the conserved octamer motif, ATGCAAATNA, found in 
the promoter or enhancer regions of many cellular genes 
(Falkner and Zachau, 1984). Transcription factors that 
interact with this motif have been identified and purified. 
One such factor, called OTF-1, is an ubiquitous protein 
present in a wide range of cell types. Initial evidence 
concerning the nature of the cellular factors interacting 
with Vmw65 was suggested when short oligonucleotides 
containing the octamer binding motif formed a complex with 
and competed efficiently for proteins binding to the 
TAATGARAT element (O'Hare and Goding, 1988). Gel 
retardation experiments using a DNA fragment derived from 
the far-upstream region of the VmwllO promoter and purified 
OTF-1 in the absence of other proteins detected a complex 
previously found in uninfected nuclear extracts. Addition 
of a Vmw65 in vitro translation product to the reaction mix 
induced inefficient IEC formation when highly purified OTF-1 
was used (Gerster and Roeder, 1988). The level of IEC was 
significantly increased by the further addition of an OTF-1 
depleted HeLa cell extract in reconstitution experiments 
(Gerster and Roeder, 1988). In summary, the cumulative 
evidence demonstrates that IEC formation requires the 
recognition of cis-acting sequences that contain the 
TAATGARAT motif by Vmw65 with OTF-1 and at least one other 
cellular factor.
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Inspection of the predicted amino acid sequence of 
Vmw65 revealed a region at the carboxy terminus which 
contained a high frequency of acidic residues (Dalrymple et 
al., 1985) that resembled the highly negatively charged 
regions described in the transcriptional activation domains 
of the prototype yeast regulatory proteins GCN4 (Hope and 
Struhl, 1986) and GAL4 (Gill and Ptashne, 1987).
Independent analyses of Vmw65 deletion (dl) mutants have 
determined the requirements for transactivation of IE gene 
expression in transient expression systems (Triezenberg et 
al., 1988b; Greaves and O'Hare, 1989). Deletion of the 
acidic domain located within the carboxy terminal 78 amino 
acids virtually abolished the trans-acting function of Vmw65 
(Triezenberg et al., 1988b; Greaves and O'Hare, 1989).
This same domain activates gene expression when fused to a 
heterologous DNA binding domain from GAL4, demonstrating 
that this region functions independently of the remaining 
Vmw65 molecule (Sadowski et al., 1988). This chimeric 
activator protein selectively inhibited activated 
transcription but not basal transcription in an in vitro 
assay (Berger et al., 1990) thought to be by sequestration 
of a cellular adaptor molecule responsible for positioning 
the activation domain in contact with the basic 
transcriptional machinery (Ptashne, 1988).
Deletion of the carboxy terminal domain does not have a 
significant effect on IEC formation. Instead, deletion of 
N-terminal amino acids or insertion mutagenesis of the same 
region disrupts the capacity of Vmw65 to interact with OTF-1 
and other cellular factors (Ace et al., 1988; Triezenberg et 
al., 1988b; Greaves and O'Hare, 1989). A stably transformed 
cell line that constitutively expressed a truncated Vmw65 
lacking the activation domain was impaired in the ability to 
support a productive HSV-1 infection particularly at low 
multiplicity of infection (moi) (Friedman et al., 1988).
This implied that the amino terminal portion of the 
polypeptide sequestered cellular DNA binding proteins 
rendering them unavailable for IEC formation with Vmw65. 
Recently, Greaves and O'Hare (1990) finely mapped two 
regions in the primary sequence of Vmw65 which were 
necessary for protein-protein interactions in vitro.
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Deletion of residues between amino acids 49-75 and 380-388 
abolished the transactivating function of Vmw65 suggesting 
that at least two domains are required for efficient complex 
assembly which may act independently or act as a single 
domain formed by juxtaposition of these regions in the 
folded protein (Greaves and O'Hare, 1990).
In conclusion, the results described above demonstrate 
that the functional domains of Vmw65 are distinct. The 
acidic domain is dispensable for tertiary complex formation 
but is absolutely necessary for the transcriptional 
activating function of Vmw65. In contrast, amino terminal 
residues are critical for complex formation.
Analysis of defined insertion (in) mutants of Vmw65, 
generated by inframe insertion of a short oligonucleotide, 
in transient transfection assays demonstrated that the 
functional domains necessary for stimulation of IE gene 
expression and structurally important regions were separable 
(Ace et al., 1988). Characterization of the mutant plasmids 
revealed that the ability to form an IEC correlated with the 
ability to transinduce expression of a heterologous gene. 
Marker rescue experiments using the mutated constructs and 
ts2203, which has a mutation in the HSV-2 homologue of Vmw65 
such that assembly of virus particles is affected, 
determined whether a given 12bp insertion had affected a 
domain crucial for the structural integrity of Vmw65. The 
protein synthesised by the plasmid with an insertion at 
Haelll site 14 (inl4) was unable to transactivate IE gene 
expression but rescued ts2203, implying that a viable virus 
containing the inl4 insertion could be constructed. The 
resulting HSV-1 mutant virus inl814 has demonstrated the 
importance of Vmw65 in a lytic infection (Ace et al., 1989). 
Mutant inl814 produces a defective Vmw65 that is unable to 
interact with cellular proteins and stimulate IE gene 
expression, resulting in an up to 10-fold decrease in the 
amount of IE proteins (Ace et al., 1989). The reduction in 
growth and cell type dependency of inl814 is most dramatic 
on human foetal lung (HFL) cells, on which the 
particle:plaque forming units (pfu) ratio is typically 
between 1x 104-5x 104 compared to values of 10-50 for wild 
type (wt) HSV-1 or the rescued virus 1814R (Ace et al.,
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1989). Preinfection of monolayers with ultra-violet light 
(UV) inactivated wt HSV-1 or prior transfection of a plasmid 
expressing the HSV-1 transactivator VmwllO complements the 
plaquing efficiency of inl814 close to that of HSV-1 or 
1814R (Ace et al., 1989). Thus, the reduced growth of in!814 
is a consequence of an inability to initiate plaque 
formation, particularly at low moi, rather than structurally 
defective particles.
The results presented by Ace et al. (1989) suggested 
that transinduction by Vmw65 is not essential for HSV IE 
gene expression at high moi and that the effect of the 
viable mutation in Vmw65 could be overcome by increased gene 
dosage of IE promoters. Consistent with this hypothesis is 
the recent report that the amount and the rate of in!814 
production is increased following infection of a cell line 
stably expressing Vmw65 compared to control Vmw65-negative 
cells (Werstuck et al., 1990).
Mutant inl814 has been employed to investigate the role 
of Vmw65 in latent infections (Steiner et al., 1990; Section 
1.3.5.).
1.2.3.2. Regulation of Early Gene Expression.
Early gene promoters respond to the IE transactivators 
Vmwl75 and VmwllO (Everett, 1984a; Gelman and Silverstein, 
1985; Quinlan and Knipe, 1985; O'Hare and Hayward, 1985a). 
Initial experimentation aimed at delineating the sequence 
requirements of early promoters employed deletion 
mutagenesis of the upstream region of the TK gene and 
microinjection of Xenopus oocytes (McKnight et al., 1981; 
McKnight and Kingsbury, 1982). Three separate components 
necessary for accurate and efficient transcription 
initiation in vivo were identified in the 5' flanking DNA of 
the TK gene that consisted of a derivative of the conserved 
TATA and CAAT box homologies and two GC-rich elements which 
bind the cellular transcription factor Spl (McKnight et al., 
1981; McKnight and Kingsbury, 1982; Jones et al., 1985; 
Figure 1.4.). Analysis of mutated, transfected TK genes 
activated by superinfection with HSV indicated that the 
requirements for regulation of TK are similar to those for
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TK gene expression in basal expression systems, implying 
that IE gene products did not bind directly to specific 
sequence elements within the TK promoter (Eisenberg et al., 
1985; El Kareh et al., 1985). Importantly, the same domains 
identified by transient transfection or microinjection of 
Xenopus oocytes were shown to be crucial in TK mRNA 
expression in the context of the viral genome (Coen et al.,
1986). The signals required for regulation of another early 
promoter, gD, were determined by short term transfection 
assay and found to lie within 83bp upstream of the RNA 
capsite (Everett, 1983). Like the TK control region, the gD 
promoter contained several functionally important domains 
including a TATA box homology and two upstream GA-rich 
elements (Everett, 1984b). Additional evidence that HSV 
early promoters lack virus inducible sequences was derived 
from the observation that IE proteins activated the 
expression of a hybrid cellular D-globin gene when fused to 
the gD promoter (Everett, 1983,1984b,1985) and that a HSV-1 
recombinant encoding the hybrid 13-globin gene expressed B- 
globin mRNA as a HSV early gene product (Smiley et al.,
1987).
1.2.3.3. Regulation of Late Gene Expression.
The sequence requirements for regulated expression of 
Ugll/ which encodes a 21kd protein regulated with the 
kinetics of a "true" late gene, have been described (Johnson 
et al., 1986; Figure 1.4.). Sequences between -31 and +39, 
which include a consensus TATA box homology at position -26, 
were sufficient for expression of Ugll from an origin (ori) 
positive template (Johnson and Everett, 1986b). Distal 
regions analogous to those found upstream of the TK and gD 
promoters (Everett, 1984b; Eisenberg et al., 1985) were 
absent from the Ugll promoter (Johnson and Everett, 1986b).
A similar sequence requirement for regulation of gC has been 
demonstrated (Homa et al., 1986). It is accepted that viral 
DNA synthesis is essential for achieving abundant late gene 
expression. A >95% reduction in Ugll-initiated 
transcription was observed from replication inhibited 
genomes and ori-negative plasmids (Johnson and Everett,
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1986a; Johnson et al. , 1986). Despite these data, HSV-1 
prototype late gene promoters may be activated in the 
absence of DNA replication (DeLuca and Schaffer, 1985; 
Godowski and Knipe, 1985; Johnson et al., 1986). Although 
Ugll gene expression was reduced 50-100 fold in the presence 
of phosphonoacetic acid, low levels of Ugll mRNA remained 
detectable using a sensitive assay technique (Johnson et 
al., 1986). Similarly, under conditions of DNA synthesis 
inhibition, the family of gC mRNAs accumulated to 10% of the 
level detected in cells infected by a replicating wt virus 
(Godowski and Knipe, 1985). DeLuca and Schaffer (1985) 
demonstrated that the late L42 promoter identified by Hall 
et al. (1982) was inducible by superinfection with wt virus 
or ts Vmwl75 mutants when fused to an indicator gene on an 
ori-negative plasmid. It was postulated that a dependence 
on increased copy number of intrinsically weak promoters 
and/or altered template structure as a consequence of DNA 
replication may explain why efficient late gene expression 
requires DNA synthesis (Johnson and Everett, 1986a). Prior 
IE and early gene expression is indirectly needed for 
activation of late gene transcription. In this regard, 
analysis of HSV mutants indicated that the IE polypeptides 
Vmw63 and Vmw68 are important for expression of some late 
genes (Sacks et al., 1985; Sears et al., 1985b).
1.2.4. Properties and Functions of HSV IE Polypeptides.
In HSV-1 infected cells the five IE genes encode the 
following polypeptides: Vmwl75, VmwllO, Vmw63, Vmw68 and 
Vmwl2 (Honess and Roizman, 1974; Watson and Clements, 1978; 
Figure 1.3.). At least three of these IE gene products are 
involved in transcriptional regulation of later classes of 
viral genes (Preston, 1979a; Everett, 1984a,1986; Sacks et 
al., 1985; Stow and Stow, 1986) and most IE proteins have 
some affinity for DNA in vitro (Hay and Hay, 1980).
The IE-3 gene is diploid as it is transcribed entirely 
within the repeats bounding Ug (Rixon et al., 1982). The 
gene product, Vmwl75, is a large nuclear phosphoprotein 
(Pereira et al., 1977) which is essential for lytic 
replication of HSV-1, since analysis of mutants with ts
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lesions in this gene demonstrated that a functional Vmwl75 
is continuously required for production of early and late 
mRNAs (Preston, 1979a; Watson and Clements, 1980) . Fine 
structure mapping indicated that the defect in tsK was 
caused by a single missense amino acid substitution in the 
central region of the polypeptide at residue 475 (Davison et 
al., 1984) which resulted in the synthesis of an abnormal 
polypeptide at the NPT that accumulated in the cytoplasm and 
was not post-transcriptionally modified to forms of lower 
electrophoretic mobility nor poly(ADP-ribosyl)ated (Preston, 
1979b; Preston and Notarianni, 1983). Other mutants, tsD 
and tsT, with lesions located towards the carboxy terminal 
end of Vmwl75 have been described (Preston, 1981). The 
characterization of mutants tsK, tsD and tsT identified 
separate features of Vmwl75 later demonstrated to be 
important for the activity of Vmwl75 in vitro and in vivo 
(DeLuca and Schaffer, 1987,1988; Paterson and Everett,
1988a,b; Paterson et al., 1990).
Vmwl75 shares sequence homology with a VZV protein with 
predicted mwt of 140kd (Davison and Wilkie, 1983b; McGeoch 
et al., 1986) that is a potent activator of gene expression 
in transient transfection assays (Everett, 1984a; Everett 
and Dunlop, 1984; Inchauspe et al., 1989). A recombinant 
Vmwl75-negative virus expressing the VZV 140kd protein under 
HSV-1 IE-3 control was able to grow on normal cell lines in 
the absence of Vmwl75, implying that the heterologous 
proteins are functionally related (Disney and Everett,
1990). However, complementation was not absolute as the 
hybrid virus, HSV-140, exhibited a multiplicity-dependent 
gene expression defect that was independent of cell type 
(Disney and Everett, 1990).
DNA binding immunoassays indicated that Vmwl75 can 
associate specifically with nucleotide sequences present in 
HSV-1 DNA (Faber and Wilcox, 1986) . The conserved core 
sequence S'-ATCGTC-l’ for Vmwl75 binding is present in 
promoter regions of IE-1, IE-3 and gD (Faber and Wilcox, 
1986; Kristie and Roizman, 1986a,b; Muller, 1987). Beard et 
al. (1986) using a modified in vitro transcription assay 
demonstrated that the initiation of gD mRNA synthesis is 
stimulated about 5-fold by the addition of a partially
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purified preparation of Vmwl75. Vmwl75 binding sequences 
have been identified in the gD gene 5 ’ to the start site for 
gD mRNA synthesis and within the gD coding region (Tedder et 
al., 1989) . It has been reported that there is a direct 
correlation between the number of consensus binding sites on 
the DNA template and the degree of stimulation of gD 
transcripts initiated in vitro (Tedder et al., 1989). In 
contrast, a recent report demonstrated that interactions 
between Vmwl75 and binding sequences in the TK promoter 
contributed little to the transactivation of TK gene 
expression in vivo (Imbalzano et al., 1990). Many promoters 
activated by Vmwl75 do not contain the consensus sequence 
(Everett, 1988b; McGeoch et al., 1985,1988). Indeed, Vmwl75 
can bind to alternative nucleotide sequences unrelated to 
the core consensus in the promoter regions and 5' 
transcribed non-coding regions of some early and late genes 
(Michael et al., 1988; Tedder et al., 1989; Imbalzano et 
al., 1990). Therefore, the sequence of the binding site may 
reflect properties of a cellular transcription factor that 
is involved in interactions with Vmwl75 (Everett, 1987b) or 
alternatively, the core sequence may represent only one of a 
family of diverse binding sites recognised by Vmwl75. Gel 
retardation assays using infected cell extracts and probes 
spanning -4 to +27 relative to the 5' terminus of IE-3 mRNA 
detected binding of Vmwl75 to its own transcription start 
site (Muller, 1987). The target sequence included the 
consensus binding site 5'-ATCGTC-3' which has been 
implicated in an autoregulatory role in the context of the 
viral genome (DeLuca and Schaffer, 1988).
Recent mutagenesis studies of the gene encoding Vmwl75 
have revealed regions of functional importance (DeLuca and 
Schaffer, 1987, 1988; Paterson and Everett, 1988a,b). 
Paterson and Everett (1988a) described the construction of a 
large panel of inframe insertion and deletion mutations in 
the coding region of IE-3. The activities of the mutant IE- 
3 polypeptides were assessed using short term transfection 
assays and defined two regions conserved between Vmwl75 and 
the VZV 140kd protein that were important for the 
transactivation of a HSV-1 early gene and repression of its 
own promoter (Paterson and Everett, 1988a). The same study
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identified a nuclear localization signal between amino acids 
682-774 (Paterson and Everett, 1988a). A subsequent study 
using nuclear extracts from HeLa cells determined that there 
was a general correlation between the ability to 
transactivate/repress gene expression in transfection assays 
and impaired ability to bind the IE-3 cap site in gel 
retardation assays (Paterson and Everett, 1988b). The 
integrity of an amino acid region located at 315-384 was 
essential for transcriptional control and DNA binding by 
Vmwl75 (Paterson and Everett, 1988a,b). Independent 
analyses using a less refined methodology defined similar 
functionally important domains (DeLuca and Schaffer, 
1987,1988). DeLuca and Schaffer (1987) reported that the 
carboxy terminal 40% and the first 90 amino acids of Vmwl75 
were not crucial for regulation of transcription in 
transient transfection assays. A viral mutant expressing a 
truncated polypeptide, encoding the first 590 residues of 
Vmwl75, was nonetheless able to form a novel DNA complex 
under conditions of elevated salt concentration (DeLuca and 
Schaffer, 1988).
Characterization of mutants with ts lesions in Vmwl75 
has revealed that the mode of action of the polypeptide is 
complicated further since mutants unable to bind DNA in 
vitro at the NPT possess the capacity to stimulate early 
gene expression albeit at reduced levels (DeLuca et al., 
1984; Paterson et al., 1990). Mutant tsl225 produced a 
polypeptide defective for autoregulation of IE-3 gene 
expression whilst retaining the ability to bind to the IE-3 
cap site that is important for autoregulation during virus 
infection (DeLuca and Schaffer, 1988).
The gene encoding IE-1 is present in the HSV-1 genome 
in two copies as it is located entirely within the long 
repeats (Preston et al., 1978) and transcripts arising from 
this gene are spliced (Perry et al., 1986). The protein 
product, VmwllO, is a nuclear phosphorylated protein capable 
of binding to DNA in crude nuclear extracts (Periera et al., 
1977; Hay and Hay, 1980; Ackerman et al., 1984). VmwllO has 
been shown to stimulate a wide range of promoters including 
those from all classes of HSV genes (O'Hare and Hayward, 
1985a,b; Gelman and Silverstein, 1985,1986,1987; Quinlan and
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Knipe, 1985; Everett, 1986; Mavromara-Nazos et al., 1986; 
Shapira et al., 1987; Sekulovich et al., 1988) and 
heterologous promoters such as the SV40 early promoter 
(O'Hare et al., 1986; Everett, 1998b) and the HIV LTR (Mosca 
et al., 1987). Introduction of Vmwl75 and VmwllO by 
cotransfection on separate plasmids into the same cell 
results in the synergistic stimulation of gene expression 
(Everett, 1984a,1986). Short term transfection assays have 
defined at least five mutation-sensitive regions that 
contribute to the function of VmwllO (Everett, 1987a,1988a). 
Mutations in the carboxy region of the protein resulted in a 
significant reduction in the expression of a heterologous 
gene in the presence of Vmwl75 (Everett, 1987a). A region 
of the IE-1 polypeptide between amino acids 13 0-160 
contains three partially overlapping copies of a cysteine- 
rich motif that has been implicated in the binding of metal 
ions and DNA (Berg, 1986). Inframe deletion mutants in 
which this cysteine-rich domain in the second exon was 
removed retained some transactivating function in the 
presence of Vmwl75 (Perry et al., 1986; Everett, 1987a). 
However, this region was absolutely essential for the 
activity of VmwllO in the absence of Vmwl75 (Everett,
1988a). The functional significance of the potential metal 
ion binding finger is unknown since VmwllO in nuclear 
extracts is retained on metal chelate affinity columns 
although the interaction is not dependent on the zinc finger 
(R.D. Everett, unpublished observations). It is clear, 
however, that this domain is crucial for the intrinsic 
ability of VmwllO to stimulate gene expression. 
Immunofluorescence studies determined that amino acids 474- 
509 contained highly basic residues that were important but 
not completely sufficient for nuclear localization (Everett, 
1988a).
Mutant viruses with ts lesions in the IE-1 gene have 
not been reported but large deletion mutants with the IE-1 
coding sequences removed in both copies have been described 
(Stow and Stow, 1986; Sacks and Schaffer, 1987). The mutant 
viruses were able to grow on normal cell lines although the 
yield of virus was 10- to 100-fold lower than that obtained 
with wt virus (Stow and Stow, 198 6; Sacks and Schaffer,
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1987). Mutant dll403 has a 2kb deletion in both TR^ and IR^ 
such that the majority of the sequences coding for VmwllO 
and about 750bp of the 3 1 region of LAT are removed (Stow 
and Stow, 1986). The growth deficiency of dll403 is 
manifest only at low moi since baby hamster kidney (BHK) 
cells infected with 5pfu/cell of dll403 or wt HSV-1 revealed 
no significant difference in the levels of polypeptide 
synthesis and DNA replication or encapsidation (Stow and 
Stow, 1986). Analysis of a number of mutant viruses with 
small inframe deletions in both copies of the IE-1 gene, 
particularly mutants FXE and D22, revealed a correlation 
between the importance of regions defined by transfection 
experiments and those required for transactivation of gene 
expresson and growth at low moi (Everett, 1989). These data 
suggest that VmwllO is not essential for efficient plaque 
formation at high moi but its presence confers a selective 
growth advantage at low moi.
The product of the IE-2 gene, Vmw63, is a nuclear 
phosphoprotein (Pereira et al., 1977; Ackerman et al.,
1984). Initial evidence that IE-2 performed an essential 
role in gene regulation was derived from the biochemical 
characterization of four ts mutants with mutations residing 
in the gene encoding Vmw63 (Sacks et al., 1985). 
Phenotypically, the expression of some HSV genes were 
affected, in particular certain IE polypeptides were 
overproduced and late protein synthesis was significantly 
reduced (Sacks et al., 1985). Inclusion of a plasmid-borne 
copy of Vmw63 in cotransfection assays in combination with 
VmwllO and Vmwl75 resulted in an increased stimulation of at 
least one late gene coding for the major capsid protein 
(Everett, 1986). Similarly, efficient expression of other 
HSV late gene products, gB and gC, were dependent on a 
functional Vmw63 (Rice and Knipe, 1988; Rice et al., 1989). 
It has been demonstrated that Vmw63 can negatively affect 
the expression of several HSV-1 IE, early and late promoters 
in transfection studies (Sekulovich et al., 1988; Su and 
Knipe, 1989). Functional activities of Vmw63 investigated 
using a set of carboxy truncated IE-2 polypeptides has 
demonstrated that the regions important for repression and 
transactivation are separable (Rice et al., 1989). The
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domain required for the negative regulatory activity of 
Vmw63 was located between amino acids 263-406 whilst the 
carboxy terminal residues were necessary for the 
transactivatinq function (Rice et al., 1989) . Likewise, an 
independent report using inframe insertion and deletion 
mutants throughout the Vmw63 gene demonstrated that the 
ability to repress or activate target gene expression were 
distinct (Hardwicke et al., 1989). Additional mutagenic 
analysis of the IE-2 polypeptide in which Vmw63 variants 
(Rice et al., 1989) were recombined into the viral genome in 
place of the wt gene identified two distinct transactivating 
domains responsible for the stimulation of 7^ genes in 
combination with viral DNA replication and expression of 72 
genes (Rice and Knipe, 1990) .
Deletion of a large portion of the carboxy end of the 
IE-4 gene resulted in a mutant virus with apparently normal 
growth properties implying that Vmw68 is not an essential 
polypeptide (Post and Roizman, 1981). Subsequent studies 
revealed that on some cell lines growth was restricted and 
that production of a late chimeric 72~TK protein was 
decreased (Sears et al., 1985b). This disparity can be 
explained if the Vmw68 function can be replaced by a cell 
factor produced in certain but not other cell lines.
The function of Vmwl2 is unclear. In contrast to other 
IE proteins, Vmwl2 is located in the cytoplasm of the 
infected cell and is not phosphorylated (Periera et al., 
1977; Hay and Hay, 1980; Marsden et al., 1982). On the 
basis of these characteristics it is likely that Vmwl2 has a 
unique role amongst the IE polypeptides that does not 
involve regulation of transcription. Mutant viruses deleted 
for Vmwl2 (or the HSV-2 equivalent) are viable, indicating 
that the product of the IE-5 gene is not essential for 
growth in tissue culture (Umene, 1986; Longnecker and 
Roizman, 1986; Brown and Harland, 1987).
1.2.5. Cleavage and Encapsidation of Viral DNA.
The process of cleavage and packaging of newly 
synthesised concatemeric viral DNA into preformed empty 
capsids is a coupled process (Ladin et al., 1982; Deiss and
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Frenkel, 1986; Deiss et al. , 1986). Cleavage of 
concatemeric molecules occurs within the a sequence situated 
between adjacent viral genomes (Davison and Wilkie, 1981; 
Mocarski and Roizman, 1982) and appears to be accompanied by 
amplification of an a sequence. The a sequence consists of 
unique and directly repeated elements and in HSV-1(F) has 
the structure DRl-Ub(DR2)22" (DR4)3-Uc-DR1 (Mocarski and 
Roizman, 1982) . The precise cleavage/packaging signal was 
mapped within the conserved unique regions in a using an 
amplicon transfection-propagation assay (Deiss and Frenkel, 
1986; Deiss et al. , 1986). Virus stocks derived from 
transfections with constructs deleted in the Uc element 
lacked the ability to propagate defective genomes whilst 
deletions in Ub affected efficiency of amplicon seed 
replication (Deiss et al., 1986). Deiss et al. (1986) 
described a model for cleavage and encapsidation of viral 
DNA wherein the juxtaposition of two directly repeated 
junctions resulted in a amplification according to the 
double stranded break and gap repair mechanism proposed by 
Szostak et al. (1983). The cleavage/encapsidation process 
may be complicated further by the presence of a "head full" 
recognition element that selects the juxtaposed a sequence 
once an upper limit of DNA has been packaged (Frenkel et 
al., 1976). Fragments shorter than full-length HSV 
molecules can become encapsidated but maturation is 
incomplete and the capsid remains unenveloped (Vlazny et 
al., 1982). HSV-1 mutants tsl201 and tsl203 are defective 
in encapsidation of viral DNA at the NPT but can be 
distinguished by the inability of tsl2 01 to process the 
Vmw40 family of polypeptides at the NPT (Preston et al., 
1983; Matz et al., 1983). Rixon et al. (1988) utilized 
tsl201 and tsl203 to determine that Vmw40 was transiently 
associated with empty capsids and Vmw40 removal was coupled 
with packaging of viral DNA into capsids. Two distinct DNA- 
protein complexes have been found in infected cell nuclei 
that consisted of HSV specific proteins bound to probes 
containing components of the a sequence (Chou and Roizman,
1989). Interestingly, one complex contained the virally 
encoded DNase and the other complex consisted of equimolar 
concentrations of a structural protein (UL3 6) and an
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unidentified 140kd polypeptide (Chou and Roizman, 1989). 
Recent characterization of an alkaline exonuclease null 
mutant also suggested that this protein was involved in the 
processing of viral DNA into capsids. The mutant was 
competent for growth and DNA synthesis on normal cells, 
although efficient production of infectious virus particles 
required a wt nuclease activity supplied in a transformed 
cell line (Weller et al., 1990). The protein product of 
gene Ul37 has been identified as a y^ non-structural, single 
stranded DNA binding protein containing a potential ATP- 
binding domain in the amino acid sequence, that has been 
postulated to function at late times during DNA replication 
in the cleavage/packaging process (Shelton et al., 1990).
1-3. Latent Infection.
Latency is central to the natural history of HSV- 
associated disease. Latent infections occur between 
episodes of acute disease and involves the persistence of 
the viral genome in specific tissues without evidence of 
replication or clinical disease whilst retaining the 
capacity to reactivate and yield infectious progeny.
Although many questions remain unanswered, the 2 0 years 
following the report by Stevens and Cook (1971) has seen the 
knowledge of HSV latency expand. This section aims to 
highlight important aspects of HSV latency research, 
beginning with the development of animal models and tissue 
culture latency systems that, in combination, continue to be 
vital for studies on HSV latency. The role of viral gene 
expression during the stages of latency, and the state of 
the latent DNA will be discussed in detail. The involvement 
of host determined factors in establishment, maintenance and 
reactivation of HSV latency will also be considered.
1.3.1. Models Employed in the Study of HSV Latency.
1.3.1.1. Animal Models of HSV Latent Infection.
Several animal model systems have been developed for 
the study of HSV latency in vivo. The most commo nly used
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laboratory animals include mice, rabbits and guinea pigs.
The favoured route of inoculation is at a peripheral site 
such as the eye (Knotts et_al. , 1973; Walz et al., 1974; 
Nesburn et al., 1977;), lip (Walz et al., 1974; Sekizawa et 
al., 1980), ear pinna (Hill et al., 1975), footpad (Stevens 
and Cook, 1971, 1973a,b; Scriba, 1975; Scriba and Tatzber, 
1981) and vagina (Scriba, 1976; Stanberry et al., 1985).
Some models utilized alternative routes of inoculation 
including intraperitoneal (Richards et al., 1981), 
intracerebral (Hill et al., 1975; Watson et al., 1980) and 
haemotogenous (Cook and Stevens, 1976). Following 
peripheral inoculation in experimental animals the virus 
moves centripetally to the sensory nerves and corresponding 
ganglia and then to the CNS.
The first animal system described in which latency was 
established in a predictable site was the mouse footpad 
model (Stevens and Cook, 1971,1973a,b; Walz et al., 1974). 
Infection of the rear footpad with HSV-1 or HSV-2 resulted 
in a local cutaneous infection that was followed by an acute 
infection of the sciatic nerve, sacrosciatic spinal ganglia, 
dorsal roots and brain. During the productive infection, 
infectious virus could be readily isolated from each of the 
above listed tissues. Virus could be isolated from the 
spinal ganglia after 48hr, titres peaked by day 4 and 
declined thereafter to undetectable levels by day 7.
Animals that recovered from acute phase infection and 
posterior paralysis within 3 weeks harboured latent virus in 
the ipsilateral spinal ganglia. Latent virus could be 
rescued up to 3 months later by cocultivation on rabbit skin 
(RS) cells but not by direct assay of homogenized tissue 
(Stevens and Cook, 1971).
A latent infection can be established in the cervical 
dorsal root ganglia subsequent to intradermal inoculation of 
the mouse ear pinna (Hill et al., 1975). Erythema developed 
within 2-5 days post inoculaton and was cleared by day 21, 
although episodes of erythema recurred sporadically over a 
period of several months. A variety of stimuli such as UV 
irradiation and stripping of the ear with cellophane tape, 
increased the frequency of recurrent herpetic disease (Hill 
et al., 1978; Harbour et al., 1983). The reproducibility of
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the model described by Hill and co-workers is dependent on 
mouse strain. In general, the incidence of virus isolated 
from the site of infection following stripping is greater in 
outbred strains compared to inbred strains exemplified by 
BALB/c (Harbour et al., 1981). The mouse ear model has been 
valuble in the study of factors that influence recurrent 
disease.
Intraocular inoculation and scarification of the mouse 
cornea induced an acute ocular infection followed by the 
establishment of a latent infection in the trigeminal 
ganglia (Knotts et al., 1974; Walz et al., 1974).
Spontaneous shedding of virus in eye secretions occurred 
rarely in mice recovered from the primary infecton (Tullo et 
al., 1982). However, a recent report described the 
development of a model in which virus shedding and recurrent 
herpetic disease occurred in the mouse eye (Shimeld et al., 
1990b). Recurrent eye disease was only observed in mice 
with eyes that remained undamaged after the initial 
infection and virus shedding was efficiently induced by a 
combination of UV light and immunosuppressive drugs (Shimeld 
et al., 1990b). To date the mouse eye model has been useful 
for the study of viral factors involved in latency. The 
model described by Shimeld et al. (1990b) should prove 
useful in the study of recurrent herpetic keratitis.
Reactivation of HSV to produce an acute infection can 
be induced in latently infected mice by neurectomy (Walz et 
al., 1974; Price and Schmitz, 1978), application of 
chemicals to the skin (Hill et al., 1978; Harbour et al., 
1983; Hill et al., 1983b), physical stimuli like UV 
irradiation (Blyth et al., 1976; Harbour et al., 1983), or 
stripping the ear with cellophane tape (Hill et al., 1978; 
Blyth et al., 1980a; Harbour et al., 1981, 1983) and by 
intratracheal injection of pneumonococci or mucin (Stevens 
et al., 1975).
The rabbit eye model has been used for the study of 
recurrent disease (Stevens et al., 1972; Knotts et al.,
1973; Nesburn et al., 1977). After corneal inoculation 
latency was established in the trigeminal ganglia. Ocular 
shedding post day 20 was considered to be spontaneous 
reactivation and occurred freguently (Berman and Hill,
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1985). Iontophoresis of 0.01% epinephrine at 0.8mA for 8min 
on 3 consecutive days induced ocular reactivation (Hill et 
al., 1985, 1986). The advantage of the rabbit eye model is 
the ability to study induced or naturally occurring 
reactivation events.
The guinea pig model for HSV infection shares many 
features with genital herpes infections in humans, including 
a natural route of inoculation, a self-limiting initial 
infection characterized by vesiculo-ulcerative lesions, and 
neurological and urological symptoms (Stanberry, 1986). 
Intravaginal infection of guinea pigs with HSV-2 caused 
inflammation of the external genital tract and extensive 
formation of local lesions resembling primary genital herpes 
in humans (Scriba, 1976; Stanberry, 1985). A latent 
infection ensued in the lumbrosacral dorsal root ganglia 
with frequently occurring mild lesions (Scriba, 1976; Scriba 
and Tatzber, 1981; Stanberry et al., 1985). The frequency 
and duration of recurrent episodes declined significantly 
with time (Scriba, 1976; Stanberry et al., 1985).
The drawbacks of animal models for studying HSV latency 
are their complexity and expensiveness, and that none 
exactly mimic the human situation in all respects.
1.3.1.2. Tissue Culture Latency Sytems.
Tissue culture, or in vitro, latency sytems inherently 
lack the complexities of whole animal model systems; 
specifically serum antibody, cell mediated immunity, 
hormones and interferon (IFN), which are known to modulate 
virus replication, are not present. Although this can be 
levied as a criticism of tissue culture latency systems, it 
is these same characteristics that make such systems an 
attractive option for studying HSV latency, enabling the 
investigator to ask simple biochemical questions with 
reproducible results. It has been proposed that the ideal 
in vitro latency system should possess the following 
features: i) a host cell derived from neuronal tissue, ii) 
subsistence of infected cells, iii) persistence of the 
entire viral genome without production of infectious virus 
particles and iv) maintenance of the viral genome in a state
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that can be stimulated to produce infectious progeny (Levine 
et_al., 1980). Additionally, in the light of recent 
developments, it should also be required that the latent 
genome is "endless" and viral gene expression be restricted 
to the production of LAT during the latent phase of 
infection. In reality no in vitro latency system that 
fulfils all these criteria has yet been described.
Several cell systems have been utilized where a 
persistent or latent HSV infection has been achieved due to 
the intrinsic properties of the cell type or by artificial 
manipulation of the environmental conditions surrounding the 
cell. In vitro latency systems have employed transformed 
cells of neuronal origin (Lancz et al., 1976; Vahlne and 
Lycke, 1977, 1978; Adler et al., 1978; Doller et al., 1979; 
Levine et al., 1980; Nilheden et al., 1985a,b), primary 
rodent neuronal cells (Zeigler and Herman, 1980; Wigdahl et 
al., 1983; Wilcox and Johnson, 1987,1988; Wilcox et al.,
1990), primary human neurones in culture (Wigdahl et al., 
1984b) and cells of non-neuronal origin (O'Neill et al., 
1972; O'Neill, 1977; Colberg-Poley et al., 1979a,b; Wigdahl 
et al., 1981,1982b; Nishiyama and Rapp, 1981; Youssoufian et 
al., 1982).
The replication of HSV-1 strain KOS has been shown to 
be inhibited in chemically transformed and differeniated 
cells derived from rat neuronal tissue (Adler et al., 1978; 
Levine et al., 1980). Reduced growth of HSV-1 (KOS) on this 
cell line is dependent on multiplicity and temperature of 
infection. At 39°C and low multiplicity, virus DNA 
synthesis was blocked although synthesis of some viral 
macromolecules occurred, specifically DNA polymerase, 
thymidine kinase and some structural proteins (Adler et al., 
1978). The production of virus could not be stimulated by 
temperature reduction to 37°C or 34°C or by treatment of 
neuroma cultures with UV light (Adler et al., 1978; Levine 
et al., 1980).
The growth of HSV on a mouse neuroblastoma cell line, 
clone C1300, was restricted compared to other murine cell 
types (Vahlne and Lycke, 1977,1978). Kemp and Latchman 
(1989) have recently shown that this effect was due to the 
failure of IE gene expression. Sodium butyrate pretreatment
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of C1300 cells reversed HSV restriction by increasing 
production of IE polypeptides and IE mRNA species (Ash,
1986; Kemp and Latchman, 1989). At very low moi a 
persistently infected culture was produced that rarely 
released infectious virus particles (Vahlne and Lycke,
1977) . The production of virus progeny required that each 
C1300 cell be infected with greater than one virus particle 
(Vahlne et al., 1981). Hyperresistant derivatives of the 
C1300 cell line (RII cells) have been generated by 
successive exposure of survivors of HSV infection to 
increasing virus dose (Nilheden et al., 1985a). A non­
replicating state could be established in a hyperresistant 
culture after infection with 0.1 pfu/cell HSV-1 and 
incubation of the monolayer in the presence of neutralizing 
antibody for two passages. Thereafter, in the absence of 
antibody, superinfection of RII cells with HSV-2 resulted in 
the production of HSV-1. The amount of quiescent HSV-1 
recovered in this manner decreased with increasing passage 
number, which suggested that the HSV genomes did not 
replicate concomittantly with the cellular DNA (Vahlne et 
al., 1985b).
Wilcox and Johnson (1987) have described an important 
in vitro latency system that is based upon the cultivation 
of primary sympathetic neurones isolated from the cervical 
ganglia of neonatal rats. Treatment of these cultures with 
20/xM fluorodeoxyuridine ensured that approximately 95% of 
cells were neuronal, the remainder being schwann and 
fibroblast cells. Infection of cells with 0.5 pfu/cell of 
HSV-1 strain F followed by the addition of 2% anti-HSV human 
serum enabled the virus to coexist in the host cell for up 
to 5 weeks without obvious cytotoxicity and detectable viral 
antigen expression. The efficiency of this system was 
increased by incubaton of latently infected cultures in the 
presence of 50/zM acyclovir (ACV) (Wilcox and Johnson, 1988) . 
Supplementation of the culture media with guinea pig anti­
mouse nerve growth factor (NGF) antibodies induced the 
production of virus progeny in a maximum of 53% of 
monolayers depending on the initial moi, which implied that 
maintenance of a stable latent infection in this system 
required NGF (Wilcox and Johnson, 1987,1989). Transient
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fluctuations in the concentration of NGF were sufficient to 
induce reactivation (Wilcox et al., 1990). Wilcox and co­
workers (1990) employed monoclonal antibodies directed 
against the NGF receptor to demonstrate that it is the 
specific binding of NGF to its receptor that is crucial for 
the induction of reactivation. Like NGF deprivation, short 
term inhibition of protein synthesis stimulated reactivation 
of virus from rat sympathetic or sensory neurones. It was 
postulated that this occurred because the cycloheximide 
block prevented the synthesis of an unstable host factor 
that is an inhibitor of reactivation and controlled by NGF 
(Wilcox et al. , 1990) . The production of LAT as well as a 
more controversial latency-associated antigen (LAA) has been 
detected in this system (Doerig et al., 1990, abstracts of 
the 15th International Herpesvirus Workshop, Washington DC, 
USA) .
There is evidence to suggest that peripheral non­
neuronal sites may support a latent infecton in vivo, which 
adds credence to the use of more accessible non-neuronal 
cell types in the study of HSV latency in vitro (Scriba, 
1981; Hill et al., 1983a; Cook et al., 1983; Al-Saadi et 
al., 1988; Clements and Subak-Sharpe, 1988; Clements and 
Jamieson, 1989; Claoue et al., 1990).
The report by O'Neill et al. (1972) set a precedent for 
the use of chemical manipulation of cultured cells to 
establish a latent infection and consequently was emulated 
and developed further (Rapp, 1984). O'Neill et al. (1972)
described a system in which a HSV-2 lytic infection was 
obviated by pretreatment of human embryonic lung (HEL) cells 
with an inhibitor of viral and cellular DNA synthesis. By 4 
days post inoculation infectious virus was undetectable and 
remained so for at least 5-6 days after arabinofuranosyl 
cytosine (Ara-C) withdrawal. The time between the 
disappearance of infectious virus and its reappearance 
defined the latent period. During this period O'Neill et 
al. (1972) determined that the proportion of infectious 
centres in HSV-2 latently infected HEL cells was very low.
On average only 1 in 4000 cells retained the capacity to 
produce infectious particles. Prolonged treatment of 
latently infected cultures with Ara-C did not ultimately
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prevent the subsequent development of cytopathic effect 
(cpe) after removal of Ara-C. Temperature elevation from 
37°C to 39.5°C-40°C immediately after removal of Ara-C was 
employed as a modification to extend the period of latency 
up to 128 days in HEL cells (O'Neill, 1977). Reactivation 
of latent HSV-2 could be stimulated by temperature downshift 
to 37°C (O'Neill, 1977; Colberg-Poley et al., 1979a,b) or by 
superinfection with either wt HCMV (Colberg-Poley et al., 
1979b) or by superinfection with HCMV ts mutants 
representing four different complementation groups unable to 
synthesise DNA at the NPT (Colberg-Poley et al., 1981). 
Scheck et al. (1987) , using HSV-1 ts mutants blocked at 
various stages in the virus lytic cycle, demonstrated that a 
(E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU) sensitive viral 
gene product(s) expressed by the superinfecting virus genome 
was required for induction of reactivation.
In analogy with the HSV-2 system described above, 
Wigdahl et al. (1981) reported an in vitro model reliant 
upon Ara-C and increased incubation temperature to establish 
a latent HSV-1 infection. Superinfection of latently 
infected HEL cultures with HCMV or HSV-2 ts mutants 
activated virus replication which was characterized as 
parental input HSV-1 by plaque reduction assay in the 
presence of BVDU, restriction endonuclease digest analysis 
of EcoRI, Hindlll, and Xbal cleavage patterns and titration 
at the NPT and permissive temperature (Wigdahl et al. , 1981, 
1982a). Wigdahl et al. (1982b) successfully increased the 
sensitivity of the existing system by treatment of cells 
with a combination of the antiviral compounds BVDU and human 
leukocyte interferon (IFN-a) prior to infection with HSV-1. 
In this manner, infection with 2.5 pfu/cell HSV-1 resulted 
in a significant increase in the number of infectious 
centres. Approximately 1 in 100 BVDU and IFN-a treated HEL 
cells harboured a virus genome that could be activated in 
the normal way. Scheck et al. (1986) determined that 
establishment of latency was not due to intrinsic properties 
of BVDU because another nucleoside analogue, ACV, also 
facilitated the establishment of latency after a high 
multiplicity infection.
It has been shown that during the processes of latency
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changes in cellular ultrastructure and viral gene expression 
occur (Hung et al., 1984). During establishment of latency 
enveloped HSV-like particles were visible by electron 
microscopy and polyadenylated (polyA+) virus-specific mRNA 
was readily detectable. However, following inhibitor 
removal neither viral mRNA or virus morphological structures 
were apparent. Superinfection of latently infected HEL 
monolayers with HCMV induced the synthesis of IE gene 
products and the development of normal nucleocapsids 
prece ded by proliferation of rough endoplasmic reticulum, 
polysomes and golgi vesicles.
Primary rat and human neurones have also been utilized 
to establish a high multiplicity latent infection with HSV-1 
upon combined inhibitor treatment followed by increased 
temperature (Wigdahl et al. , 1983,1984b). A repressed HSV 
infection in HEL cells has also been induced with 
phosphonoacetic acid, cycloheximide and by use of an UV 
irradiated virus (Colberg-Poley et al., 1979a; Nishiyama and 
Rapp, 1981; Shiraki and Rapp, 1986). The synthesis of viral 
proteins in the HEL latency system in which latency is 
established in the presence of cycloheximide was apparently 
confined to the major DNA-binding protein and VmwllO during 
the maintenance phase (Shiraki and Rapp, 1989).
Youssoufian et al. (1982) described a persisjently 
infected T-cell line, CEM, in which viral gene expression 
could be modulated by mitogen treatment. Under normal 
circumstances the lymphoblastoid cells contained multiple 
copies of the HSV-1 genome and were productively infected. 
However, two natural non-productive states occurred in which 
each cell contained 1-2 copies of the virus genome.
Treatment with c6^ c.a.Aa.i/n4w\ A resulted in a stable latent 
state that could be reversed by phytohaemagglutinin 
treatment. During stages of non-production, infectious 
virus and viral antigens were undetectable.
HSV has been isolated from the ocular tissues of man 
and experimental animals (Shimeld et al., 1982; Tullo et 
al., 1985; Cook et al., 1987). Three separate cultures were 
isolated from rabbit corneas and used to establish an in 
vitro model for HSV-1 latency (Cook and Brown, 1986, 1987). 
Rabbit cornea epithelium, keratocyte and endothelium cells
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were distinguished on the basis of morphology and indirectly 
by cell specific markers (Cook and Brown, 1986). All three 
cell types were capable of supporting a lytic infection, but 
under non-permissive conditions of temperature elevation, 
41.5°C, and infection at very low multiplicity, a latent 
state could be maintained in these cell cultures (Cook and 
Brown, 1987). Spontaneous reactivation occurred by 
downshift to 37°C or was triggered by superinf ection of the 
monolayers with a HSV-1 Xbal mutant (Cook and Brown, 1986,
1987) . Treatment of infected cultures with ACV, which 
eliminates persistent infections, indicated that the host­
cell interaction observed appeared to be latency rather than 
persistence (Cook and Brown, 1987).
Russell and Preston (1986) described an in vitro 
latency system for HSV-2 based on work originating from Rapp 
and colleagues. However, this system differed in two 
important aspects: i) latency was established at low moi in 
HFL cells at the supraoptimal temperatue of 42°C without the 
use of inhibitors of virus growth, and ii) a stable latent 
state was maintained at the temperature permissive for virus 
growth (37°C). Wrzos and Rapp (1987) later adopted a 
similar approach, but relied upon the use of DNA-negative ts 
mutants of HSV-1 to establish a latent infection in HEL 
cells at the NPT (40.5°C) without the use of antiviral 
agents. Routinely, parental input HSV-2 was reactivated by 
intertypic superinfection of latently infected HFL cells at 
the NPT (38.5°C) with ts mutants or with HCMV (Russell and 
Preston, 1986), notable exceptions to this being adenovirus 
type 5 (Ad5) and the HSV-1 deletion mutant dll403 (Russell 
et al., 1987). This system has been extensively 
characterized (Russell, 1989) and, importantly, it has been 
shown that the latent HSV-2 genome is predominately non­
linear (Preston and Russell, 1991) which compares with 
observed phenomena in vivo (Section 1.3.3.2.3.) . Thus, 
despite similarities with the system described by Wigdahl et 
al. (1981,1982b) the differences are fundamental because in 
contrast the latent genome in this system is non-integrated 
and linear (Wigdahl et al., 1984b; Scheck et al., 1986).
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The in vitro latency system described by Russell and 
Preston (1986) forms the basis of the experimental work 
presented in this thesis.
1.3.2. Establishment of Latency.
1.3.2.1. Site of HSV Latency.
Although the nature of viruses was not known, a 
consideration of earlier experimental and clinical findings 
led Goodpasture (1929) to postulate that latent HSV-1 
infections were established specifically within nervous 
tissues, including the trigeminal ganglia, since these were 
known to supply sensory enervation to the ophthalmic and 
orofacial areas in which herpetic lesions were observed to 
recur.
In subsequent years suggestive evidence supporting this 
hypothesis was gathered culminating with the direct 
demonstration of latency in sensory ganglia (Stevens and 
Cook, 1971) . Virus could not be detected in cell free 
homogenates of nervous tissue but by means of explantation 
and in vitro cocultivation chronic latent infections were 
demonstrated in the spinal ganglia of mice (Stevens and 
Cook, 1971) and the trigeminal ganglia of rabbits (Stevens 
et al., 1972). Additional supportive evidence was generated 
by other workers (Knotts et al
., 1973; Baringer and Swoveland, 1974; Scriba, 1975,1976). 
Subsequently, Cook and Stevens (1973) demonstrated that 
following inoculation of virus on the skin, HSV travelled 
via subserving nerves to the corresponding sensory ganglia. 
Furthermore, it appeared that latency could be established 
in any murine sensory nerve ganglia depending on the route 
of inoculation (Walz et al. , 1974) as well as ganglia of the 
autonomic nervous system (Price et al., 1975a).
By in vitro cultivation of human trigeminal ganglia 
obtained at post mortem it was possible to recover HSV 
(Bastian et_al., 1972; Plummer, 1973; Baringer and 
Swoveland, 1973; Rodda et al. , 1973). HSV-1 has been 
isolated from human superior cervical ganglia and vagus 
ganglia, indicating that, as in experimental mice, virus was
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present in the autonomic and somatic ganglia of the natural 
host (Warren et al., 1978). HSV-2, which infects genital 
regions, has been shown to reside latently in human sacral 
ganglia (Baringer, 1974).
HSV has also been detected in the CNS of experimental 
animals by explantation of brain or spinal cord tissue 
(Plummer, 1973; Knotts et al., 1973; Cook and Stevens, 1976; 
Cabrera et al., 1980). Cabrera et al. (1980) showed that
95% of trigeminal ganglia of latently infected mice 
contained virus that could be recovered by explantation. In 
comparison, only 5% of brain hemisphere explants were shown 
to harbour latent virus. However, HSV specific DNA 
sequences could be detected by liquid hybridization in 30% 
of the brains of mice that had latent HSV in the trigeminal 
ganglia implying that explantation provided an underestimate 
of the amount of latent virus in the CNS, presumably because 
of differences between the CNS and peripheral nervous system 
(PNS) and the ability of virus to reactivate in these 
tissues. Other workers have detected latent HSV DNA 
sequences in the CNS of mice (Puga et al. , 1978; Rock and 
Fraser, 1983; Stroop et al. , 1984) and humans (Sequiera et 
al. , 1979; Fraser et al., 1981).
1.3.2.2. Identification of Latently Infected Cells within 
the Nervous System.
During an acute HSV infection schwann, satellite and 
other support cells undergo an abortive infection (Dillard 
et al., 1972; Schwartz and Elizan, 1973; Cook and Stevens, 
1973; Knotts et al. , 1974). Limited data suggests that 
latent virus cannot be recovered from nerve roots, although 
virus particles pass through them to the ganglia after a 
peripheral infection, and nerve root tissues are capable of 
supporting a productive infection in culture (Baringer and 
Swoveland, 1973; Cook and Stevens, 1973). There is strong 
evidence, both direct and indirect, to suggest that HSV 
resides in neurones during latency. A report by Cook et al. 
(1974) implicating neuronal latency was described in which 
viral DNA in explanted ganglia was detected by in situ 
hybridization using a complementary RNA probe. In the same
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study, synthesis of viral DNA, antigens and particles in 
reactivating ganglia occurred in the neurone before 
detectable spread to surrounding support cells. Similarly, 
Kennedy et al. (1983) showed that HSV antigen expression was 
first observed 3 days after dissociation of latently 
infected dorsal root ganglia in neurones and spread later to 
fibroblast and schwann cells. Reactivation of a ts mutant 
stimulated under non-permissive conditions (to prevent the 
development of secondary foci of infection) by explantation 
in vitro and neurosurgery in vivo permitted the unambigous 
identification of the neuronal body cell as the site for 
harbouring latent virus (McLennan and Darby, 1980).
Recently, viral gene expression in sensory ganglia during 
the latent phase of infection has been the object of intense 
study (Section 1.3.5.4). This followed the initial 
observation by Stroop et al. (1984) in which latency 
specific mRNA detected by in situ hybridization was shown to 
be confined to the neuronal nucleus.
1.3.2.3. Extraneural Sites of HSV Latency.
There is a mounting body of evidence indicating that in 
a variety of experimental systems latent virus may be 
harboured in cell types other than neurones. In guinea pigs 
both HSV-1 and HSV-2 have been recovered from the primary 
sites of infection (Scriba, 1976,1977; Walz et al., 1977; 
Donnenberg et al., 1980). Scriba (1981) reported that HSV 
was isolated frequently from inoculated footpad (94%) and 
vaginal (30%) explanted tissues. However, treatment of 
explanted peripheral tissues with phosphonacetic acid 
inhibited the recovery of virus, implying that the phenomena 
observed by Scriba (1976,1977,1981) were a consequence of a 
low level productive infection. HSV-1 was recovered from 8% 
of explants of ear skin taken from latently infected mice in 
the absence of clinical lesions (Hill et al. , 1980). In 
addition, the prolonged persistence of HSV-1 and HSV-2 was 
demonstrated in mouse footpads following inoculation at that 
site (Al-Saadi et_al., 1983; Subak-Sharpe et al., 1984; 
Clements and Subak-Sharpe, 1988; Al-Saadi et al. , 1988).
ACV chemotherapy provides a means of distinguishing a
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persistent HSV infection from a latent infection which is 
not sensitive to treatment with this drug (Fields et al., 
1979; Blyth et al., 1980a; Klein et al., 1981). Extended 
treatment of mice latently infected with ACV administered in 
drinking water or combined with intraperitoneal injection 
did not prevent the recovery of HSV from footpad or ocular 
tissue following explant and culture (Clements and Subak- 
Sharpe, 1988; Al-Saadi et al., 1988; Claoue et al., 1990). 
This suggested that the virus isolated was not derived from 
a chronic low grade infection but was due to a latent 
infection. Furthermore, since nucleated neuronal cell 
bodies are absent from the footpad, then by extrapolation 
the site of latency must be non-neuronal cells. Latency in 
extraneural tissues was established independently of sensory 
ganglia (Scriba, 1981; Al-Saadi et al., 1988; Hill et al. , 
1983a; Clements and Subak-Sharpe, 1988) . Interest has 
arisen in the type of peripheral cell that could serve as a 
reservoir of latent virus. Potential candidates in guinea 
pigs may be vaginal, uterine and cervical epithelial cells, 
cervical and uterine glandular epithilium and myometrium 
(Scriba, 1981), although these cell types are probably sites 
of persistent and not latent infections. Cook and Brown 
(1987) presented data for the ability of HSV-1 to establish 
a latent infection in vitro in epithelial, endothelial and 
keratocytes derived from rabbit cornea. Clements and 
Jamieson (1989) demonstrated directly by in situ 
hybridization the cell types in the mouse footpad from which 
reactivation occurred. HSV specific RNA was detected in the 
basal and root sheath cells of hair follicles, epithelial 
cells of sebaceous glands and epidermis cells (Clements and 
Jamieson, 1989). The relevance of extraneural sites for 
latency in recurrent human disease is not clear. Cultures 
of skin explants from sites in humans at which recurrences 
had been observed did not yield virus (Rustigan et al. ,
1966). However, recurrent herpetic lesions have been 
observed in patients with accidently denervated areas of 
skin (Hoyt and Billson, 1976). Also, HSV has been isolated 
from human corneas removed during routine corneal 
transplantation as therapy for chronic stromal keratitis 
(Shimeld et al., 1982; Tullo et al., 1985).
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1.3.2.4. Axonal Transport.
A number of theories have been considered with regard 
to the mode by which HSV travels from peripheral sites of 
inoculation to the sensory ganglia, the CNS and within the 
CNS (Wildy et_al., 1982; Price, 1986). There is 
overwhelming evidence for transport within axons as the most 
important route by which virus spreads. Other routes, such 
as travel by replication in support cells, may have a 
secondary role. The time interval between initial infection 
of the mouse footpad and arrival of the virus has been 
measured (Cook and Stevens, 1973). The translocation rate 
was estimated to be between 2 0-24hr, consistent with the 
rapid movement of macromolecules and organelles by 
retrograde transport and apparently incompatible with 
repeated cycles of peripheral replication. Interruption of 
axonal flow by nerve section or treatment with inhibitors of 
axonal transport eg. colchicine, blocks viral passage to the 
ganglion (Wildy, 1967; Kristensson et al., 1971). Virion 
particles contained within vesicles have been observed in 
the axoplasm of peripheral nerves by direct electron 
microscopic examination (Hill et al., 1972; Cook and 
Stevens, 1973; Baringer and Swoveland, 1974). In cultured 
rat dorsal root ganglia enveloped virions have been 
visualized attached to the neurites prior to internalization 
of nucleocapsids which presumably resulted from viral and 
cellular membrane fusion (Lycke et al., 1984).
1.3.2.5. Host Factors Involved in Establishment of Latency.
Host responses are important in the pathogenesis of 
herpetic disease. Some neuronal cells may be non-permissive 
for HSV replication (Levine et al. , 1980) . However, if the 
host is too restrictive the initial acute infection would 
not occur or recurrence would be aborted. Conversely, if 
the host fails to restrict viral replication then the period 
during which virus could spread would be abbreviated. It 
has been shown that reinoculation of a peripheral site does 
not permit colonization by a second virus (Klein et al.,
1977, 1978; Gerdes and Smith, 1983) which suggested that
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local factors produced in response to the initial infection 
may have prevented a second latent infection. In apparent 
agreement with these conclusions, analyses of viruses 
recovered from human ganglia at post mortem with restriction 
enzymes indicated that a single virus could be recovered 
from a colonized ganglion (Lonsdale et al., 1979). However, 
other studies have produced conflicting results (Brown et 
al., 1979; Lewis et al., 1984; Thomas et al., 1985).
Indeed, Meignier et al. (1983) demonstrated that more than 
one HSV strain could reside in a latent form in the same 
murine trigeminal ganglion. The course of HSV infections 
can be modified by host strain, age, dose and route of 
infection. Increased host resistance favours a latent 
infection rather than a productive infection (Price et al.,
1979). Likewise, the integrity of post ganglionic axons 
influences the outcome of a herpesvirus infection.
Neurectomy performed after the virus arrived at the 
superiorcervical ganglion induced acute phase viral 
replication (Price et al., 1979). Altered neuronal
permissiveness can also be induced in the presence of HSV
neutralizing antibody, facilitating the establishment of a 
persistent HSV infection in rat neurotumour cells in vitro 
(Poller et al., 1979).
Experimental evidence has suggested that latency may be 
established very early, within 24hr post infection (Steiner 
et al., 1990). This may reflect events under natural 
circumstances and therefore, at the molecular level the host 
immune system may never play a role in the establishment of 
latency. However, a body of evidence has accumulated
indicating that in animals a range of immune responses are
elicited during the primary infection that may restrict the 
spread of replicating virus. In non-immune mice extensive 
centrifugal spread of virus back to the eye (the site of 
inoculation) contributed significantly to the later 
development of severe ocular damage (Dyson et al., 1987). 
Tullo et al. (1982) reported that the severity of eye 
infection correlated with the frequency and site of latency, 
as the severity of acute infection increased the likelihood 
of latency in non-ophthalmic branches of the trigeminal 
ganglia increased. Passive immunization of immunocompetent
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mice inoculated at various sites with rabbit hyperimmune 
serum or human 7-globulin curtailed virus growth and 
dissemination within the peripheral site of infection and 
the nervous system and, although the incidence of latent 
infections was generally reduced, latency was not absolutely 
excluded (Openshaw et al., 1979; Kino et al., 1982; Shimeld 
et al., 1990a). In congenitally athymic mice, passive 
transfer of polyclonal or monoclonal anti-glycoprotein D 
serum reduced the amount of virus reaching the nervous 
system but elimination of the virus from the ear pinna of 
virus required cell mediated immunity (Kapoor et al., 1982). 
In a study of the effects of prior oral exposure to HSV-1 on 
the clinical response of animals following subsequent 
intravaginal inoculation with HSV-2, a reduced percentage of 
guinea pigs developed genital lesions, although 56% of 
animals (including some asymptomatic hosts) eventually 
developed recurrent symptoms (Bef^stein et al., 1989) . 
McKendall et al. (1977) suggested that in mice immune to 
HSV-1 a lower incidence of HSV-2 infection ensued after 
footpad challenge 3 weeks after the initial infection, in 
comparison to nonimmune controls. The number of animals 
harbouring latent virus in uterine tissue was reduced when 
challenged with the homologous serotype (Walz et al., 1977). 
Active immunization with live virus prevented CNS fatal 
involvement although latent superior cervical, lumbrosacral 
and trigeminal ganglionic infections still developed in the 
presence of high titres of neutralizing antibody (Price et 
al., 1975a,b). In summary, it is clearly more difficult to 
establish a latent infection and such latency is limited 
when previously infected, passively immunized or vaccinated 
animals are reinfected.
1.3.3. Maintenance of Latency.
1.3.3.1. Antibody-mediated Immunity and Physiology of the 
Neurone.
Stevens and Cook (1974) originally proposed that immune 
mechanisms were important for maintaining HSV latency. 
Latently infected murine spinal ganglia implanted in
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millipore chambers into the peritoneal cavity of a recipient 
animal, removed four days later and assayed for the presence 
of viral antigens were more likely to reactivate when 
implanted into non-immune animals (Stevens and Cook, 1974). 
Furthermore, the adoptive transfer of anti-herpes 
immunoglobulin G was as effective as whole rabbit anti-HSV 
serum in reducing the level of virus (Stevens and Cook,
1974). However, Sekizawa et al. (1980) reported that serum 
neutralizing antibody against HSV was unnecessary for the 
maintenance of latent HSV infections. In this report, mice 
were inoculated with HSV-1 by the lip or corneal route and 
passively immunized two days later by intraperitoneal 
injection of rabbit anti-HSV antibodies. Circulating 
neutralizing antibody declined to undetectable levels two 
months post infection and 90% of antibody negative mice 
harboured latent infections in the trigeminal ganglia. In 
support of the hypothesis that neutralizing antibody is 
unlikely to effect maintenance, it is known that in humans 
there is no correlation between observed levels of anti-HSV 
antibodies and the frequency of recurrent disease (Corey et 
al., 1980).
Although immune mechanisms could be involved in the 
control of maintenance, it is likely that the physiology of 
the neurone is a more important factor. The neurone is a 
terminally differentiated and highly specialized cell. Many 
biochemical functions in the neurone are repressed. The 
permissiveness of neuronal cells to HSV replication is 
variable and may be influenced by exogenous factors that 
alter the metabolism of ganglionic cells (Price and Schmitz, 
1978) . After the neonatal period cell division does not 
occur in individual neurones, although in cultured neurones 
in vitro repair synthesis of DNA has been detected (Sanes 
and Okun, 1972). In latently infected neurones viral DNA is 
treated like cellular nucleic acids and organized into 
chromatin (Deshmane and Fraser, 1989) which may facilitate 
the development of a long term stable relationship between 
the latent viral genome and the neurone.
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1 . 3 . 3 .2 . Organization of the Latent HSV Genome.
1.3.3.2.1. Dynamic versus static latency.
It has been hypothesised that during latency viral DNA 
could be maintained in cells in a non-replicating form in 
which virus multiplication is reversibly interrupted (static 
latency) or in a state that replicates at an undetectable, 
slow rate that is prevented from inducing a recurrent lesion 
by components of the host immune system (dynamic latency) 
(Roizman, 1966). The evidence collected to date does not 
permit an absolute discrimination between static or dynamic 
latency.
Baringer and Swoveland (1974) detected by electron 
microscopic examination of rabbit trigeminal ganglia 
sections the presence of rare morphologically abnormal 
neurones that contained viral nucleocaspsids. However, this 
low level of replication may represent spontaneous 
reactivation of active infection in a minority of latently 
infected neurones. Using organ culture techniques, Schwartz 
et al. (1978) reported the isolation of infectious virus 
from mouse ganglion homogenates.
In contrast, other workers have reported that 
infectious virus could not be recovered from latently 
infected ganglia when assayed directly (Stevens and Cook, 
1974), and that virus specific antigens or products could 
not be demonstrated by immunofluorescence or ultrastructural 
examination of latently infected ganglia (Stevens and Cook, 
1971) . Furthermore, it is known that DNA-negative ts 
mutants of HSV can establish latency (Lofgren et al., 1977; 
McLennan and Darby, 1980; Al-Saadi et al. , 19813) .
An alternative hypothesis, round-trip latency, suggests 
that a combination of static and dynamic latency occur. In 
this case, latency is predominantly static but episodes of 
reactivation occur that produce virus particles which are 
transported intra-axonally to the cell surface where 
following replication the virus infects adjacent nerve 
termini, thus inducing a latent infection in new neuronal 
cell bodies (Klein et al., 1976).
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Certain lines of evidence suggest that the dynamic and 
round-trip hypotheses are not operative: i) antiviral 
therapy using drugs like ACV, which act at the level of 
viral DNA replication, do not eliminate latent infections 
arguing against a dynamic maintenance of latent DNA (Field 
et_al., 1979; Blyth et al., 1980b; Field and de Clercq,
1981), ii) in some experimental systems reinfection of 
ganglia harbouring a latent infection with a second virus is 
an unusual event (Klein et al., 1977,1978; Gerdes and Smith, 
1983) and iii) in studies on the effect of antiviral 
treatment of recurrent human herpesvirus lesions, it has 
been reported that antiviral therapy eradicatedACV- 
resistant isolates but the variants were not detected in 
subsequent recurrences implying that the ACV-resistant 
isolates were unable to re-establish a latent infection 
(Parris and Harrington, 1982; Ellis et al., 1987) which, 
together with point ii), suggests that the round-trip 
mechanism for conservation of the latent genome is not 
tenable.
1.3.3.2.2. Determination of copy number.
Although it is accepted that the sensory neurone 
harbours latent HSV (Cook et al., 1974; McLennan and Darby, 
1980; Kennedy et al. , 1983) an accurate determination of the 
number of latent genomes per infected neurone has not been 
made. Quantitative blot hybridization studies have produced 
several estimates of the number of viral genomes in latently 
infected cells. Efstathiou et al. (1986) determined that in 
human trigeminal ganglia 0.01-0.1 HSV copies per cell genome 
equivalent were present, and 0.78 HSV copies per cell were 
found in mouse cervical ganglia. Latent HSV DNA has been 
detected in the CNS of mice, in total brain tissue at 
between 0.015-0.15 copies (Rock and Fraser, 1983) and at a 
mean concentration of 0.26 and 0.19 copies in brain stem and 
spinal cord tissue respectively (Efstathiou et al. , 1986).
In a tissue culture latency system in which latency was 
established in the presence of BVDU and IFN-a, latent HSV 
was retained in HEL cells or rat foetal neurones at 0.25-0.5 
or 8-10 copies per haploid cell genome equivalent
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respectively (Wigdahl et al., 1984b). Youssoufian et al. 
(1982) detected 1 copy of the latent HSV genome per cell 
equivalent in a T-cell line persistently infected HSV.
Liquid phase hybridization studies detected 1.2-2.0 and 0.11 
HSV copies per cell equivalent in acutely and latently 
infected murine trigeminal ganglia respectively (Puga et 
al., 1978).
Infectious centre assays have been used to evaluate the 
percentage of cells within murine dorsal root ganglia 
infected with HSV. It was estimated that during the acute 
phase of infection (6-8 days post inoculation) 1.0% of 
ganglion cells were infected, after which the percentage 
declined to approximately 0.1% and remained constant during 
a period considered to be the latent phase of infection (6 
weeks to 15 months post inoculation) (Walz et al. , 1976) .
Only 5-10% of cells that constitute a ganglion are 
neurones (Walz et al. , 1976) . The percentage of neurones 
that harbour latent infections has been estimated by the 
reactivation potential of HSV following dissociation of 
dorsal root ganglia. This method predicts that between 0.2- 
0.4% of neurones contain reactivatable virus (Walz et al., 
1976; Kennedy et al. , 1983). The true value is believed to 
be greater, indeed the percentage of neurones expressing LAT 
is approximately 3% (Rock et al., 1987a), suggesting that a 
portion of neurones harbouring latent infections cannot be 
induced to reactivate following explantation of ganglia, a 
situation that clearly occurs in the CNS of mice (Cabrera et 
al., 1980). Moreover, if reactivation is asynchronous, the 
0.2-0.4% value may be an underestimate since this pertains 
to a single time point.
1.3.3.2.3. Molecular biology of the latent HSV genome.
Information on the physical nature of the latent genome 
is crucial for a complete understanding of the molecular 
mechanisms involved in the virus-cell interactions that 
occur during latency. It has been postulated that HSV DNA 
during latency may be organized in one of a number of states 
that are illustrated in Figure 1.5. Analysis of the 
restriction endonuclease cleavage patterns of latent DNA and
Figure 1.5. SCHEMATIC REPRESENTATION OF THE POSSIBLE PHYSICAL 
ORGANIZATION OF THE LATENT HSV GENOME.
The genome of HSV-1 is a double-stranded DNA molecule that is 
unit length and linear (Roizman, 1979). The latent HSV-1 (F) 
genome lacks the terminal restriction fragments BamHl P and S, 
and contains a bimolar joint fragment BamHl PS generated by the 
fusion of BamHl P and S. Therefore, the latent HSV genome may 
be organized into a form that is circular, concatermeric, 
concatermeric and integrated, or unit length, linear and 
integrated via regions other than the termini (Rock and Fraser, 
1983,1985; Efstathiou et al. 1986). Current evidence suggests 
that latent HSV DNA is a circular episome (Mellerick and Fraser, 
1987) .
UNIT LENGTH :
1. Linear
ENDLESS :
2. Circular
3. Concatermeric
□  EZE M TZl  EZEM 3Z3---------- C ZX K I
4. Integrated, concatermeric 
V C Z 3 "■CZTM IEZ]------------ l~~nH Z E Z n-------- --  EZ E X Z Z V
5. Integrated, linear
v
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comparisons with parental virion DNA has been employed to 
determine which of the predicted structures reflects that 
found during latency. DNA molecules that lack terminal 
restriction fragments have been called "endless" and could 
be generated from the covalent linking of the termini to 
form a closed circle or multimer which may or may not 
integrate into the host genome, or linear and integrated 
into the cellular genome via regions other than the termini. 
Alternatively, the latent viral genome could persist in a 
unit length form similar to that found in virus particles.
Following reverse phase chromatography of digested 
mouse DNA, Puga et al. (1984) detected terminal fragments of 
uncharacteristic size implying that either rearrangements of 
the viral genome had occurred or that viral sequences had 
integrated randomly into the host genome at a limited number 
of sites. Alternatively, this result may reflect the 
purification of cellular sequences that hybridize to 
homologous regions in the HSV termini (Peden et al., 1982).
In some instances, viral DNA detected in the CNS of 
normal and neuropathological cadavers was found to contain 
apparently normal terminal restriction fragments (Fraser et 
al., 1981). This result resembled that obtained using an in 
vitro latency system, in which the predominant form of 
latent DNA isolated from HEL cells or rat foetal neurones 
retained the terminal fragments suggesting that the latent 
HSV-1 genome was non-integrated and linear (Wigdahl et al., 
1984a).
Rock and Fraser (1983) established a latent infection 
in mice with HSV-1 by corneal inoculation, and determined 
that the majority of viral genome was present during latency 
in the trigeminal ganglia and CNS. However, a fragment 
composed of the internal repeat sequences did not hybridize 
to HSV-1 terminal DNA fragments in samples of total mouse 
brain or pooled trigeminal ganglia, although HSV-1 junction 
fragments could be detected in these samples. This implied 
that, unlike previously described data, latent HSV DNA was 
maintained as an "endless" molecule that was qualitatively 
different from that found in mature virions. Efstathiou et 
al. (1986) confirmed that viral DNA in latently infected 
mouse tissue was "endless" and extended this analysis to the
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examination of unselected human trigeminal ganglia at post 
mortem. Importantly, latent viral DNA detected in the 
natural host contained sequences in a similar organization 
to that found in latently infected mice. Also, EcoRI 
digestion of latent DNA detected Ul and Us inversions which 
provided evidence for the existence of all four isomeric 
forms of viral DNA (Efstathiou et al., 1986).
In virion DNA the joint and unique sequences are 
present in a molar ratio of 1:1. A combination of specfic 
BamHl fragments has been used to compare the relative 
molarities of joint to unique sequences in DNA extracted 
from mouse brain tissue latently infected with HSV-1 strain 
F. The BamHl B fragment hybridizes to two unimolar 
fragments of the HSV-1 (F) genome, BamHl B and BamHl E, 
whilst BamHl PS hybridizes to the junction between the 
unique sequences IRl /IRs . Southern hybridization with BamHl 
B and PS, followed by densitometric analysis, indicated that 
in latently infected mouse brain tissue the joint region was 
over represented and present in a molar ratio that 
approximated to 2:1 relative to BamHl B or E (Rock and 
Fraser, 1985). Thus, the "endless" DNA noted by Rock and 
Fraser (1983) seemed to be generated by the joining of 
termini to form an additional fragment equivalent to the 
virion joint fragment either by concatermerization or 
circularization but not by integration via the termini.
Mellerick and Fraser (1987) subjected viral DNA to 
buoyant density gradient centrifugation which exploits the 
differences in G+C content of cellular and herpesvirus DNA. 
Latently infected mouse brain samples contained DNA with 
distinct viral and cellular peaks enabling the latent HSV 
DNA to be recovered independently without excessive 
shearing. A very small proportion of hybridizing DNA could 
not be separated from the chromosomal peak by repeated 
centrifugation and probably represented cross hybridization 
with cellular sequences. Thus, it was proposed that the 
majority of latent HSV-1 DNA was extrachromosomal and in a 
circular, compact form that resisted trapping (Mellerick and 
Fraser, 1987).
The degree of methylation of cytosine bases plays a 
major role in the control of gene expression (Doerfler et
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al., 1981). Several drugs are thought to promote 
hypomethylation of DNA in vitro. Experiments with 5- 
azacytidine and N,N'-hexamethylene bisacetamide (HMBA) have 
shown that incorporation of these agents into growth media 
at explantation increases the rate of recovery and the 
number of isolates from sensory ganglia of latently infected 
guinea pigs and mice (Bernstein and Kappes, 1988; Whitby et 
al., 1987; Stephanopoulos et al., 1988). This type of 
experiment has suggested a role for methylation in the 
maintenance of the latent state by down regulation of viral 
gene expression. Although 5-azacytidine and HMBA prevent 
methylation of DNA their mode action may be via other 
mechanisms (Kolalta, 1985; Sheffery et al. , 1982; Cohen and 
Sheffery, 1985; Ramsay et al., 1986). In an in vitro model 
for latency, a persistently infected human lymphoblastoid 
cell line was shown by the use of methylation sensitive 
restriction enzymes to be extensively methylated during non­
productive periods (Youssoufian et al., 1982). The 
examination of the methylation pattern of HSV-1 DNA in 
latently infected mouse brains revealed that a subset of the 
potential CG dinucleotides, including those present in the 
5 1 regulatory regions of known HSV genes, were not 
extensively methylated in vivo (Dressier et al., 1987).
Recently, Deshmane and Fraser (1989) have shown that 
latent samples contained HSV DNA that was sensitive to 
digestion with micrococcal nuclease which attacks the linker 
between nucleosome units generating an oligomeric ladder 
with a repeat of about 150bp. 80% of the the latent HSV-1 
DNA in mouse brain stem tissue was associated with 
nucleosomes, including the transcriptionally active region 
of the latent genome, in an arrangement that resembled 
chromatin (Deshmane and Fraser, 1989). Chromatin formation 
may be an important factor in the long term stability of the 
viral genome in the neuronal nucleus during maintenance of 
the latent state.
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1-3.4. Reactivation, Recurrence and Recrudescence of 
Clinical Disease.
Reactivation of virus in the nervous tissue can arise 
spontaneously as a consequence of external stimuli. 
Thereafter, the virus is transported to the periphery 
it initiates a lesion in the neurodermatome relating to a 
particular sensory ganglion (recrudescence) (Wildy et al.,
1982). Recrudescent disease does not automatically follow 
reactivation. Indeed, HSV-1 has been demonstrated in the 
skin of mice and guinea pigs without the development of 
clinical lesions (recurrence) (Scriba, 1977; Hill et al.,
1980). Reactivation presumably results in the production of 
infectious progeny for orthograde export to the periphery. 
Consequently, it is likely that virus induced and immune- 
mediated death of the neurone occurs. Each recurrence would 
be expected to result in neuronal loss. Perpetuation of the 
number of latently infected cells must rely either on an 
initial large resevoir of infected cells or a round-trip 
mechanism (Klein, 1976). Clinical observations in man 
suggest that denervation and parathesias appear to be 
insignificant, implying that reactivation must be a limited 
event in which virus metabolic toxicity is restricted.
1.3.4.1. Recrudescent Disease.
A wide variety of factors are able to induce recurrent 
herpetic eruptions in man and experimental animals. The 
most common are exposure to UV light, trauma, fever, 
hormonal changes, stress and immunosuppression (Wildy et 
al., 1982; Hill, 1985). Attempts have been made to develop 
animal models to examine the control of recurrence and 
recrudescence. One of the most detailed studies has been 
made by Hill and coworkers using mice (Hill et al., 1975, 
1978; Blyth et al., 1976,1984). The strain of mouse is 
critical to the success of inducing recurrence or 
recrudescence and outbred strains have been of most value 
(Harbour et al., 1981). Recently, Norval et al. (1987) have 
developed a reproducible murine model for recrudescent 
disease in which the host was genetically defined at the
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major histocompatibility locus, thereby facilitating the 
study of immunological parameters in recrudescence.
Early experiments demonstrated that UV irradiation of 
the originally infected ear produced recurrent HSV in the 
skin of 21% of mice (Blyth et al., 1976). Production of 
recurrent HSV disease could also be induced by mild trauma 
in the skin of latently infected mice (Hill et al., 1978; 
Harbour et al., 1981,1983). The effects of stripping the 
skin of the ear of a latently infected mouse include the 
development of erythema, formation of vesicles and 
appearance of virus in the skin 2-5 days later at the site 
of primary inoculation (Hill et al., 1978). Reactivation 
can be deliberately stimulated by the application of 
dimethyl sulphoxide (DMSO) at the site of infection (Harbour 
et al., 1983; Hill et al., 1983a). DMSO caused a low 
incidence of clinical disease (10%) but virus could be 
isolated from the skin of 28% of animals, a percentage 
equivalent to that produced by cellophane stripping of the 
ear (Harbour et al., 1983). In the same study, DMSO induced 
the greatest incidence of virus isolated from the ganglia of 
all the stimuli tested, which implied that DMSO was an 
efficient ganglion trigger.
The mechanism for reactivation is not clearly 
understood although various theories have been advanced, 
namely the ganglion trigger and skin trigger hypotheses.
The ganglion trigger theory states that latent viral genomes 
resident in sensory ganglia are reactivated by a stimulus to 
the ganglia. The virus proceeds to the epidermal cells via 
peripheral nerves and induces a skin lesion. However, 
clinical disease does not develop in every animal in which 
virus is reactivated and the ganglion trigger theory does 
not explain how skin stimuli affect ganglia (Blyth and Hill, 
1976; Hill et al., 1985). The skin trigger theory 
postulates that virus is shed frequently from the ganglia to 
form microfoci of infected epidermal cells which are usually 
eliminated by host defence mechanisms. These develop into 
clinically apparent lesions only if the presence of virus 
coincides with conditions in the skin that favour virus 
growth (Blyth and Hill, 1976; Hill, 1985). The skin trigger 
theory is supported by the observation that HSV could be
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isolated by organ culture of clinically normal tissue 
(Scriba, 1977; Hill et al., 1980). Hoyt and Billson (1976) 
reported that recurrent herpes simplex developed in patients 
with blow-out fractures that had severed the nerve supply to 
the area involved, such that lesions must have arisen from 
virus already present in the skin. Although the results 
described above are best explained by the skin trigger 
theory, latency in the cells of the skin cannot be excluded 
(Section 1.3.2.3.). It is probable that a combination of a 
ganglion trigger and a skin trigger are required for 
recurrence of disease.
Prostaglandins are potent mediators of inflammation in 
the skin and induce reactivation of latent virus when 
injected subcutaneously onto the site of previous infection 
(Blyth et al., 1976). It has been suggested that 
prostaglandins, particularly of the E series, may be 
candidates for mediating the skin trigger effects (Hill and 
Blyth, 1976; Blyth et al., 1976).
In experimental animals reactivation can be induced in 
response to specific stimuli, notably explantation of 
latently infected ganglia or other nervous tissues (Stevens 
and Cook, 1971). Homotypic superinfection of explanted 
human trigeminal ganglia resulted in the recovery of virus 
identical to the wt virus spontaneously released from other 
explanted ganglia of the same individual (Brown et al.,
1979; Lewis et al., 1984). Furthermore, superinfection of 
latently infected mice at the original site of inoculation 
with a heterotypic HSV strain in vivo stimulated the latent 
endogenous genome to reactivate (Thomas et al., 1985). 
Experiments with DNA hypomethylating or demethylating agents 
demonstrated that the recovery of latent HSV-2 and
^herpesvirus s<juuniri (HVS) could be enhanced by the 
presence of these chemicals in vitro (Whitby et al., 1987; 
Berstein and Kappes, 1988; Stephanopoulos et al., 1988; 
Mossman et al., 1989). Neurectomy has been shown to be a 
reproducible stimulus for HSV reactivation in humans (Carton 
and Kilbourne, 1952). Postganglionic nerve section induced 
reactivation of virus that could be detected by direct 
homogenization of murine sensory ganglia whereas sham- 
operated controls failed to yield virus (Walz et al., 1974;
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Price and Schmitz, 1978). However, an intact peripheral 
nerve supply is essential for the development of recurent 
herpes simplex lesions in humans and in mice (Carton and 
Kilbourne, 1952; Hill et al., 1983a).
1.3.4.2. Immune Control of Reactivation and Recurrent 
Infections.
The incidence of reactivation is increased by 
immunosuppression. Openshaw et al. (1979) induced 
reactivation of HSV in a maximum of 70% immunocompetent mice 
in which cell mediated immunity was suppressed by 
intraperitoneal administration of cyclophosphonamide and/or 
X-irradiation. Furthermore, reactivated virus was 
demonstrated in 10-20% of eye homogenates in the presence of 
high anti-HSV antibody titres, which implied that 
neutalizing antibody may not prevent reactivation but may 
restrict the extracellular spread of virus and hence the 
severity of recurrent disease (Openshaw et al., 1979).
Other workers, using corticosteroid treatment and anti­
thymocyte serum, did not report an increase in the 
recurrence rate in the mouse ear model (Blyth et al.,
1980a). Shillitoe et al. (1977) reported that cyclical 
changes in the specific cell mediated immune response to HSV 
correlated with recurrent herpetic lesions. In patients 
with recurrent herpes labialis it was observed that 
circulating lymphocytes that produced macrophage inhibition 
factor (MIF) were absent or present in reduced amounts and 
thus insufficient MIF may have predisposed an individual to 
recurrent disease (Shillitoe et al., 1977). Similar 
observations have been made in the guinea pig model for 
recrudescence (Donnenberg et al., 1980). The production of 
MIF correlated with delayed type hypersensitivity responses 
in vivo which implied that a defective T-cell function was 
responsible for reduced immune surveillence (Nash et al., 
1981). Alternatively, B suppressor cells which regulate the 
intensity of delayed type sensitivity reactions to HSV and 
are present during latency may diminish host immunity (Nash 
and Gell, 1980).
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1-3.5. The Role of Viral Gene Expression During Latency.
The availability of HSV mutants has permitted an 
analysis of the viral factors involved in latency. The 
rationale behind this approach is that if the virus fails to 
initiate a latent infection or cannot be rescued then the 
mutated gene has an implied role in either the 
establishment, maintenance or reactivation processes. The 
HSV genome has a large coding capacity and examination of 
HSV-1 deletion mutants has shown that many characterized 
viral genes are not essential for establishment, maintenance 
or reactivation of latency. These include the IE proteins 
Vmwl2 and Vmw68 (Meignier et al., 1988; Sears et al.,
1985b), glycoproteins D and E , and a viral protein kinase 
(Meignier et al., 1988). Also, the HSV-1 orir, is not 
required for latency (Polvino-Bodnar et al., 1987). The 
analysis of HSV mutants in relation to latency has been 
augmented by the use of indirect methods aimed at detecting 
viral gene products during the various stages of latency. 
Rather than consider these approaches separately the aim of 
this section is to draw together the available information 
to answer the following questions: i) does viral replication 
necessarily precede latency, ii) do incoming components of 
the virion participate in regulating initiation of latency, 
and iii) is expression of viral gene products required for 
initiation of latency or reactivation from the latent state.
The probability of a latent infection occurring 
increases after symptomatic HSV disease (Harbour et al.,
1981). However, full lytic infection in neuronal cells may 
require a commitment to cell death. Thus, in the nervous 
system replication of viral DNA could only be tolerated in a 
limited form. Numerous ifw.oU .^5 hA/e analyzed the behaviour 
of HSV-1 and HSV-2 ts mutants in experimental mice which 
conveniently have a core body temperature (38.5°C) that is 
non-permissive for virus growth. It has been noted that 
examples of HSV ts mutants that do not replicate DNA at the 
NPT still induce a latent infection in mice (Lofgren et al., 
1977; McLennan and Darby, 1980; Watson et al., 1980; Al- 
Saadi et al., 1983). The use of neutralizing anti-HSV 
antibodies to limit viral replication less clearly defined
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the necessity for DNA replication. Intravenous 
administration of rabbit hyperimmune anti-HSV serum pre or 
post inoculation did not prevent reactivation of virus in 
mice (Sekizawa et al., 1980). Independently, Walz et al. 
(1977) showed that substantial protection developed against 
a HSV-1 latent vaginouterine infection in passively 
immunized mice. Systemic or localized treatment of mice 
with ACV reduced or prevented the establishment of a latent 
infection in the sensory ganglia (Klein et al., 1979; Field 
et al.,1979; Field and de Clercq, 1981), although ACV 
treatment was not effective against a pre-existing latent 
infection (Field et al., 1979; Blyth et al., 1980b; Field 
and de Clercq, 1981). Thus, the use of the drug ACV to 
inhibit viral DNA synthesis suggested that (c
was a prerequisite for latency. However, ACV 
does not prevent the establisment of a latent infection in 
vitro (Wilcox and Johnson, 1988).
The product of the HSV-1 gene product Ul 48, Vmw65, is a 
major structural phosphoprotein located in the tegument 
(Heine et al., 1974; Marsden et al., 1978). Vmw65 is 
responsible for the sequence specific transinduction of IE 
gene expression in combination with other cellular 
transcription factors (Preston et al., 1988; O'Hare and 
Goding, 1988). The importance of Vmw65 activity in lytic 
infections has been demonstrated by the construction and 
characterization of a HSV-1 mutant in!814 which has a 12bp 
inframe insertion in Vmw65 such that the polypeptide is 
unable to form a complex with cellular proteins and 
therefore IE gene transcription is reduced (Ace et al.,
1989). In the mouse eye model for latency, inl814 
established a latent infection without detectable 
replication in the cornea or trigeminal ganglia, which 
implied that Vmw65, IE gene expression and viral replication 
were not essential for establishment or reactivation of 
latency in vivo (Steiner et al., 1990).
To date no HSV gene product has been identified that is 
required for establishM*^ of latency. Watson et al. (1980) 
characterized the latency phenotype of a number of HSV-1 ts 
mutants. Mutant tsl was described as latency-negative by 
the criteria of <15% recovery by explantation at 105 pfu
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infecting dose. However, subsequent studies revealed that 
this mutant had at least one further ts mutation which 
affected replication in mouse cells of neuronal origin and 
consequently affected the rescuent RI-1 (Cook et al., 1986). 
There is a growing body of evidence to suggest that very 
little or no viral gene expression is required for 
establishment of latency (Russell et al., 1987; Steiner et 
al. , 1990; Wilcox et al. , 1990, abstracts of the 1 5 ^  
International Herpesvirus Workshop, Washington DC, USA) . 
Furthermore, it has been hypothesised that suppression of IE 
promoters by a neuronal specific repressor may predispose a 
virus to latency (Kristie and Roizman, 1988; Kemp et al.,
1990).
The role of certain HSV gene products, notably Vmwl75, 
VmwllO, TK and LAT, in the establishment/reactivation of 
latency have attracted a great deal of individual attention. 
These are discussed below with respect to their proposed 
roles in the stages of latency.
1.3.5.1. Vmwl75.
On the basis of the latency-negative phenotype of tsK 
which has a ts mutation in the gene encoding Vmwl75, (Watson 
and Clements, 1978; Preston et al., 1979a,b) it was 
postulated that at least this IE gene product was essential 
for initiation or maintenance of the latent state in vivo 
(Watson et al., 1980). More recently, Leib et al. (1989b) 
described two non-replicating Vmwl75 mutants which were 
unable to reactivate in a conventional cocultivation assay. 
In contrast, the mutants tsK and inl411 (which also does not 
synthesis<-Vmwl75) were not defective for establishment, 
maintenance or reactivation in a tissue culture latency 
system (Russell et al., 1987). It is likely that the 
observed differences in the requirement for Vmwl75 between 
animal and in vitro latency systems is due to complex 
interactions with the host. For example, replication and 
survival at the site of inoculation and transport to the 
ganglia are processes absent in vitro and therefore the 
requirement for Vmwl75 may be obviated. Green et al. (1981) 
reported the detection of Vmwl75, in the absence of late
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proteins by indirect immunofluorescence in 95% of rabbits 
harbouring latent HSV-1. However, it was not clear if the 
Vmwl75 detected was a residual from the initial acute 
infection or if it was actively synthesised during latent 
infections of rabbit trigeminal ganglia. It remains possible 
that the presence of this polypeptide may be a reflection of 
spontaneous reactivation which is not uncommon in the rabbit 
model for latency. Indeed, an independent study using a 
different methodology, the avidin-biotin complex assay, did 
not detect Vmwl75 in the trigeminal ganglia of mice (Pepose 
et al., 1986).
1.3.5.2. VmwllO.
The deletion mutants dlx0.7, dlx3.1 and dll403 have 
been used to examine the importance of the IE polypeptide 
VmwllO in latent infections. In the mouse eye model for 
latency mutants dlxO.7 and dlx3 .1 were unable to 
spontaneously reactivate upon explantation of latently 
infected trigeminal ganglia. The inability of dlx3.1 to 
reactivate, but not dlx0.7, was circumvented by inclusion of 
200mM DMSO in the explantation growth media or by 
superinfection of explanted ganglia with a replication 
defective virus (Leib et al., 1989b). Mutant dll403 
exhibited reduced virulence but retained the ability to 
establish a latent infection in the sensory ganglia of mice 
following corneal or footpad inoculation (Clements and Stow, 
1989; Leib et al., 1989b). Although Leib et al. (1989b) 
reported that the reactivation profile of dll403 was 
unaltered, the rate at which dll403 reactivated was 
dependent on the initial dose of virus and host strain 
(Clements and Stow, 1989). Likewise, Gordon et al. (1990b) 
showed that host species and virus strain differences were 
important factors that determined whether dlx3 .1 could 
establish a latent infection or spontaneously reactivate in 
vivo. D11403 established a non-lytic interaction in HFL 
cells (Russell et al., 1987; Stow and Stow, 1989) but failed 
to complement and induce reactivation of latent HSV-2 in a 
tissue culture latency system (Russell et al., 1987). A 
functional domain of the protein VmwllO which was crucial
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for reactivation of latent HSV-2 in an in vitro latency 
system has been resolved (Harris et al., 1989). This domain 
was located within the N-terminal portion of VmwllO and 
correlated with a region important for the intrinsic 
ability of VmwllO to transactivate gene expression in 
transient transfection assays (Everett, 1988). In summary, 
the absence of functional VmwllO is dispensible for the 
establishment of a latent infection, neither does the lack 
of VmwllO preclude reactivation in vivo. Nevertheless, in 
vitro latency studies suggest that reactivation in vivo 
could be triggered by cellular factor(s) that mimic the 
action of VmwllO. Important in this regard is the finding 
that a functional VmwllO was critical for the de novo 
synthesis of infectious virus particles after transfection 
of viral DNA (Cai and Schaffer, 1989). In analogy, 
reactivation from latency is thought to occur in the absence 
of pre-existing viral proteins and therefore, the data 
presented by Cai and Schaffer (1989) predicts a role for 
VmwllO or a homologous component of the cellular 
transcription machinery in the process of reactivation.
1.3.5.3. Thymidine Kinase.
HSV-2 RNA mapping to the region encompassing TK has 
been detected in human tissues (Galloway et al., 1982) and 
viral specific TK activity has been demonstrated in latently 
infected animals (Yamamoto et al., 1977). However, these 
data are not supported by other independent studies in which 
HSV-1 TK gene expression was undetectable using in situ 
hybridization or the polymerase chain reaction (PCR)
(Stevens et al., 1987; Puga and Notkins, 1987; Deatly et 
al., 1987; Rock et al., 1987a; Steiner et al., 1988; Lynas 
et al., 1989a,b). Early studies reported that arabinosyl 
thymine selected TK" mutants were reduced for neurovirulence 
and impaired for latency in mice and guinea pigs (Tenser and 
Dunstan, 1979; Tenser et al., 1979). These findings implied 
that expression of TK played a major role in the 
establishment and maintenance of the latent state or in 
reactivation. A number of defined HSV mutants have been 
used to determine which of these features of latency is
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affected by the absence of TK. The establishment of latency 
was not compromised by the incorporation of chimeric TK 
genes into the HSV genome (Sears et al., 1985a). A well 
characterized TK mutant HSV-1 (F) A 305 described by Post et 
al. (1981) was effective at establishing a latent infection 
in rabbits but not in a mouse host (Meignier et al., 1988) . 
Recently, two independent reports have described TK” viruses 
which retained the capacity to establish an efficient latent 
infection in murine spinal ganglia. However, these mutants 
were reactivation negative and reduced for growth on primary 
neuronal cell cultures (Tenser et al., 1989; Leist et al., 
1989) . The TK” viruses discussed thus far may also have 
disrupted the promoter or coding sequences of Ul 24 which 
partially overlaps TK. Mutations in Ul 24 can reduce the 
growth of HSV in cultured cells (McGeoch et al., 1988; 
Jacobson et al., 1989). Efstathiou et al. (1989) described 
the use of a defined TK” mutant, lacking 816bp of the TK 
coding sequences which affect only the TK ORF, in the mouse 
ear model of latency. This mutant replicated at reduced 
efficiency in the ears of infected mice and viral specific 
DNA could not be detected in latently infected mouse neural 
tissue which is consistent with previous studies using TK” 
mutants. However, the TK" virus employed by Efstathiou et 
al. (1989) was recovered by superinfection of explanted 
ganglia with wt virus. This is supported by independent 
evidence in which an ACV resistant HSV-1 mutant, 
specifically deleted in only the TK gene, established a 
latent infection as judged by the expression of LAT in the 
neuronal nuclei (Coen et al., 1989). Moreover, 
superinfection of the mouse trigeminal ganglia with a 
replication-incompetent mutant rescued the TK deficient 
virus (Coen et al., 1989). Therefore, it seems probable 
that TK is not essential for establishment of a latent 
infection, rather that the importance of TK expression in 
HSV latency may be to facilitate the replication of 
reactivated virus particles in the neurones.
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1.3.5.4. Latency Associated Transcripts.
A preliminary attempt to analyse the status of viral 
gene expression during latency was reliant upon available 
technology. Puga et al. (1978) examined the effect of large 
excesses of viral specific RNA, isolated from latently 
infected mouse trigeminal ganglia, on the reassociation 
kinetics of an iodinated HSV-1 probe. Using this method, 
limited transcription from as much as 5% of the viral genome 
was beyond the levels of detection. As a consequence of 
insufficient sensitivity Puga et al. (1978) failed to detect 
virus mRNA, although 0.11 HSV genome equivalents per 
latently infected ganglion were demonstrable. This 
suggested that the transcriptional activity of the majority 
latent genome was severely depressed. In situ hybridization 
analysis of deparaffinized sections of mouse trigeminal 
ganglia and brain tissue detected the presence of HSV-1 
specific RNA during the latent phase of infection that was 
limited to the neuronal nuclei (Stroop et al., 1984).
Later, in another study using in situ hybridization, Stevens 
et al. (1987) demonstrated positive signals only when 
latently infected murine spinal ganglionic sections were 
hybridized with groups of cloned viral DNA fragments that 
included the terminal repeats. More refined analysis 
suggested that the virally encoded mRNA was localized to the 
region encompassing VmwllO (Stevens et al., 1987). 
Furthermore, Northern blot data illustrated the presence of 
a 2.6kb RNA transcribed from the opposite strand to that 
encoding VmwllO (Stevens et al., 1987). Subsequently, other 
workers reported the detection of a family of transcripts 
estimated to be present in amounts between 2xl04 and 2xl05 
molecules per latently infected neurone (Wagner et al., 
1988a). These transcripts were termed LAT and have been 
found in the trigeminal ganglia of mice (Puga and Notkins, 
1987; Spivack and Fraser, 1987; Deatly et al., 1987,1988), 
rabbits (Rock et al., 1987a; Wagner et al., 1988b; Gordon et 
al., 1990a) and humans (Croen et al., 1987; Stevens et al., 
1988; Krause et al., 1988; Steiner et al., 1988; Wechsler et 
al., 1988b; Gordon et al. , 1990a). A similar pattern of 
transcription was also noted in the CNS of latently infected
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mice (Deatly et al., 1988).
There are at least two LAT species, whose sizes depend 
on the strain of virus and experimental animal studied. The 
predominant transcript is approximately 1.8-2.2kb in length 
and the other less abundant transcript is 1.2-1.5kb in size 
(Spivack and Fraser, 1987; Rock et al., 1987a; Wagner et 
al., 1988b; Steiner et al., 1988; Weschler et al., 1988a). 
During latency LAT has an unexpected subcellular 
distribution. In latently infected tissue sections a dense 
in situ hybridization signal was observed overlying the 
neuronal cell nucleus whereas, in contrast, LAT was detected 
in both the neuronal cytoplasm and nucleus during a 
productive infection (Stevens et al., 1987; Rock et al., 
1987a; Croen et al., 1987; Krause et al., 1988; Wagner et 
al., 1988; Steiner et al., 1988; Stevens et al., 1988;
Gordon et al. , 1990a). Evidence for a polyadenylated LAT 
species is limited. Puga and Notkins (1987) utilized polyA+ 
RNA isolated from latently infected murine sensory ganglia 
to direct the synthesis of oligo(dT) primed complementary 
DNA (cDNA) probes. Furthermore, Spivack and Fraser (1987) 
reported the isolation of LAT mRNA in an enriched polyA+ 
sample, but transcripts of identical size were also present 
in a non-polyadenylated (polyA") fraction in amounts 
comparable to those in a total cell RNA extract. Most LAT 
in extracts from latently infected mouse or rabbit 
trigeminal ganglia was recovered in the polyA" fraction upon 
oligo(dT)-cellulose chromatography and thus appeared not to 
be extensively polyadenylated (Wagner et al., 1988a,b). It 
is not clear whether the small amount of polyadenylated LAT 
detected is a consequence of contamination of polyA" 
fractions with polyA+ RNA or reflects the presence of a 
minor polyA+ species (Figure 1.6.).
Viral RNA expressed during latency in the trigeminal 
ganglia of mice and rabbits was derived entirely from BamHI 
B and E HSV-1 (F) fragments (Spivack and Fraser, 1987; Rock 
et al., 1987a; Figure 1.6.). Analysis of human autopsy 
material by in situ hybridization confirmed the presence of 
LAT transcribed from the terminal repeats (Steiner et al., 
1988; Stevens et al., 1988; Gordon et al., 1990a). The 
genomic location of the smaller spliced 1.3-1.5kb message
Figure 1.6. THE GENOMIC LOCATION OF THE TRANSCRIPTS EXPRESSED 
DURING A LATENT INFECTION.
Illustrated is the physical structure of the HSV-1 genome
and beneath a schematic representation of the mRNAs associated 
with latency in relation to other transcripts arising from the 
repeat regions. During a productive infection the following 
transcripts can be detected: IE-1, IE-3, ICP34.5, polyA+ mLAT 
which is up to 8.5kb in length and the approximately 2.Okb 
larger polyA" LAT. During latency transcription is limited to 
mLAT, 2.Okb LAT and an additional smaller 1.3-1.5kb LAT. The 
exact 3 1 end of LAT is not known. The 3' terminus of mLAT is 
thought to be 55bp to the left of the polyadenylation signal for 
IE-3 mRNA. The predicted ORFs encoded by LAT, 0RF1 and 0RF2, are 
indicated.
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has been shown to be colinear with the 1.8-2.2kb RNA (Wagner 
et_aT., 1988b; Spivack and Fraser, 1988a). Wechsler et al. 
(1988a) proposed the existence of a second splice between 
nucleotide 1757 to 1847 in rabbits latently infected with 
HSV-1 McKrae and in human ganglionic sections. Independent 
examination failed to detect the additional splice 3 1 of the 
characterized 730bp intron (Wagner et al., 1988a). Two 
complementary approaches to the physical mapping of LAT have 
defined these RNAs in detail (Wagner et al.f 1988a; Wechsler 
et al. , 1988a). Wagner and coworkers (1988a) used the mouse 
footpad model for latency to localise the 5' and 3' limits 
of the major LAT species of HSV-1 KOS. SI nuclease and 
primer extension analysis placed the 5' end of LAT within 
approximately 500 bases to the left of the Kpnl site at 
0.783mu and the cap site within the sequence TCCAGGTAGG 
which is a potential 5 1 splice signal (Padgett et al. ,
1986). The 3' end of LAT was mapped to within 310bp to the 
right of the Sail site at 0.790mu and therefore LAT overlaps 
the IE-1 transcript by about 1000 nucleotides. The nearest 
polyadenylation signal for LAT is close to 5.5kb downstream 
of LAT and just 55bp downstream of the polyadenylation 
signal for IE-3 (Perry and McGeoch, 1988) . LAT RNA in human 
sensory neurones was indistinguishable from that found in 
animal model systems (Wechsler et al., 1988b).
Only the larger approximately 2.Okb RNA was present, in 
reduced amounts, in acutely infected mouse trigeminal 
ganglia and spinal ganglia (Spivack and Fraser, 1987; Wagner 
et al., 1988a). Similarly, unspliced LAT has been detected 
in very low abundance in cultured RS, CV-1 and Vero cells 
(Stevens et al., 1987; Spivack and Fraser, 1987; Krause et 
al. , 1988). Thus spliced LAT appears to be specific to 
latently infected neurones.
The suggestion by Spivack and Fraser (1988b) that LAT 
represented a novel class of HSV-1 genes because LAT was 
produced in the absence of IE genes (Stevens et al., 1987; 
Rock et al., 1987a; Spivack and Fraser, 1987) and LAT 
synthesis was inhibited by cycloheximide and phosphonoacetic 
acid, remains unconfirmed. To the contrary, in other tissue 
culture cells the 2.Okb transcript was produced in the 
presence of a cycloheximide block which implied that LAT
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could be expressed like an IE gene in the absence of de novo 
protein synthesis. (Wagner et al., 1988b).
The sequence of the LAT region for three strains of 
HSV-1 (17 syn+, KOS[M] and F) has been determined (McGeoch 
et_al., 1986; Wagner et al., 1988a; Wechsler et al.# 1988a) 
and on the basis of this two promoter elements and ORFs were 
suggested (Figure 1.6. and Figure 1.7.). Convention 
assigned postion 1 to the predicted 5 1 end of LAT which is 
equivalent to nucleotides 6897 and 11947 in BamHI E and B 
respectively (by the numbering system of McGeoch et al.,
1988).
Examination of the sequences 5' of the proposed LAT cap 
site indicated the presence of a RNA polymerase II promoter 
which had weak homologies for a TATA box and two CAAT boxes 
located at positions -25, -51 and-56 respectively (Wagner et 
al., 1988a). However, Wechsler et al. (1988a,b) noted a 
putative promoter present further upstream which was 
comprised of a potential TATA box, CAAT box, two poor 
TAATGARAT motifs and three GC rich tracts or Spl binding 
sites. The second candidate eukaryotic promoter was 
atypical in that it was located about 700bp upstream of the 
5* end of LAT. Transfection assays demonstrated that DNA 
fragments containing the second promoter element (not the 
minimal promoter immediately 5' to the nominal start of LAT) 
were most efficient at directing the transcription of a 
heterologous gene (Zwaagstra et al. , 1989; Batchelor and 
O'Hare, 1990). Dobson et al. (1989) constructed a 
recombinant virus that had the B-globin gene under the 
control of the putative LAT promoter and which produced a 
polyadenylated, cytoplasmic B-globin mRNA in latently 
infected murine spinal ganglia. Also, deletion of a 200bp 
PstI fragment, which contains the predicted TATA box 
homology and 90bp 3' to the expected cap site, obviated 
expression of LAT during the latent phase of infection 
(Dobson et al., 1989).
In summary, these results provided evidence that 
transcription during latency was regulated by a promoter 
located about 700bp upstream of the proposed 5' end of LAT. 
Therefore, production of LAT is either under unique 
transcriptional control or the sequences between the
Figure 1.7. DNA SEQUENCE ELEMENTS UPSTREAM OF LAT.
Sequence analysis indicated the presence of an RNA polymerase II 
promoter element 5 1 of the LAT cap site which has weak 
homologies for a TATA box and 2 CAAT boxes (Wagner et al.,
1988a). However, the functional LAT promoter is located, 
uniquely about 700bp upstream of the 5 1 end of LAT and consists 
of TATA and CAAT box homologies; TAATGARAT and Spl motifs which 
seem to be unimportant in vitro; a Vmwl75 binding site and a CRE 
which regulate LAT constructs in tissue culture; neuronal 
specific sequences located between nucleotides -797 and -1267 
relative to the LAT start site (Zwaagstra et al., 1989,1990; 
Batchelor and O'Hare, 1990; Leib et al., 1990)
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promoter elements and the cap site are an unstable, 
undetected intron.
The functional dissection of the putative LAT promoter 
by transient transfection experiments suggested that LAT was 
controlled by a relatively strong orientation dependent 
promoter and that deletion of the Spl sites or CAAT box did 
not significantly reduce CAT gene activity. Also, the LAT 
promoter was not stimulated by Vmw65, which suggested that 
the TAATGARAT motifs were not functional (Zwaagstra et al., 
1989; Batchelor and O'Hare, 1990). Batchelor and O'Hare 
(1990) demonstrated that the LAT promoter was negatively 
regulated by the protein encoded by IE-3. Deletion of a 
55bp region that removed a potential binding site for Vmwl75 
eliminated the activity of the LAT promoter in CAT assays in 
HeLa cells. In gel retardation assays Vmwl75 binds to the 
LAT promoter region containing the consensus sequence 
ATCGTCNNNNGCGRC. However, this does not correlate with 
independent observations that Vmwl75 neither stimulated nor 
repressed expression from the LAT promoter, although it 
remains possible that the constructs used in this study 
disrupted the Vmwl75 binding site (Zwaagstra et al., 1989).
The LAT promoter is selectively active in cells of 
neuronal origin due to a cis-acting signal located between 
nucleotides -797 to -12 67 (Batchelor and O'Hare, 1990; 
Zwaagstra et al., 1990). A cellular factor found in mouse 
neuronal and non-neuronal nuclei has a specific binding 
affinity for this cis-domain (Zwaagstra et al., 1990, 
abstracts of the 15th International Herpesvirus Workshop, 
Washington DC, USA). A single element essential for 
expression of eukaryotic genes in neuronal tissues has not 
been demonstrated (Bray et al., 1988; Johnson et al., 1989; 
Danciger et al., 1989).
In analogy with HSV, the genomes of two other a- 
herpesviruses, bovine herpes virus type 1 (BHV—1) and 
pseudorabies virus (PRV), are transcriptionally active 
during latency (Rock et al., 1986; Rock et al., 1988) . It 
is interesting to note that BHV-1 LAT maps to a 1.9kb 
Hindlll D region which encodes at least one IE gene and that 
LAT expression is controlled by an orientation dependent 
promoter active in primary rabbit sensory neurones (Rock et
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al., 1987b; Jones et al., 1990).
Recently it was demonstrated that the LAT promoter was 
diff1erentially sensitive to extracellular signals such that 
altered regulation of LAT transcription may have an 
important role in the reactivation of latent virus. A 7bp 
consensus cAMP response element (CRE), TGCGTCA, located at 
position -38 in the LAT region appeared to be functionally 
significant (Leib et al., 1991). Chemicals that raise cAMP 
levels positively stimulated the LAT promoter in transfected 
rat pheochromocytoma cells, which contain a factor that 
binds specifically to the CRE, and induced the reactivation 
in vitro of viruses possessing intact LAT but not a LAT- 
negative (LAT”) mutant (Leib et al., 1991). Reactivation of 
latent HSV-1 in rat sensory neurones in vitro was inducible 
by stimulation of cAMP dependent pathways with a variety of 
pharmacological agents (Smith et al., 1990, abstracts of the 
1 5 ^  International Herpesvirus Workshop, Washington DC,
USA). The BHV-1 LAT promoter was negatively effected by the 
synthetic glucocorticoid dexamethasone (Jones et al., 1990) . 
Corticosteroid treatment induced reactivation of BHV-1 in 
the natural host and in an experimentally infected animal 
model (Sheffy and Davies, 1972; Rock and Reed, 1982).
Two significant ORFs were predicted by computer 
analysis of the LAT genomic sequence (Wechsler et al.,
1989). 0RF1 and 0RF2 have a theoretical coding capacity of 
36kd and 12kd respectively. 0RF2 is a single exon within 
ORF1 but in a different reading frame. Antibodies raised 
against synthetic peptides from these ORFs were unable to 
detect a LAT protein (Wagner et al. , 1988a; Wechsler et al. ,
1989) which suggested that LAT was not protein coding. 
Furthermore, direct sequence analysis of a PCR product 
produced by the amplification of LAT sequences from total 
cell RNA extracted from murine trigeminal and cervical 
ganglia latently infected with HSV-1 strain SC16 was found 
to contain several base changes and deletions with respect 
to the published HSV-1 strain KOS(M) and 17 sequences (Lynas 
et al., 1989b). These mutations or deletions in SC16 
introduced termination signals within the putative ORF2, 
suggesting that LAT does not function through translation to 
a protein. Comparison of HSV-1 and HSV-2 LAT specific
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sequences revealed insignificant conservation and atypical 
codon usage by triplet periodicity tests (McGeoch et al., 
1990, abstracts of the 15th International Herpesvirus 
Workshop, Washington DC, USA). Additional evidence that the 
LAT regions of a-herpesviruses are widely divergent comes 
the fact that the region of the BHV-1 genome that is 
transcriptionally active during latency and HSV-1 LAT 
regions do not cross hybridize (Rock et al., 1987b).
Moreover, it is also known that LAT accumulates in the 
nucleus and is not extensively polyadenylated. The mapped 
5 1 terminus of LAT is at a splice donor signal and a splice 
acceptor consensus lies 1.95kb downstream. Thus, LAT has 
the properties of an intron excised from a much larger 
transcript. Indeed, recent evidence has demonstrated that 
the LAT gene was processed as an intron. The potential LAT 
intron was cloned into the B-galactosidase gene and Northern 
blot analysis of transcripts produced in transfected cells 
detected a correctly sized 3.5kb B-galactosidase and 2. Okb 
LAT RNA, indicating that LAT was spliced from the primary 
transcript generating an intact B-galactosidase transcript 
(Farrell et al. , 1991) . This result combined with PCR 
analysis of the LAT species termini, provide evidence that 
the consensus splice sites are functional in transfection 
assays. Furthermore, the LAT intrort reduced VmwllO 
transactivation of the TK promoter by 50-80% in co­
transfection assays utilizing a vector containing the LAT 
region DNA fragment, including the splice signals, cloned 
into the B-galactosidase gene (Farrell et al. , 1991). The 
importance of LAT inhibition of VmwllO activity during 
latency remains to be elucidated, but it has been speculated 
that nuclear accumulation of the stable LAT intron may act 
as an antisense mRNA which interferes with VmwllO function 
thereby suppressing full viral gene expression during
reactivation events.
HSV mutants that abrogate LAT expression have been used 
to examine the biological relevence of LAT during the 
establishment, maintenance and reactivation processes of 
latency. The extents of these mutations are summarised in 
Figure 1.8. To date all LAT mutants studied retained the 
ability to establish and maintain a latent infection in the
Figure 1.8. LOCATION OF THE MUTANT VIRUSES USED IN STUDIES OF 
LAT FUNCTION.
The HSV-1 prototype genome arrangement is shown with BamHl B and 
E enlarged. The position and direction of synthesis of the IE- 
1, LAT, Ul I, Ul 2 , IE-2, Ul 55, and Ul 56 mRNA are illustrated. 
Beneath are the extent of the deletions of the five mutant 
viruses described in the text. X10-13 is a HSV-1 x HSV-2 
recombinant predominately HSV-1 except between the region 0.396- 
0.404mu which was derived from HSV-2, and spontaneously deleted 
between 0.019-0.076mu and 0.743-0.808mu (Javier et al., 1988). 
1704 is a HSV-1 variant which is deleted in TRl /Ul  and IR^/Ul 
(MacLean and Brown, 1987). The exact end points of the 
deletions are unknown but the deletions are about 1.2kb and 
3.8kb in TRl /Ul  and IRl /Ul  respectively. Mutant dlLATl.8 has a 
1.8kb deletion in the LAT sequences between a PstI and Hpal site 
which removes the putative LAT promoter and 1015bp of the 
sequences specifying LAT (Leib et al. 1989a). 8117 is a mutant
virus deleted for 950bp in TRl and IRL between 0.042-0.048mu and 
0.778-0.784mu (Izumi et al., 1989). The Hpal P fragment of HSV- 
1 (F) is not present in the genome of strain HFEM indicating a 
deletion that spans the co-ordinates 0.762-0.790mu (Rosen and 
Darai, 1985). TB1 is derived from HFEM and contains an 
additional 440bp segment of bacteriophage lambda DNA in place of 
a 168bp deletion in the transcribed portion of LAT (Block et 
al., 1990).
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absence of detectable LAT gene expression (Javier et al., 
1988; Leib et al., 1989a; Sedarati et al.# 1989; Steiner et 
al., 1989). Defined LAT“ deletion mutants (dlLAT1.8 and 
8117) and a LAT“ mutant (1704) reactivated with reduced 
efficiency upon explantation and cocultivation of latently 
infected ganglia, although similar amounts of DNA reached 
the ganglia compared to wt or rescued viruses (Leib et al., 
1989a; Sedarati et al., 1989; Steiner et al., 1989; Mitchell 
et al., 1990b) . Mutant TB1 is an engineered virus that does 
not produce full length LAT but reactivated with normal 
kinetics and therefore defined a 168bp region not involved 
in the slow reactivation phenotype (Block et al., 1990).
The reactivation profile of the HSV-lxHSV-2 recombinant X10- 
13 has been examined in the rabbit eye model in which 
reactivation occurs spontaneously or is inducible by 
iontophoresis of epinephrine (Hill et al., 1990). In accord 
with results described above, expression of LAT had little 
effect on the frequency of spontaneous or in vitro recovery 
of X10-13 but the percentage of rabbits induced to shed 
virus in vivo that reactivated X10-13 was reduced and 
statistically different from those rabbits infected with a 
LAT-positive (LAT+) rescued derivative of X10-13 (Hill et 
al., 1990).
A minor species of LAT (mLAT) present in 0.3% of 
neurones was detected by in situ hybridization of rabbit, 
mice and human ganglionic tissues using the HSV-1 BamHI SP 
fragment (Spivack and Fraser, 1987; Rock et al., 1987a; 
Deatly et al., 1988; Krause et al., 1988; Steiner et al. , 
1988) . Mitchell and coworkers (1990a) analyzed the extent 
of transcription of mLAT in latently infected mice by 
probing ganglionic sections with subclones of BamHI B and 
SP. At most 8.5kb of DNA was transcribed rightwards through 
LAT, IE-1, 734.5 and terminated at a polyadenylation signal 
close to the 3' end of IE-3 sequences in IRS (Dobson et al., 
1989; Mitchell et al., 1990a). An 8.5kb transcript was 
detected by Northern blot hybridization of a polyA+ extract 
from productively infected cells (Dobson et al., 1989) . 
Recently, a transcript estimated to be between 8 and 9kb in 
size was detected m  the trigeminal ganglia of latently 
infected rabbits (Zwaagstra et al., 1990). Failure to
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produce mLAT did not preclude establishment or maintenance 
of a latent infection (Mitchell et al., 1990b).
The available data suggest that the HSV LAT region may 
have a dual function. Firstly, the LAT intron may act as a 
biologically stable antisense inhibitor of VmwllO mRNA 
synthesis, or it may sequester VmwllO transcripts in the 
neuronal cell nucleus rendering them inaccessible for 
translation, or LAT may act on VmwllO itself preventing 
activation of HSV gene expression. Secondly, the finding 
that LAT+ viruses generally have a selective reactivation 
advantage is most easily understood if a portion of the 
polyadenylated mLAT that extends beyond the LAT intron 
encoded a polypeptide. There is minimal evidence to suggest 
that the LAT region produces a functional mRNA encoding a 
protein. However, preliminary immunocytochemistry using 
rabbit antiserum raised against a LAT fusion protein points 
to the existence of a LAA in vitro (Doerig et al. , 1990, 
abstracts of the 1 5 ^  International Herpesvirus Workshop, 
Washington DC, USA). External stimuli that increase LAT 
promoter activity may provide the link between a LAA and 
reactivation.
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2. MATERIALS.
2.1. Virus Stocks.
HSV-2 wt strain HG52, HSV-1 wt strain 17 and HSV-1 
mutant tsK (Marsden et al. # 1976) were obtained from stocks 
held in the Institute of Virology and maintained by M. 
Murphy. Dr. C.M. Preston provided UV tsK, irradiated to 
reduce the titre at 31°c by a factor of 5xl05 and obviate 
gene expression (Notarianni and Preston, 1982). Mutant tsK 
plaqued with syncytial morphology. HSV-l deletion mutants 
dll403 (Stow and Stow 1986), FXE and D14 (Everett, 1989) 
were provided by E.C. Stow and Dr. R. Everett. The 
insertion mutant inl814 (Ace et al., 1989) was provided by 
Dr. C.M. Preston.
The adenoviruses Ad5 and the recombinants AdMLP-110 and 
Adll0-110 (Zhu et al., 1988) were suppplied by Dr. R. Hay 
and Professor S. Silverstein respectively. The Ad5 deletion 
mutant dlEl,3 was a gift of Dr. F. Graham.
HCMV strain AD169 was provided by Dr. J. Russell.
2.2. Tissue Culture Cells.
BHK-21 clone 13 cells (Macpherson and Stoker 1962) were 
used for the growth and titration of HSV. HFL monolayers 
were used to establish a latent infection in vitro as 
described by Russell and Preston (1986). HFL cells were 
originally provided by Dr. B. Carritt, although latterly 
Flow 2002 cells provided by Flow Laboratories were used.
The 293 cell line established by Graham et al. (1977), was 
used to propagate and titrate adenovirus stocks.
2.3. Tissue Culture Media.
All cell types were propagated in Glasgow Modified 
Eagles Medium (Busby et al., 1964) supplemented with 0.25% 
sodium bicarbonate, 4iaM L—Glutamine, 100 units/ml 
penicillin, 100^g/ml streptomycin and modified as indicated 
below:
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ETC10 10% new born calf serum (Gibco),
10% tryptose phosphate broth.
EF10 & EF5 10% or 5% foetal calf serum (Gibco),
1% non-essential amino acids (Gibco).
EHu5 & EHu2 5% or 2% human serum (Flow Laboratories) .
For titrations of adenovirus stocks, monolayers were 
overlaid with Eagles agar overlay medium, without phenol 
red, containing 0.65% Noble agar, 0.02% calf serum and 
12.5/xM MgCl2 . Other media routinely used are as follows:
170mM NaCl, 3.4mM KC1, ImM Na2HP04 , 2mM 
KH2PO4 and buffered to pH7.2.
6.8mM CaCl2 .
4.9mM MgCl2 .
8 parts PBSA : 1 part PBSB : 1 part PBSC
140mM NaCl, lOmM KC1, lOmM Tris-HCl, ImM 
MgCl2 , pH7.0.
140mM NaCl, 3 0mM KC1, 280mM Na2HP04 , 1 
mg/ml glucose, 25mM Tris-HCl (pH7.4), 
0.001% (w/v) phenol red, 100 units/ml 
penicillin, 100/xg/ml streptomycin.
0.25% (w/v) trypsin (Difco) dissolved in 
Tris-saline.
0.6M EDTA in PBSA containing 0.0015% (w/v) 
phenol red.
Phosphate 
buffered saline 
(PBS) A
PBSB
PBSC
PBS
Tris-buffered
saline
Tris-saline
Trypsin
Versene
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2-4. Host Bacteria for Plasmid Propagation,
E. coli strain K12 DH-1 (rec Al, nal A, r R-, m R-, 
endo B” , rel Al) was used throughout for plasmid 
amplification (Hanahan, 1983).
2-5. Bacterial Growth Media.
Bacteria were routinely grown in suspension in L-Broth 
[1% (w/v) NaCl, 1% (w/v) Bactopeptone, 0.5% (w/v) yeast 
extract] or on L-Broth agar plates [L-Broth plus 1.5% (w/v) 
agar], supplemented with 50jug/ml ampicillin as required.
2.6. Plasmids.
Genomic libraries of cloned HSV DNA fragments were 
established in the Institute of Virology and clones were 
grown from seed stocks supplied by Dr. C.M. Preston.
2.7. Enzymes.
Restriction endonucleases were obtained from Bethesda 
Research Ltd. and Boerhinger Mannheim. Bethesda Research 
Ltd. also suppied the enzymes DNA polymerase I and Moloney 
Murine Leukaemia Virus (MMLV) RNase H” reverse 
transcriptase. Lysozyme, proteinase K, bovine pancreas 
RNase A and DNase I were from Sigma Chemical Company Ltd. 
Boer inger Mannheim provided DNA polymerase (large fragment) 
and T4 polynucleotide kinase. Perkin-Elmer Cetus supplied 
recombinant Thermus aquaticus (Tag) DNA polymerase. RNase- 
free DNase came from the Promega Corporation.
2.8. Reagents.
Chemicals used were of the highest purity available and 
obtained from the following suppliers listed below:
BDH Chemicals, Beecham Research Laboratories, Bethesda 
Research Laboratories, Bio-Rad Laboratories, Fluka,
Kochlight Ltd, May and Baker, Melford Laboratories, Merke
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Sharp and Dohme International, Pharmacia Chemicals, and 
Sigma Chemical Company Ltd.
2.9. Radiochemicals.
Amersham International Pic supplied all the 
radiochemicals used throughout. Specific activities were 
40-60 Ci/mmol for [3H]-thymidine, >800 Ci/mmol for [35S]- 
methionine, 3000 Ci/mmol for a-[32P]-dNTPs, and >5000 
Ci/mmol for 7-[32P]-dATP.
2.10. Oligonucleotides.
Oligonucleotides were synthesised using a Biosearch 
8600 DNA Synthesiser by Dr. J. McLauchlan. Sequences of the 
oligonucleotides employed are listed below :
LAT 1 5 ' - GCGCTCGCGGAAACTTAACACCACC - 3 1
LAT 2 5'- GGGCAGGCTCTGGTGTTAACCACAG -3'
TK 1 5 1- CATACCGACGATCTGCGACC -3'
TK 2 5'- CGTCATAGCGCGGGTTCCTT -3'
2.11. Commonly Used Buffers.
TE lOmM Tris-HCl, ImM EDTA (pH7.5).
TEN 5mM Tris-HCl, 150mM NaCl, 5mM EDTA
(pH7.5).
TNE 2 0mM Tris-HCl, lOOmM NaCl, ImM EDTA
(pH7.5).
2.12. Electrophoresis Buffers.
10 x E buffer 36mM Tris, 30mM NaH2P04 , ImM EDTA (pH7.8).
10 x electro- 5mM sodium acetate, ImM EDTA, 4 0mM Tris-
elution buffer HCl (pH7.8).
(EEB)
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10 x TBE buffer 90mM Tris, ImM EDTA, 90mM boric acid
(pH8.3).
Gel-elution 
buffer (GEB)
250mM ammonium acetate, 20mM Tris-HCl 
(pH7.4), 2.5mM EDTA.
5 x dye-ficoll 
loading buffer
10% (w/v) ficoll, 0.1M EDTA, 5 x E buffer, 
0.1% (w/v) bromophenol blue.
5 x TBE loading 50% (v/v) 1 x TBE, 1% (w/v) SDS, 50% (v/v)
buffer glycerol, 0.1% (w/v) bromophenol blue.
2.13. Lysis Buffers.
Cell lysis 2 0mM Tris-HCl, 0.5% SDS, 2.5mM
buffer EDTA (pH7.5), 0.25mg/ml proteinase K.
Guanidinium 4M GSCN, 50mM Tris-HCl (pH7.5), 0.5% (w/v)
thiocynate (GSCN) N-lauryl sarcosine, 2mM EDTA (pH7.5),
buffer lOOmM B-mercaptoethanol, 0.33% (v/v)
antifoam A.
TK lysis buffer 20mM Tris-HCl (pH7.5), 2mM MgCl2 , lOmM
NaCl, 0.5% (v/v) Nonidet P40.
2.14. PCR Buffers.
DNase buffer 40mM Tris-HCl (pH7.9), lOmM NaCl, 6mM
MgCl2 .
10 x PCR buffer lOOmM Tris-HCl (pH8.2), 0.5M KCl, 15mM
MgCl2 .
5 x reaction 250mM Tris-HCl (pH8.3), 375mM KCl, 15mM
buffer MgCl2 .
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2-15. Polypeptide Electrophoresis Buffers.
3 x boiling mix 50mM Tris-HCl (pH6.7), 0.4% SDS, 30% (v/v)
glycerol, 5% B-mercaptoethanol, 0.1% (w/v) 
bromophenol blue.
Gel buffer 1.5M Tris-HCl (pH8.9), 0.4% SDS.
Stacking gel 0.5M Tris-HCl (pH6.7), 0.4% SDS.
buffer (SGB)
Tank buffer 52mM Tris, 53mM glycine, 0.1% SDS.
2.16. Southern Transfer and Hybridization Solutions.
50 x Denhardts 1% (w/v) ficoll, 1% (w/v) bovine serum
solution albumin (BSA) fraction V, 1% (w/v)
polyvinylpyrollidone.
20 x SSC 3M NaCl, 0.3M sodium citrate.
Transfer solution 0.4M NaOH, 0.6M NaCl.
Neutralizing 0.5M Tris-HCl (pH7.0), 1M NaCl.
solution
Prehybridization 6 x SSC, 5 x Denhardts, 0.1% SDS, 18jLtg/ml,
mix denatured and sonicated calf thymus DNA.
Hybridization mix 20mM Tris-HCl (pH7.5), 7xSSC, 10 x
Denhardts, ImM EDTA, 0.6% SDS, 60 /xg/ml 
denatured and sonicated calf thymus DNA.
2.17. Radiolabelling Solutions.
Kinase buffer 70mM Tris-HCl (pH7.6), lOmM MgCl2 , 5mM
DTT.
10 x Nick 0.5M Tris-HCl (pH7.5), lOOmM MgCl2 , ImM
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translation DTT, 500/ig/ml BSA.
buffer
Oligo reaction 250mM Tris-HCl and 25mM MgCl2 buffered to
mix pH8.0, 50mM fi-mercaptoethanol, 1M Hepes
(pH6.6) , 30 OD units/ml pd(Ng) in TE.
2.18. Other Solutions
Destain 5% methanol, 3.5% glacial acetic acid.
Fix 1% glacial acetic acid, 9% methanol.
Giemsa 1.5% (v/v) suspension of giemsa stain in 
glycerol heated to 56°C for 2hr and 
diluted with an equal volume of methanol.
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3. METHODS.
3.1. Cell Culture.
HFL cells were grown in EF10 in 175cm2 plastic culture
flasks from a seed stock of approximately 1.5xl07 cells at
37°C in an atmosphere of 5% CO2 and 95% air. HFL monolayers
were passaged every 3-4 days and harvested by addition of
10ml 1:1 mix of versene:trypsin followed by 10ml of fresh
EF10. A homogeneous cell suspension was used to seed
subsequent monolayers.
A confluent monolayer of HFL cells in a 35mm or 50mm
diameter plastic petri dish yielded approximately 106 and
3xl06 cells respectively.
293 cells were handled in the same manner except that
10ml of versene only was used to detach the cells from
plastic surfaces.
BHK cells were grown in ETC10 from a seed stock of
about 107 cells in an 850cm2 plastic roller bottle at
37°C in an atmosphere of 5% CO2 and 95% air. Cultures were
passaged every 2 days as described for HFL cells.
A confluent monolayer of BHK cells in a 35mm diameter dish
contained on average 106 cells.
.1 *3  CM U? W-t/v* I - Hr U  10
3.2. Virus Stocks.
3.2.1. Herpes Simplex Virus.
3.2.1.1. Preparation of a Stock.
Confluent BHK monolayers in 850cm2 plastic roller 
bottles were infected with virus at 0.01 pfu/cell in 100ml 
ETC10. Cells were incubated at 37°C for 3-4 days when 
extensive cpe was apparent. The bottles were shaken to 
disperse cells into 20ml of medium and centrifuged at 2,000 
revolutions per minute (rpm)for 2hr at 4°C in a Sorvall GSA 
rotor. This procedure separated the virus preparation into 
cell released virus (supernatant) and a pellet of virus 
associated with cells. The pellet was sonicated in 10ml 
ETC10 and recentrifuged at 2,000 rpm for 15min in a Beckman
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GPR centrifuge to remove cell debris. The cell released 
virus in the supernatant was centrifuged at 12,000 rpm in a
Sorvall GSA rotor for 2hr at 4°C and the pellet resuspended
in ETC10.
All viral stocks were sterility tested on blood agar plates 
and stored at -70°C in small aliquots.
3.2.1.2. Titration of a HSV Stock.
HSV stocks of virus were titrated on 35mm petri dishes 
of confluent BHK monolayers. Serial 10-fold dilutions were 
made in ETC10 and 200/xl of each dilution was used to infect 
a monolayer (usually in duplicate) from which the medium had 
been aspirated. Following adsorption at 37°C for lhr, cells 
were overlaid with EHu2 or EHu5 and incubated at the 
temperature permissive for virus replication for up to 3 
days. The medium was removed and cells stained with giemsa 
at room temperature for 3 0min. Plaques were counted on 
rinsed plates under a dissecting microscope and the number 
of pfu/ml determined.
3.2.2. Adenovirus.
3.2.2.1. Preparation of a Virus Stock.
Monolayers of 80% confluent 293 cells were grown in 
90mm diameter petri dishes and infected at a multiplicity of 
0.1 pfu/cell of crude seed stock. Virus was absorbed to the 
cell monolayer in 0.3ml Tris/saline for 1-1.5hr at 37°C.
15ml of medium containing 1% foetal calf serum (normal 
medium contained 10% foetal calf serum) was added and 
monolayers incubated at 37°C for 5-7 days until extensive 
cpe was evident. Cells were harvested by scraping the 
cells into the medium with a rubber policeman and decanted 
into a 50ml Falcon tube. Cells were pelleted by 
centrifugation at 2,000 rpm for lOmin at 4°C in a Beckman 
GPR centrifuge. The supernatant was aspirated and 
discarded. The pellet was resuspended in 2ml of 
Tris/saline, transferred to two black cap vials and frozen 
and thawed three times. The contents of the vials were
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recombined in a 15ml Falcon tube and recentrifuged as above. 
The supernatant was stored in small aliquots at -70° C.
3.2.2.2. Titration of an Adenovirus Stock.
Serial 10-fold dilutions of virus were made in 
Tris/saline and 100/xl of each dilution was added to a 50mm 
petri dish containing an 80% confluent monolayer of 293 
cells. Virus was absorbed at 37°C with occasional gentle 
rocking. Monolayers were overlaid with 5ml of Eagles agar 
overlay medium prewarmed to 37°C and incubated at 37°C for 
10 days. On day 4 or 5 monolayers were supplemented with 
2ml fresh Eagles agar overlay. On day 10 monolayers were 
fixed with glutaraldehyde for a minimum of 3 hr, then stained 
with giemsa and the number of pfu/ml calculated.
3.3. The In Vitro Latency System.
The model system outlined below and in Figure 3.1 was 
described in detail by Russell and Preston (1986).
Usually 35mm plates of confluent HFL cells were 
infected with 3000 pfu/plate in a 0.3ml volume of EF10. The 
monolayers were incubated at 37°C for lhr with occasional 
rocking to allow the inoculum to adsorb to and penetrate the 
cells. The inoculum was removed with a pasteur pipette and 
cultures washed gently with 2ml EF10 twice. Monolayers of 
infected HFL cells were overlaid with 2ml EF5 prewarmed to 
42°C and incubated at 42°C for 6 days. On the 6th day 
cultures were shifted to 37°C (the temperature permissive 
for virus growth) for a further 4 days. Throughout this 10 
day period medium was replaced with 2ml of EF5 (prewarmed to 
the appropriate temperature) on alternate days. After 4 
days at 37°C monolayers were examined for spontaneous 
reactivation by visual inspection. Monolayers free from 
spontaneous reactivation were superinfected with a relevant 
virus over a range of moi (usually 0.1, 0.01, 0.001 
pfu/cell) or mock-superinfected. The superinfecting virus 
was permitted to adsorb to and penetrate the latently 
infected HFL cells for lhr at 37°C. For examination of 
plaque numbers monolayers were overlaid directly with EHu2
H F L  C E L L S
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MAINTENANCE
\
SUPERINFECTION AT VARIOUS MULTIPLICITIES REACTIVATION  
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I
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_________ I____________
\------------------------------ I
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♦ \
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Figure 3.1. SCHEMATIC REPRESENTATION OF THE IN VITRO MODEL FOR HSV LATENCY
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or EHu5, incubated at the appropriate temperature for 2-3 
days and stained with giemsa. Alternatively, monolayers 
were overlaid with 2ml EF5 for 2-3 days until cpe appeared, 
then the cells and medium were combined, sonicated and 
titrated on or reamplified (for cytoplasmic DNA extraction) 
by infection of a BHK cell monolayer.
The system was modified slightly to allow the 
establishment of a high moi stable latent infection of HFL 
cells with inl814. Routinely at 37°C (with or without prior 
42°C treatment) monolayers latently infected with in!814 
were overlaid with 2ml EF5 plus 50/xg/ml Ara-C.
3.4. Large Scale Preparation of Plasmid DNA.
Routine large scale preparations of plasmid DNA were 
carried out using a modified "hard-lysis" procedure (Guerry 
et al., 1973).
50/xl of the glycerol stock of bacteria containing the 
required plasmid was added to 10ml L-Broth plus 50/xg/ml 
ampicillin and incubated at 37°C overnight. From this 
overnight culture 2ml was used to inoculate 200ml L-Broth 
plus antibiotic and shaken at 37°C for 6hr. Chloramphenicol 
was added to a final concentration of 25jLtg/ml and incubation 
continued overnight. The culture was centrifuged at 8,000 
rpm in a Sorvall GSA rotor for lOmin. The supernatant was 
decanted and the pellet resuspended in 5ml 25% sucrose/50mM 
Tris-HCl, pH8.0. 2.5ml of freshly made lOmg/ml lysozyme was
added and the mixture put on ice for 3 0min. 2ml of 250mM 
EDTA, pH7.5 was then added and incubation continued on ice 
for a further 5min, after which 1.5ml 5M NaCl and 1.5ml 20% 
SDS were each added in turn. The mixture was mixed well and 
left on ice for 2-3hr and then centrifuged at 20,000 rpm in 
a Sorvall SS34 rotor. The supernatant was extracted twice 
with phenol/chloroform and once with chloroform followed by 
precipitation in 2 volumes of ethanol at -2 0°C. The 
partially purified DNA was pelleted by centrifugation at 
2,500 rpm for 15min in a Beckman GPR centrifuge and 
dissolved in 9ml 20mM Tris—HC1, pH7.5, lOOmM NaCl, ImM EDTA 
plus 20/xl 5mg/ml RNase and incubated at 37°C for 2-4hr.
0.5ml of a 100/zg/ml proteinase K solution was added and
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incubation continued at 37°C overnight. The proteinase K 
was removed by two phenol/chloroform extractions and a 
chloroform extraction. The final volume was adjusted to 9ml 
with water, and 1ml 3M sodium acetate, (pH7.0) was added.
The DNA was precipitated at room temperature by addition of 
5ml of isopropanol. After centrifugation at 5,000 rpm for 
15min at 20°C in a Beckman GPR centrifuge the pellet was 
washed with ethanol, dried and dissolved in 300/xl distilled 
water (DW).
3.5. Extraction of Nucleic Acid.
3.5.1. Preparation of Cytoplasmic and Nuclear DNA.
Monolayers on 35mm petri dishes were harvested for 
cytoplasmic DNA extraction when cpe was evident. The medium 
was removed carefully and the cell monolayers washed with 
2ml of ice cold PBS. 1ml of fresh PBS was added and cells 
were scraped into this using a rubber policeman. The cell 
suspension was transferred to 1.5ml reaction vials and 
centrifuged for 3min at 5,000 rpm in a benchtop microfuge. 
The supernatant was decanted and the cell pellet resuspended 
in 100/xl TK lysis buffer by vortexing. Samples were placed 
on ice for 5min and then centrifuged at 13,000 rpm for 2min 
in a benchtop microfuge. The supernatant was transferred to 
a fresh vial and 300/zl of TEN was added. Samples were 
phenol/chloroform extracted and ethanol precipitated. RNA 
present in the cytoplasmic fraction was degraded by 
treatment with lOO/xg/ml RNase A at 3 7°C for 3hr. Five 
monolayers, on 50mm petri dishes, of latently infected HFL 
cells were scraped into 10ml PBS with a sterile rubber 
policeman and transferred to a 50ml Falcon tube. Cells were 
pelleted at 2,000 rpm for 5 min in a Beckman GPR centrifuge. 
1.5ml of TK lysis buffer was added to the pellet, and the 
mixture was vortexed and incubated on ice for 5min. The 
sample was centrifuged at 2,500 rpm in a Beckman GPR 
centrifuge to pellet the nuclei, which were resuspended in 
9ml CLB plus 0.25mg/ml proteinase K. The mixture was 
incubated at 37°C overnight. NaCl was added to 0.1M and the 
glutinous extract extracted with phenol/chloroform. The DNA
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precipitated immediately at room temperature in 2 volumes of 
ethanol and was lifted from the ethanol with a pipette.
Dried DNA pellets were resuspended in 1ml of DW.
The volumes of solutions used were adjusted according 
to the scale of the cell harvest.
3.5.2. Preparation of Total Cell RNA.
Total RNA was isolated by single extraction with an 
acid GSCN-phenol-chloroform mixture described by Chomczynski 
and Sacchi (1987). This rapid method provides a pure 
preparation of undegraded RNA in high yield.
To each monolayer of cells on a 50mm petri dish, 0.9ml 
GSCN buffer was added and the lysed cell mix transferred to 
a 10ml Sarstedt polypropylene tube. Sequentially, 90jul 2M 
sodium acetate, pH4.0, 0.9ml phenol (saturated with water), 
and 180/xl of chloroform/iso-amyl alcohol mixture (49:1) were 
added with thorough mixing after addition of each reagent. 
The final solution was vortexed for lOsec and cooled on ice 
for 15min. Samples were centrifuged at 9,000 rpm for 15min 
at 4°C in the outer ring of a Sorvall SM24 rotor. The 
aqueous phase was transferred to a fresh tube, mixed with 
0.9ml of isopropanol and precipitated at -20°C for lhr 
exactly. Sedimentation of RNA at 9,000 rpm for 15min in the 
outer ring of a Sorvall SM24 rotor was performed and the 
resulting pellet dissolved in 0.3ml GSCN buffer and an equal 
volume of isopropanol. The sample was precipitated at -20°C 
for >lhr or overnight. After centrifugation as above the 
pellet was resuspended in 800jtil DEP-treated DW, 0.3M sodium 
acetate and 75% ethanol. The RNA was stored at this stage 
as a salt and ethanol precipitate at -20°C until ready for 
use. RNA was sedimented as above, the pellet washed twice 
with 70% ethanol and dissolved in 50/xl DEP-treated sterile 
DW. The concentration of the RNA stock was adjusted to
5/xg/Ml.
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3•6. Separation of DNA by Gel Electrophoresis,
3.6.1. Miniqels.
Small amounts of DNA were analysed by electrophoresis 
in a 0.8% agarose, 50ml minigel (100mm x 70mm x 7mm) in 1 x 
TBE. Samples were loaded in 1 x TBE loading buffer in a 
total volume of 10/xl and electrophoresed in 1 x TBE at 40mA 
for lhr. The gel was stained by addition of 3/xg/ethidium 
bromide after 45min, visualised by exposure to UV 
illumination and photographed on Polaroid 667 film.
3.6.2. Large Agarose Gels.
300ml horizontal slab gels (260mm x 160mm x 7.5mm) 
containing 1% agarose in 1 x E buffer plus 0.5/xg/ml ethidium 
bromide were used for analysis and preparation of DNA 
restriction fragments. Alternatively, for Southern transfer 
of DNA samples, a 0.6% agarose, 1 x E buffer, 0.5/xg/ml 
ethidium bromide, 200ml horizontal gel (2 60mm x 160mm x 5mm) 
was employed. Samples were loaded in 1 x dye-ficoll and 
electrophoresed in 1 x E buffer (plus 0.5/xg/ml ethidium 
bromide) at 40mA for 16-18hr. Separation of high molecular 
weight latent DNA was achieved by electrophoresis at 50mA 
for 2 0hr.
3.6.3. Polyacrylamide Gels.
Vertical non-denaturing gels were used for resolving 
fragments generated by PCR amplification of HSV specific 
sequences.
A 50ml solution containing 6% acrylamide (from a stock 
solution of 29% acrylamide and 1% N,N'methylene 
bisacrylamide), 0.55 x TBE and 10% ammonium persulphate was 
prepared. 50/xl TEMED was added immediately prior to pouring 
the mixture into a gel sandwich (260mm x 160mm x 1mm). 
Samples were loaded into the polymerized gel in 1 x TBE 
loading buffer with a capillary tube. Electrophoresis was 
carried out in 0.55 x TBE at 200V for 3-4hr. Bands were 
visualized by soaking the gel in 0.55 x TBE and 1/xg/ml
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ethidium bromide prior to UV illumination. Gels were 
photographed on Polaroid 655 film and those containing 
radiolabelled DNA fragments were dried and subjected to 
autoradiography.
3.7. Purification and Characterization of Nucleic Acids.
3.7.1. Restriction Enzyme Digestion.
DNA was routinely digested in a volume of 20-30/zl, in 
reaction conditions specified by the manufacturer of the 
enzyme, with the addition of 0.01% BSA. Restriction digests 
were generally carried out at 37°C for 3hr.
Digestion of high molecular weight total cellular DNA 
was carried out in a 1.5ml volume at 37°C overnight in the 
presence of 100 units BamHl, an additional 50 units of BamHl 
was added and incubation was continued for a further 5hr 
period.
3.7.2. Phenol/Chloroform Extraction of Nucleic Acids.
Purification of DNA from protein was achieved by 
extraction in an equal volume of distilled phenol and 
chloroform mixed in a 1:1 ratio, agitation and 
centrifugation at 13,000 rpm for 5min in a benchtop 
microfuge for samples <1.5ml or at 2,000 rpm for 15min in a 
Beckman GPR centrifuge. The aqueous phase was re-extracted 
as above and then extracted once with chloroform to remove 
residual phenol. Generally, DNA in aqueous solution was 
precipitated by addition of sodium acetate to 0.3M or NaCl 
to 0.1M in an equal volume of isopropanol at room 
temperature for >2hr or in 2-3 volumes of ethanol at -2 0°C 
for >2hr.
DNA was pelleted by centrifugation at 13,000 rpm in a 
benchtop microfuge for lOmin or 2,500 rpm for 15min in a 
Beckman GPR centrifuge. DNA was then washed in ethanol, 
dried and dissolved in DW.
RNA was pelleted by centrifugation at 9,000 rpm in the 
outer ring of a Sorvall SM24 rotor, washed with 70% ethanol, 
dried and dissolved in sterilized DEP-treated DW.
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3.7.3. Ultracentrifugation of DNA in a Caesium Chloride 
Gradient.
Purification of viral DNA from latently infected cells 
was achieved by ultracentrifugation of DNA through a 
gradient of refractive index (RI) 1.4 (density 1.707g/ml). 
The basis of this protocol was the differential high G+C 
content of HSV DNA sequences relative to the majority of 
cellular sequences. HSV infected cellular DNA isolated from 
five 50mm plates was digested with BamHl to completion and 
mixed with a solution of CsCl to a final RI of 1.4 and a 
volume close to 18ml. The mixture was transferred to a 
TV865B centrifuge tube, balanced with CsCl of RI 1.4 and 
filled to the base of the tube neck with liquid paraffin.
The tube was sealed in a crimper and centrifuged in a TV865B 
vertical rotor at 40,000 rpm in a Sorvall OTD50B 
ultracentrifuge at 15°C for approximately 18hr. The 
gradient was collected in 10 drop fractions by piercing the 
base of the centrifuge tube with a syringe needle. The RIs 
of the samples were determined and those with a RI between 
1.4036 and 1.4002 were pooled with 20/zg E.coli RNA and 
dialysed against 1 x TE for 2-3hr at 4°C. Dialysis buffer 
was changed and the dialysis continued overnight. The 
volume of the sample was reduced to approximately 1ml by 
addition of an equal volume of butan-2-ol. The upper phase 
was discarded and remaining butan-2-ol evaporated by 
incubation at 65°C for 2hr. The final sample was divided 
into 2 parts of 0.5ml each and precipitated in ethanol. The 
washed and dried pellet was dissolved in 40/xl DW.
3.7.4. Electroelution of DNA Fragments.
The required DNA fragment excised from an agarose gel 
was eluted onto dialysis membrane in 1 x EEB in an 
electroelution chamber at 20mA/sample at 4°C for 1.5hr. The 
DNA was removed from the dialysis membrane in 2 00/zl 1 x EEB 
by vigorous pipetting. The final volume of the sample was 
adjusted to 400/zl by addition of sodium acetate, pH7.0, to 
0.3M and DW. The preparation was extracted with 
phenol/chloroform, isopropanol precipitated, dried and
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redissolved in DW.
3.7.5. Estimation of Nucleic Acid Concentration.
A series of dilutions of plasmid DNA, linearized with 
an appropriate restriction endonuclease, or of a purified 
DNA fragment were prepared and electrophoresed in a minigel 
beside an applicable DNA control of known concentration.
DNA bands were visualized under UV illumination and 
photographed on Polaroid 665 film. An estimate of DNA 
concentration was derived by densitometric analysis of 
images on negative film.
Estimations of HSV DNA concentrations in in vitro 
latency experiments (Section 4.4.2.) were obtained by 
densitometric analysis of autoradiographs using a Joyce- 
Loebel scanning densitometer. The areas beneath the peaks 
of the densitometric trace were determined utilizing a 
programme, DENS, written by Dr. P. Taylor for a DEC PDP 
11/44 computer linked to a digitizing table.
The concentration of total cell RNA was estimated by 
measuring the OD at 260nm and 280nm in a Beckman Du-62 
spectrophotometer.
3.8. In Vitro l^P-Labelling of DNA Fragments.
3.8.1. Nick Translation.
DNA was labelled with 32P as described by Rigby et al. 
(1977). 0.5/zg of plasmid DNA in 2.5/zl of 1 x Nick
translation buffer and 20jum each of non-radioactive dATP and 
dTTP was incubated at room temperature for 2-3min following 
addition of 2xl0_4jiig DNase. The mixture was placed on ice 
and DW added so that the final volume after addition of 
radioactive isotopes and enzyme was 25/il. 3jul (30/itCi) each 
of a-[32P]-dCTP and a-[32P]-dGTP were added followed by 2 
units of E.coli DNA polymerase I. The reaction was 
incubated at 14°C for lhr and stopped by addition of 4jul 
250mM EDTA, pH7.5. Unincorporated dNTPs were separated from 
32p_iaken ed dna by centrifugation through a 1ml Sephadex 
G50 (fine) spun column at 2,000 rpm in a Beckman GPR
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centrifuge.
3.8.2. Hexanucleotide Primer Extension.
Random primer extension was carried out as described by 
Feinberg and Vogelstein (1983) . lOOng of DNA in 20/zl was 
heated in a dri-block at 90°C for lOmin, centrifuged briefly 
and cooled on ice. The DNA was incubated in a 50jiil reaction 
mix containing 0.4mg/ml BSA, l O f i l  oligo reaction mix, 20^M 
each non-radioactive dATP, dGTP, dTTP, 5/xl (50/xCi) of a- 
[3 2p]-dCTP and 6 units of Klenow fragment DNA polymerase at 
room temperature overnight. The labelled DNA fragment was 
purified through a G50 sephadex spun column.
3.8.3. 5 '-end Labelling of Fragments.
15-20mmoles of the 5' (sense) oligonucleotide in l/zl 
was incubated at 37°C for l-2hr in kinase buffer plus 50/iCi 
of 7- [32p]-ATP and 2 units of T4 polynucleotide kinase in a 
total volume of 5 0 f j , l  (Arrigo et al. , 1989) . The labelled 
probe was purified by passage through a 10ml Sephadex G50 
(medium) column. The probe was eluted in approximately 1ml 
of DW.
3.8.4. Determination of Percentage Incorporation.
A 3jll1 volume of a 1/10 dilution of a sample from the 
labelling reaction was spotted onto a Whatman No.l filter 
paper disc. The discs were dried under a heat lamp and 
washed once in 10% (w/v) trichloroacetic acid (TCA), once in 
5% (w/v) TCA and twice in ethanol. Discs were redried, 
placed in a scintillation vial containing 3ml Ecoscint A 
(National Diagnostics). Radioactivity was measured in a 
scintillation counter and compared to an equivalent sample 
that had not been TCA washed (total counts).
3.9. Southern Transfer and Hybridization.
The method employed was essentially as described by 
Southern (1975) with modifications as indicated.
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3.9.1. Transfer of DNA from Agarose to a Membrane.
Following electrophoresis DNA fragments were 
transferred to GeneScreen Plus membrane (DuPont) by alkaline 
transfer (Chomczynski and Qasba, 1984). The agarose gel was 
placed in transfer solution for 3 0min with gentle agitation. 
The gel was then laid on two sheets of pre-wet Whatman 3MM 
paper supported by a glass plate and designed to act as a 
wick. GeneScreen Plus membrane, cut to dimensions identical 
to the gel, was pre-soaked in transfer solution and placed 
"B" side down on the gel. Capillary transfer in transfer 
solution was achieved through two sheets of 3MM paper and a 
large stack of paper towels. A weight was placed on the 
towels and DNA transfer allowed to proceed for 16-18hr. The 
blotting assembly was dismantled and the membrane soaked in 
neutralizing solution for 15min with occasional shaking.
The membrane was dried at room temperature for a minimum of 
lhr.
3.9.2. DNA/DNA Hybridization.
The GeneScreen Plus membrane containing immobilized DNA 
fragments was incubated at 65°C for 2hr in 100ml of 
prehybridizaton solution sealed in a polythene bag in a 
shaking water bath. The radiolabelled probe in 8 0 0 / j l I  DW was 
denatured by addition of 200jul 1M NaOH for lOmin at room 
temperature. The solution was neutralized by addition to 
8.8ml hybridization solution plus 200/zl 1M HC1. The 
prehybridization solution was removed from the polythene bag 
and replaced with 10ml of hybridization solution containing 
the 32P-labelled DNA probe. Hybridization was carried out 
at 65°C for 16-18hr in a shaking water bath. The 
hybridization solution was removed and the membrane washed 
at room temperature for 45min in 10 x Denhardts and 1 x SSC, 
once each at 65°C for 3 0min in a solution of 2 x SSC and 
0.25% SDS, followed by 0.3 x SSC and 0.1% SDS. Finally, the 
membrane was washed in water and allowed to air dry before 
autoradiography.
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3.10. Purification of Oligonucleotides.
The supplied oligonucleotide, in a volume of 
approximately 1ml, was heated at 55°C for 5hr to remove 
protecting groups and dispensed into four equivalent 
samples. Two portions were stored at -70°C, the remaining 
oligonucleotide samples were lyophilised and redissolved in 
50/Ltl 90% (v/v) deionised formamide and 1 x TBE. A 150ml 
denaturing acrylamide gel (15% acrylamide with 4% crosslink) 
was polymerised for lhr and pre-run in 1 x TBE for 2hr at 
20W. Urea was flushed from the wells with a 50ml syringe 
and lOjul of xylene cyanol/bromophenol blue loaded in an end 
well and run in parallel with the oligonucleotide samples. 
Electrophoresis was carried out at 3 5W for about 3hr or 
until the marker dye band had progressed beyond 7cm. The 
oligonucleotide bands were visualized by the shadow casting 
technique. In this method, the gel was removed from the gel 
plates onto clingfilm and placed on a fluorescent thin layer 
chromatography plate under a shortwave UV lamp. The slowest 
moving dark band was excised with a brand new scalpel blade, 
diced and incubated overnight at 45°C in 2ml gel elution 
buffer. Oligonucleotide samples were separated from 
acrylamide by passing the mixture through a Whatman glass 
microfibre GF/C filter. The filtrate was dispensed in 0.4ml 
aliquots and 2 volumes of ethanol added to precipitate 
samples at -20°C. Oligonucleotides were centrifuged at 
15,000 rpm in a Sorvall SS34 rotor, washed in ethanol, dried 
and resuspended in 50 (il DW.
3.11. Amplification of HSV Specific Sequences by PCR.
The technique utilised was a modification of that 
described by Saiki et al. (1988). Autoclaved solutions 
(where possible) that had been divided info small aliquots 
and positive displacement pipettes were used throughout to 
minimise the possibility of contamination.
50/xg of RNA was treated with 1 unit of RNase free DNase 
in a 50/il volume of DNase buffer at 37°C for lhr. The 
samples were extracted with water saturated 
phenol/chloroform-isoamyl alcohol and precipitated in 2
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volumes of ethanol at -2 0°C for 2hr. Precipitated RNA was
centrifuged for lOmin at 13,000 rpm in a benchtop microfuge,
washed, dried and dissolved in 10/zl of 250mM KCl. RNA 
samples were boiled at 100°C for lmin in a 0.5ml reaction 
vial in a 11/xl volume that contained approximately 50/xg RNA 
and 0.5-0.6mmoles antisense oligonucleotide. Vials were 
cooled on ice. The RNA/primer mixture was subjected to a 
primer extension hybridization reaction and incubated at the 
hybridization temperature for 3 0min in 250mM KCl. The 
hybridization temperature is determined by the number of 
each nucleotide in the primer sequence, and thus is unique 
to each primer and given by the equation :
4 (G+C) + 2 (A+T) - 5°C
Samples were cooled and conditions adjusted by the addition 
of 1 x reaction buffer, 40 units of MMLV reverse 
transcriptase and DW to a total reaction volume of 50/xl.
RNA samples were converted to complementary DNA by reverse 
transcription at 42°C for lhr. Complementary DNA samples 
were phenol/chloroform-isoamyl alcohol extracted, NaCl was 
added to 0.1M and precipitated in an equal volume of 
isopropanol at room temperature for 2hr. Centrifugation was 
carried out at 13,000 rpm in a benchtop microfuge for lOmin 
and pellets dissolved in 20/xl DW. A 5 / j l I  aliquot of primer 
extended RNA was subjected to PCR. The PCR amplification mix 
contained 1 x PCR buffer, 200/zM each dATP, dTTP, dCTP, 0.5- 
0.6mM unlabelled antisense oligonucleotide, 0.5-0.6mmoles 
sense oligonucleotide 5'-end labelled with T4 polynucleotide 
kinase (Arrigo et al., 1989) and 1 unit of Tag polymerase. 
Each 50/zl reaction was supplemented with the following :
LAT specific reactions : 150/zM dGTP and 50/xM 7-deaza-2'
deoxyguanosine.
TK specific reactions : 200/xM dGTP.
Each PCR amplification was performed under 100/xl of mineral 
oil in an automated thermal cycler (Cambio) as follows : 1 
cycle of denaturation at 93°C for 6min, annealing at 55°C
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for O.lmin and polymerization at 72°C for 4min. 3 0 cycles 
of 93°C for lmin, 55°C for O.lmin, 72°C for 4min and 
completed with 2 cycles at 93°C for O.lmin, 55°C for O.lmin, 
and 72°C for 8min. PCR amplified products (10/xl) were 
separated on a 6% polyacrylamide non-denaturing gel, and the 
gel was dried and the bands visualised by autoradiography.
3.12- Analysis of Polypeptides from Virus Infected Cells.
3.12.1. Pulse-Labelling of Cells.
Confluent monolayers of HFL cells in 35mm petri dishes 
were mock infected or infected with 5 particles/cell of 
inl814 or 1814R. Following incubation at 37°C for lhr the 
monolayers were overlaid with 2ml EF5 and incubated at the 
appropriate temperature (42°C or 37°C). At a predesignated 
time post-infection cultures were pulse-labelled. HFL 
monolayers were washed with prewarmed PBS and 0.3ml of 
50/LtCi/ml [35S]-methionine and actinomycinI>(l/xg/ml) in PBS 
was added. After lhr the radiolabelled medium was decanted 
and the cells were washed once with ice cold PBS followed by 
addition of 0.2ml ice cold 1 x TE. The cells were harvested 
after 5-10min on ice with a rubber policeman. The labelled 
cell mixture was transferred to a 1.5ml reaction vial, mixed 
with 100/zl of 3 x boiling mix and heated to 90°C for 15min. 
At this stage samples were stored at -70°C until analysis.
3.12.2. SDS-Polyacrylamide Gel Electrophoresis.
A gel mix solution was prepared by combining 10ml of 
gel buffer, 13ml 30% acrylamide/3% DATD, 0.5ml 10% (w/v) 
ammonium persulphate in a 40ml volume, 40/xl TEMED was added 
last and mixed. The gel mix was poured into a prepared gel 
sandwich (260mm x 160mm x 1mm) to fill 75% of the space. 
Using a pasteur pipette, 20ml of 0.25 x gel buffer was used 
to overlay the gel mix immediately to ensure a good 
interface. After about lhr when the acrylamide had 
polymerized the 0.25 x gel buffer was poured off. 20ml of 
SGB [plus 0.5ml 10% (w/v) ammonium persulphate and 25/xl 
TEMED] was added after the surface of the gel had been
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rinsed twice with 0.25 x gel buffer. 15min later the well 
former was removed and excess acrylamide displaced by 
rinsing the wells with tank buffer. Samples were 
electrophoresed in a vertical tank at 40mA constant current 
for approximately 5hr in tank buffer. The gel was soaked 
overnight in a 1:1 mix of gelfix and destain at room 
temperature, dried under vacuum and autoradiographed.
3.13. Estimation of Protein Concentration.
An estimation of protein concentration was made by the 
method described by Bradford (1976) . 10/xl of cell extract
was added to 1ml of Bradford reagent (0.01% comassie 
brilliant blue G, 0.0003% SDS, 4.75% (v/v) ethanol, 8.5% 
phosphoric acid) in plastic curvettes. Samples were covered 
with a portion of Nesco film, inverted and left for lOmin at 
room temperature. The absorbance at 595nm was measured and 
compared with the standard curve of known concentrations of 
BSA at OD^g^.
3.14. Determination of Thymidine Kinase Activity.
Cells in 35mm petri dishes were infected at the 
appropriate moi, incubated at 37°C or 42°C and cytoplasmic 
extracts were made as described in Section 3.5.1 with the 
exception that 6.5mM B-mercaptoethanol was incorporated in 
the TK lysis buffer. Up to 20/xl of cytoplasmic cell extract 
was assayed in a reaction mix of 50/xl containing lOmM MgCl2, 
5mM ATP, 100juM dTTP and 100/xCi/ml [3H]-thymidine (47Ci/mmol) 
at 30°C for 2hr. The reaction was terminated by addition of 
10/xl of a 1:1 mix of 2mM thymidine and 50mM EDTA, pH7.5 and 
heated in a dri-block to 90°C for 3-4min. Samples were 
cooled on ice for 5min and then centrifuged in a benchtop 
microfuge at 13,000 rpm for 5min. 50jttl of the supernatant 
was spotted onto Whatman DE81 discs which, after drying, 
were then washed 3 times in 4mM ammonium formate (pH4.0), 
lOmM thymidine at 37°C and a further 2 times in absolute 
alcohol at room temperature for 5min each. Discs were dried 
under a heat lamp and placed in scintillation vials plus 3ml 
Ecoscint A (National Diagnostics). Radioactive counts per
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minute (cpm) were measured in a scintillation counter.
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4.1. RESULTS.
4.1. Objectives.
A distinctive feature of HSV is the ability to reside 
in the neuronal cells of the sensory ganglia in a latent 
state and to persist in this non-infectious form throughout 
the lifetime of its host. The aim of the work presented in 
this thesis was to investigate, at the molecular level, the 
events which occur during establishment and maintenance of 
the latent state, and during reactivation from latency 
using, a well characterized tissue culture latency system 
that is schematically outlined in Figure 3.1. (Russell and 
Preston, 1986; Russell et al., 1987; Russell, 1989). The in 
vitro latency system relies on the ability of HFL cells to 
withstand prolonged periods of incubation at the 
supraoptimal temperature of 42°C. Infection of HFL cell 
monolayers at low moi results in a virus-cell interaction 
that is stable after incubation at 42°C for 6 days followed 
by 4 days at temperature permissive for virus growth. The 
latent virus genome is activated by superinfection of the 
cultures, for example with tsK at 38.5°C, by which means 30- 
100% of the initial inoculum is recovered.
Emphasis was placed on the examination of the 
reactivation process, particularly the role of the HSV-1 
polypeptide VmwllO, and characterization of mutant in!814 to 
elucidate the physical organization of the latent viral 
genome and the status of viral gene expression. Recent 
evidence has indicated that during latency in vivo, the HSV 
genome is probably a circular episome that is in a 
chromatin-like arrangement (Rock and Fraser, 1983,1985; 
Efstathiou et al., 1986; Mellerick and Fraser, 1987;
Deshmane and Fraser, 1989) and transcription is limited to a 
family of RNA molecules originating from the long repeats of 
the genome (Croen et al., 1987; Rock et al., 1987a; Spivack 
and Fraser, 1987; Stevens et al., 1987).
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4.2. Experimental Reactivation Induced by Superinfection.
Previous findings utilizing the in vitro latency system 
demonstrated that latent HSV-2 could be reactivated 
experimentally at high efficiency by superinfection of 
monolayers with wt HSV-1 or HCMV but not with Ad5 (Russell 
et al., 1987). Reactivation of the latent HSV-2 genome by 
intertypic superinfection with ts mutants that do not 
synthesise functional Vmwl75 and are defective for 
progression to later phases of HSV gene expression 
demonstrated that at most only the IE proteins plus the 
early polypeptide Vmwl3 6 were involved in reactivation 
(Russell et al., 1987). Interestingly, mutant dll403 failed 
to rescue latent HSV-2 upon superinfection of latently 
infected cultures, implying a role for VmwllO in the process 
of reactivation. D11403 is deleted for 2kbp in both repeats 
bounding Ul such that the altered polypeptide it is 
predicted to encode is derived from the N-terminal 105 amino 
acids (exon 1 and part of exon 2) fused to 56 residues 
specified by an ORF that is not normally used (Stow and 
Stow, 1986, Figure 4.1.). Recent characterization of the 
transcripts produced during latency revealed that d!1403 
was, in fact, a double mutant as the majority of the 3' 
portion of LAT which overlaps VmwllO is also removed (Figure
4.1.). Therefore, the lack of reactivation induced by 
superinfection with dll403 did not exclude the possiblity of 
a role for LAT. Furthermore, in infected BHK cells the 
profile of proteins synthesised by dll403 are 
indistinguishable from those produced by wt HSV-1 apart from 
the absence of VmwllO (Stow and Stow, 1986). Therefore, 
other HSV polypeptides, particularly IE proteins, may act in 
conjunction with VmwllO during the reactivation process. 
These aspects of reactivation were investigated using 
adenovirus recombinants and defined HSV-1 deletion mutants.
4.2.1. Reactivation Induced by Superinfection with 
Adenovirus Recombinants.
The VmwllO genomic coding sequence, controlled by the 
natural VmwllO promoter or the adenovirus major late
Figure 4.1. POSITIONS OF THE DELETION MUTANTS D11403, FXE AND 
D14 IN RELATION TO LAT AND THE VmwllO TRANSCRIPT.
Numbering of nucleotides begins at the IRL junction a sequence 
(Perry et al., 1986). The genomic locations of VmwllO and LAT 
in IRl are indicated in the expansion; the exact 3' end of LAT 
is uncertain as denoted by the parentheses. The dashed line 
represents the 2.Okbp region deleted in d!1403. Solid boxes 
indicate the position of deletions D14 and FXE.
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promoter, was cloned into the the El region of Ad5 
generating Adll0-110 and AdMLP-110 respectively (Zhu et al., 
1988). Upon infection of HeLa or 293 cells, the hybrid 
adenoviruses expressed a VmwllO transcript and polypeptide 
at late times that appeared identical to that produced by wt 
HSV-1. Virus replication in the recombinant infected cells 
occurred only in 293 cells which supply Ela gene products in 
trans, indicating that VmwllO was unable to substitute for 
Ela functions (Zhu et al., 1988).
HFL cell monolayers were mock infected or infected with 
HSV-2 at 0.003 pfu/cell and, following absorption at 37°C, 
the cultures were maintained at 42°C for 6 days and then at 
37°C for a further 4 days. The viruses tested for the 
ability to reactivate latent HSV-2 in culture were HCMV, 
tsKsyn, Ad5, Ad5 dlEl,3 (Haj-Ahmad and Graham, 1986) and the 
adenovirus recombinants. Cultures were superinfected at a 
multiplicity of 0.1 pfu/cell with the various viruses at 
37°C, or 38.5°C for tsKsyn. The cultures were harvested and 
sonicated in growth medium after 3 days at the appropriate 
temperature when extensive and equivalent cpe was evident. 
Cell lysates were titrated on BHK monolayers in the presence 
of human serum and plaque numbers determined after 
incubation at 37°C or 38.5°C.
It has been demonstrated previously that reactivation 
of HSV-2 from its latent state can be induced efficiently by 
superinfection with HSV-1 ts mutant viruses or HCMV in 
related in vitro latency systems (Colberg-Poley et al., 
1979b,1981; Russell and Preston, 1986). In agreement with 
these findings, the results presented in Table 4.1. indicate 
that superinfection at 0.1 pfu/cell with HCMV or tsKsyn 
rescued latent HSV-2. Similarly, superinfection with the 
adenovirus hybrids AdMLP-110 or Adll0-110 reactivated latent 
HSV-2. However, the yield of HSV-2 recovered was 
consistently lower than that observed upon superinfection 
with HCMV or tsKsyn possibly because significant amounts of 
VmwllO are not produced until late in infection (Zhu et al., 
1988). In contrast, the synthesis of VmwllO in tsKsyn 
infected cells occurs during the IE phase of infection. 
Furthermore, at the NPT tsKsyn IE gene products accumulate 
to high levels (Preston, 1979b). In comparison,
Table 4.1. REACTIVATION OF LATENT HSV-2.
SUPERINFECTING NUMBER OF REACTIVATED MEAN TITRE
VIRUSa CULTURES13 (pfu/ml)c
Mock 0
Ad5 1 1.0 x 102
Ad5 dlEl,3 0
tsKsyn 5 1.1 x 105
HCMV 5 1.1 x 105
AdMLP-110 5 7.6 x 103
Adll0-110 5 2.8 x 103
a HFL cells were infected with 0.003 pfu/cell of HSV-2 and 
superinfected with the indicated virus at 0.1 pfu/cell
following incubation at 42°C for 6 days and 4 days at
37°C. Superinfection with tsKsyn was carried out at the
NPT 38.5°C.
b In each case the number of cultures examined for 
reactivation was 5.
c Superinfected HFL cell cultures and growth medium were 
harvested, sonicated and titrated on BHK cells.
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superinfection of latently infected monolayers with Ad5 
dlEl,3 failed to reactivate HSV-2 (Table 4 . 1 . ) *  Ad5 dlEl,3 
was included as a control as both hybrids are deleted for 
the El region and AdMLP-110 is also deleted for E3 (Zhu et 
al., 1988). The majority of latently infected cultures did 
not release HSV-2 upon superinfection with Ad5 (Table 4 . 1 . ) .  
The virus recovered by Ad5 superinfection arose from 1 out 
of 5 plates and was probably a consequence of a low level 
reactivation event that has been documented previously 
(Russell and Preston, 1986), although the possibility that 
the products of Ad5 Ela can reactivate latent HSV-2 at a 
reduced frequency, that was not detected in earlier studies, 
cannot be excluded.
The virus produced following superinfection and culture 
at the appropriate temperature was identified as HSV-2 by 
the ability to form plaques on BHK cells, which are non- 
permissive for HCMV and adenovirus, and the predominance of 
plaques on this cell type with non-syncytial morphology at 
the NPT for growth of tsKsyn.
The results presented in this section demonstrate that 
a functional VmwllO supplied by the adenovirus recombinants 
can reactivate latent HSV-2 in the absence of other known 
HSV proteins.
4.2.2. Superinfection of Latently Infected Cultures with
Deletion Mutants of HSV-1.
HSV-1 mutants with defined alterations have been used 
to examine the specific functional domains of VmwllO that 
contribute to the role of this polypeptide in reactivation. 
Everett (1989) described the construction of a number of 
HSV-1 mutants with small inframe insertions or deletions 
within VmwllO. Mutant FXE has a 45 amino acid inframe 
deletion in the second exon of VmwllO between nucleotides 
2944-3076 with respect to the numbering system described by 
Perry et al. (1986) (Everett, 1988a, 1989; Figure 4.1.).
The deletion in FXE specifically disrupts a cysteine-rich 
region homologous to the metal ion binding domain described 
by Berg (1986), although the affinity of VmwllO for zinc 
ions is not dependent on the intregrity of the cysteine-rich
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motif (R.D. Everett, unpublished observations). D14 has a
41 amino acid inframe deletion towards the carboxy end of 
VmwllO between bases 4803-4922 (Everett, 1988a,1989; Figure
4.1.). By virtue of the 3' complementarity of VmwllO and 
LAT, D14 also lacks 41 amino acids from the C-terminus of 
the LAT ORF1 and therefore affects LAT whereas FXE does not. 
Importantly, the domain in which D14 is located is required 
for transactivation of a heterologous gene in transient 
transfection assays in the presence, but not the absence, of 
Vmwl75 whereas the region of the polypeptide in the 
proximity of deletion FXE is crucial for the intrinsic 
trans-acting function of VmwllO (Everett, 1988a). Mutant 
FXE is as impaired for growth on BHK and HFL cells as the 
larger deletion mutant d!1403 (Everett, 1989). In 
comparison, D14 exhibits a reduced growth phenotype on these 
cells that is intermediate between dll403 and wt HSV-1 
(Everett, 1989).
HFL cells infected with 0.003 pfu/cell HSV-2 and 
maintained at 42°C for 6 days followed by incubation at 37°C 
for 4 days were superinfected over a range of multiplicities 
with wt HSV-1, dll4 03, FXE and D14, or mock superinfected. 
Cultures were harvested after 1-2 days at 37°C when 
extensive cpe was observed. A portion of the cell lysate 
was amplified by replication through BHK cells, cytoplasmic 
DNA extracted and digested with Hindlll. The DNA fragments 
were separated by gel electrophoresis and the presence of 
HSV-2 in these samples was determined by Southern 
hybridization analysis using a cloned HSV-2 Hindlll L 
fragment (Figure 4.2.) or a cloned 655bp fragment derived 
from the unique 3 1 end of the HSV-2 glycoprotein G gene 
(McGeoch et al., 1987).
In Figure 4.3. the presence of the HSV-2 specific 
Hindlll L fragment in latently infected cultures was 
distinguished from the HSV-1 bands Hindlll b, e, g and n 
(Figure 4.2.), which cross hybridize, by virtue of the 
differences in their electrophoretic mobility. The HSV-1 
homologous bands act as an internal control indicating the 
replication efficiency of the superinfecting virus.
As expected, wt HSV-1 reactivated latent HSV-2 over a 
100-fold range of superinfecting multiplicities but the
Figure 4.2. THE LOCATIONS OF THE HSV-2 Hindlll L AND HOMOLOGOUS
HSV-1 Hindlll FRAGMENTS ON THE HSV GENOME.
The relative positions of the HSV-2 Hindlll L restriction
*9fragment and the HSV-1 framents Hindlll b, e, g and n, which 
cross hybridize, are illustrated. The scale in mu is indicated 
above the diagram.
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Figure 4.3. REACTIVATION OF LATENT HSV-2.
HFL cells were infected with 0.003 pfu/cell wt HSV-2 (lanes 
labelled L) or were mock infected (lanes labelled M ) . Cultures 
were superinfected with 0.1 (lanes 2, 7, 11 and 16), 0.01 (lanes 
3, 8, 12 and 17) or 0.001 (lanes 4, 9, 13, and 18) pfu/cell of 
wt HSV-1 (lanes 1-4), dll403 (lanes 6-9) , D14 (lanes 10-13), or 
FXE (lanes 15-18). Lanes 5 an^l4 contain latently infected 
samples mock superinfected. Cytoplasmic DNA was extracted from 
BHK cell monolayers in which reactivated virus progeny was 
amplified. Hindlll restricted DNA was subjected to Southern 
hybridization analysis using a HSV-2 Hindlll L probe.
MOCK MOCK
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18
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Hindlll L fragment was not detected in cultures that had 
been superinfected with dll403. Mutant D14 reactivated 
latent HSV-2, as shown by the presence of the Hindlll L 
band, whereas FXE did not, although hybridization with HSV-1 
specific bands confirmed that FXE, like the other 
superinfecting viruses, had replicated efficiently.
Hybridization was repeated with a HSV-2 specific probe 
with which minimal hybridization to HSV-1 sequences was 
observed (Figure 4.4.). In this experiment, HSV-2 Hindlll L 
was detected in cytoplasmic DNA samples from cultures 
superinfected with wt HSV-1 or D14 but not dll403 or FXE. 
thus corroborating the evidence presented in Figure 4.3.
These results demonstrate that the region of VmwllO 
defined by the deletion in FXE is essential for reactivation 
of latent HSV-2 in vitro. It is formally possible that the 
presence of replicating FXE in superinfected cultures 
induced the reactivation of latent HSV-2 but inhibited the 
subsequent multiplication of reactivated virus. However, 
this explanation for the failure of FXE or dll403 to 
reactivate HSV-2 seems unlikely on the basis of previous 
experimentation in which HFL cells coinfected with wt HSV-2 
and d!1403 indicated that dll403 did not interfere with HSV- 
2 replication (Russell et al., 1987).
4.2.3. Discussion.
The results presented in this section demonstrate that 
VmwllO is the only HSV-1 gene product required for 
reactivation of HSV-2 in the in vitro latency system. 
Moreover, the domain affected by deletion of the cysteine- 
rich motif in VmwllO is vital for reactivation. Transient 
transfection assays have indicated that VmwllO is a potent 
transactivator (Everett, 1984; Gelman and Silverstein, 1985; 
O'Hare and Hayward, 1985a). Dissection of VmwllO by inframe 
insertion/deletion mutagenesis has demonstrated that the 
region including FXE is important for the trans-acting 
function of this protein (Everett, 1988a) indicating that 
the events which precC' de reactivation are initiated by the 
activation of gene expression. The adenovirus recombinants 
do not encode the 5' portion of LAT, including the LAT
Figure 4.4. REACTIVATION OF LATENT HSV-2.
Experimental details are described in detail in the legend to 
Figure 4.3. Southern hybridization was carried out with a 655bp 
HSV-2 specific probe derived from a unique region of the 
glycoprotein G gene.
HL, HSV-2
HSV-1 ___| MOCK |___ dl 1403   ^ _^_  D14   ^ MOCK _^__ FXE
^ L L L L M L  L L M L L L  L M L L  L
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18
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promoter, and D14 is simultaneously deleted for 41 amino 
acids in the C-terminus of the predicted LAT 0RF1 (Figure 
1.6.)• Therefore, production of LAT is not necessary for 
reactivation since superinfection of latently infected 
monolayers with these viruses induces reactivation of HSV-2.
An extended analysis of the regions of VmwllO important 
for reactivation in vitro has been reported using adenovirus 
mutants derived from the recombinant AdMLP-110 that express 
altered forms of VmwllO (Zhu et al., 1990). In this study, 
mutations which affected the ability of VmwllO to 
transactivate gene expression in transfection assays were 
defective for induction of reactivation. In particular, an 
adenovirus expressing VmwllO with a deletion spanning the 
cysteine-rich motif failed to reactivate latent HSV-2, in 
agreement with the results presented in this thesis. 
Interestingly, a recombinant deleted for amino acids 628-697 
in the carboxy terminus of VmwllO failed to reactivate 
latent HSV-2 (Zhu et al., 1990). In contrast, mutant D14 
defective in the same region retained the ability to 
stimulate the HSV-2 genome upon superinfection of latently 
infected monolayers (Figure 4.3. and 4.4.). It is plausible 
that the non-overlapping region defined by residues 628-680 
may be responsible for the differing reactivation phenotypes 
of the two mutants. Alternatively, the combined effect of 
other HSV transactivators that are present during 
superinfection with D14 may compensate for other deletions 
in the carboxy end of VmwllO.
The mode of action of VmwllO in the induction of 
reactivation remains unresolved. However, it is apparent 
that the ability of VmwllO to reactivate latent HSV-2 
distinguishes this polypeptide from the other HSV-1 
transactivators, Vmwl75, Vmw63 and Vmw65 which are present 
in a functional form during superinfection with dll403 or 
FXE. Presumably, HSV-2 Vmwll8 (the homologue of VmwllO), 
present in the endogenous latent genome, is inaccessible to 
the combined effect of Vmwl75, Vmw63 and Vmw65 suggesting 
that the latent genome is in a novel quiescent state. It is 
postulated that due to the lack of target sequence 
specificity, VmwllO may act directly on the latent genome by 
displacing DNA binding proteins from the genome, that is
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organized in an inactive form resembling chromatin, thus 
rendering the genome accessible to cellular transcription 
factors. Alternatively, VmwllO may function at a post 
transcriptional level by activating cellular genes whose 
products are responsible for reactivation.
Clearly, expression of VmwllO is not required for 
reactivation of latent virus in vivo since VmwllO deletion 
mutants capable of establishing a latent infection in mice 
can be reactivated by ganglionic explantation (Clements and 
Stow, 1989; Leib et al., 1989b). The logical explanation 
for these differing observations is that reactivation in 
vivo is triggered by cellular factors that mimic the action 
of VmwllO. Evidence supporting this hypothesis is provided 
by the demonstration that the efficiency of plaque formation 
of VmwllO mutant viruses is increased significantly by 
growth on 2.5 BHK cells. 2.5 BHK cells were derived from 
repeated passage of BHK cells in medium normally used for 
HeLa cells, which causes a increase in growth rate and loss 
of contact inhibition (Everett, 1989). This suggests that 
2.5 BHK cells can complement the mutants due to the presence 
of a cellular factor which can substitute for VmwllO 
function and that is presumably absent or ineffective in BHK 
or HFL cells (Everett, 1989). Also, in contrast to the 
results presented in this thesis, mutants d!1403 and FXE 
were competent for reactivation upon induction of 
reactivation by NGF deprivation in an in vitro latency 
system based on the cultivation of rat sensory neurones 
(Wilcox et al., 1990; abstracts of the 15th International 
Herpesvirus Workshop, Washington DC, USA). These 
experiments imply that physiological alterations to neuronal 
cells in culture results in activation of a cellular factor 
able to compensate for defects in VmwllO during 
reactivation.
4.3. Manipulation of Latently Infected Cultures.
The mechanism of reactivation was examined further by 
application of various treatments to latently infected 
cells.
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4.3.1. Chemical Treatment of Latently Infected Monolayers.
A number of groups have used hypomethylating agents to 
increase the incidence and rate of reactivation from 
explanted neural tissue latently infected with HSV (Whitby 
et al., 1987; Bernstein and Kappes, 1988; Stephanopoulos et 
al., 1988). In this section, experiments are described in 
which latently infected cells exposed to the demethylating 
agents HMBA and DMSO were examined for reactivation of HSV- 
2.
The mode of action of DMSO and HMBA as DNA 
hypomethylating agents is unclear. The effects of HMBA 
include the induction of terminal differentiation of murine 
erythroleukaemia cells in a multistage process during which 
expression of a number of cellular transcripts is altered, 
particularly the down regulation of several proto-oncogenes 
(Ramsay et al., 1986) and accumulation of a and B globin, 
and rRNA transcripts (Sheffery et al., 1982; Cohen and 
Sheffery, 1985). Incoporation of 5mM HMBA into the growth 
media at explant of latently infected dorsal root ganglia or 
genital skin increased the frequency of recovery of HSV-2 
(Bernstein and Kappes, 1988). DMSO is also known to have 
diverse effects on many cellular functions (Higgins, 1983; 
Rifkind et al., 1983). Application of undiluted DMSO on to 
the mouse skin is a potent inducer of reactivation of HSV in 
associated ganglia in vivo (Harbour et al., 1983). 
Explantation of latently infected mouse cervical ganglia and 
culture in the presence of 200mM DMSO resulted in the 
increased detection of virus reactivated from individual 
ganglia (Whitby et al., 1987). Other workers have employed 
DMSO to circumvent the failure to reactivate of certain 
VmwllO deletion mutants (Leib et al., 1989b).
HFL cells were infected with HSV-2 (0.003 pfu/cell) and 
incubated at 42°C for 6 days followed by 4 days at 37°C. 
Growth media wcr* replaced with EF5 or EF5 plus HMBA or DMSO 
at a variety of concentrations indicated in Table 4.2. Each 
parameter was assayed over 5 latently infected monolayers. 
After 3 days at 37°C monolayers were stained and examined 
for the presence of plaques. In contrast to the 
observations made using in vivo model systems, the data
Table 4.2. MANIPULATION OF LATENTLY INFECTED CULTURES.
TREATMENT3 CONDITIONS PLAQUES PER PLATEb
HMBA: 0, 2.5, 5.0, 7.5, lO.OmM 0/5
DMSO: 0, 2.5, 5.0% 0/5
TRIGEMINAL +/- explanted trigeminal 0/5
GANGLION ganglion
Cultures were infected with HSV-2 at 0.003 pfu/cell, 
incubated at 42°C for 6 days and then at 37°C for 4 days 
in EF5 prior to exposure to the treatments indicated. 
Each treatment was carried out as detailed in the text.
b The number of plaques per monolayer for each experimental 
condition. Tvm. k s u  (*ts tu < fctju * ^  ^Y
^  fi AvncI$ MS6 / Ivj i caA
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presented in Table 4.2. indicate that incorporation of HMBA 
or DMSO over a range of concentrations failed to stimulate 
the reactivation of HSV-2 from its latent state in vitro.
4.3.2. Addition of Explanted Mouse Ganglia to Latently 
Infected Monolayers.
HFL cells were infected with HSV-2 at low moi (0.003 
pfu/cell) and incubated in EF5 at 42°C for 6 days and then 
at 37°C for a further 4 days. EF5 was removed from 
monolayers and replaced with 2ml EF5 or 2ml EF5 containing a 
trigeminal ganglion dissected from a 4-6 week old BALB/c 
mouse. Monolayers were incubated at 37°C and observed for 
reactivation over a 7 day period. A 200/xl aliquot of each 
sonicated cell harvest was assayed for the presence of 
infectious virus particles on 35mm plates of BHK cells in 
duplicate. Monolayers were overlaid with EHu2 and stained 
after 2 days at 37°C. The results presented in Table 4.2. 
show that reactivation of latent virus was not induced by 
addition of explanted neurological tissue in the growth 
media.
4.3.3. Discussion.
The results presented in this section describe attempts 
to experimentally reactivate HSV-2 by disruption of the 
latent state in vitro utilizing chemical and physical 
manipulations. However, each treatment proved to be 
unsuccessful in the stimuation of reactivation.
•X UukMilu ivrt* -hMl/t a*f "Kvt WDT XI \*<Xm  uv. H-acWrK** ils •eJtjc ch.»K'
1 On the assumption that HMBA or DMSO treatment of
latently infected cells demethylated the latent genome, then 
hypomethylation is apparently unable to induce sufficient 
HSV gene expression to produce lytic phase replication.
This implies that latency in vitro is not a consequence of 
extensive methylation of the HSV genome and correlates with 
observations, using the same model system, that latent HSV-2 
is not reactivated by inclusion of 5-azacytidine at 
concentrations between 0.75-6.0/iM in the growth media 
(Russell, 1989). Furthermore, independent evidence has 
demonstrated that the latent HSV-1 genome is not heavily
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methylated in vivo (Deshmane and Fraser, 1987). In 
contrast, other in vivo findings suggest that 5-azacytidine, 
HMBA and DMSO induce reactivation of latent HSV from 
explants of neural tissue (Whitby et al., 1987; Bernstein 
and Kappes, 1988; Stephanopoulos et al., 1988). This 
apparent dichotomy may be explained if the documented 
pleiotropic effects of these hypomethylating agents involves 
the induction of a normally quiescent cellular function, 
absent or inactive in HFL cells, that presumably does not 
occur via demethylation.
It has been hypothesised that reactivation in vitro, by 
explantation of latently infected ganglia, may be induced by 
the release of a diffusable factor(s) produced upon the 
degeneration of the explanted tissue. The data presented in 
Table 4.2. indicates that addition of explanted neuronal 
tissue to the growth media of latently infected HFL cells 
did not reactivate HSV-2 over a 7 day period which is 
sufficient for reactivation in explanted ganglia latently 
infected with HSV (Stevens and Cook, 1971). This may be 
interpreted in either one of two ways: i) the theory is 
incorrect and soluble cellular factors are not responsible 
for reactivation in vitro, ii) or that latent HSV-2 during 
latency in tissue culture is refractory to the effect of 
prolonged exposure to these potential factors.
4.4. Characterization of Mutant Inl814 in the In Vitro 
Latency System.
4.4.1. Establishment of a Latent Infection by Inl814.
In the mouse eye model for latency inl814 establishes a 
latent infection in the trigeminal ganglia and reactivates 
from latency upon explant co-cultivation. Mutant inl814 was 
tested for the ability to establish latency in a tissue 
culture latency system.
4.4.1.1. Latent Infection with Inl814 at Low MOI.
HFL cells were infected with inl814 or 1814R at 0.1 
particle/cell (low moi) and following a lhr absorption
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period at 37°C the cultures were incubated at 42°C for 6 
days and then at 37°C for 4 days. Superinfection of 
latently infected cultures with tsKsyn, followed by 
incubation at 38.5°C for 2 days in the presence of 
neutralizing serum, resulted in the appearance of non- 
syncytial plaques, demonstrating that reactivation of both 
1814R and inl814 had occurred (Table 4.3.). Mock 
superinfected cultures did not yield infectious virus.
The data presented in Table 4.3. indicates that inl814 
is able to establish a latent infection, despite the fact 
that the initial inoculum contained fewer pfu of inl814 (5) 
compared to 1814R (5500). Therefore, on the basis of 
particles, rather than pfu, inl814 established a latent 
infection as efficiently as 1814R.
4.4.1.2. Latency with Inl814 at High MOI.
A problem inherent with the current in vitro latency 
system is that of low starting moi. The possibility of 
increasing the initial moi and hence the sensitivity of the 
latency system was investigated by exploiting the 
characteristic reduction in IE gene expression and growth of 
inl814 on HFL cells.
HFL cells were infected with 5, 2, or 1 particle of 
in!814/cell and incubated at 42°C for 6 days. During the 
incubation period at 37°C the growth medium was replaced 
with EHu2. After 2 days at 37°C the monolayers were stained 
and plaque numbers counted. Simultaneous with the 
establishment of latency the number of potential pfu within 
the initial inoculum was assessed by titration at 37°C on 
HFL cells.
Latency is established at 42°C when HFL cell cultures 
are infected at 5, 2, or 1 particle/cell of in!814.
However, upon temperature downshift a small proportion of 
cells apparently harbour non-latent particles which, in the 
absence of Vmw65, replicate and form a plaque (Table 4.4.). 
Despite the presence of discrete plaques, the remaining HFL 
monolayer survived intact without obvious cytotoxity. A 4- 
fold decrease in plaque number is observed for in!814 
following incubation at 42°C for 6 days (Table 4.4.)
Table 4.3. ESTABLISHMENT OF LATENCY WITH Inl814 AND 1814R.
INITIAL INFECTION3
SUPERINFECTION MOIb 1814R inl814
Mock - 0C 0
tsKsyn 0.1 ND 200
0.01 12 19
0.001 2 ND
a Monolayers were infected with 0.1 particles/cell and
incubated for 6 days at 42°C followed by 4 days at 37°C.
b Cultures were mock superinfected or superinfected at 
multiplicities of 0.01 and 0.OOlpfu/cell of tsKsyn, 
overlaid with EHu2 and stained after 2 days at 38.5°C.
c Non-syncytial plaque numbers/plate; expressed as a mean 
of 3 plates.
ND Not done.
Table 4.4. ESTABLISHMENT OF A HIGH MULTIPLICITY LATENT
INFECTION.
INITAL INFECTION3 AFTER TITRATION*3 AFTER LATENCY0
5 27.0 7.4
2 10.5 2.6
1 6.0 1.4
a Latent infections were established in HFL cells at high 
moi using the standard in vitro latency protocol (Russell 
and Preston, 1986). Whilst at 37°C human serum was 
included in the growth medium.
b Titration of the inoculum was carried out at 37°C in 
parallel with establishment of latent infections; 
expressed as plaques/plate and a mean of 2 plates.
c Plaques/plate after the in vitro latency system; 
expressed as a mean of 5 plates.
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indicating that 42°C treatment does not reduce
the titre of inl814.
4.4.1.3. Latency with Inl814 at the Temperature Permissive 
for Virus Growth.
Mutant dll403, which does not express a functional 
VmwllO, has a phenotype similar to in!814 in that growth is 
reduced in a cell dependent manner. Low multiplicity 
infections of HFL cells with dll403 result in a non­
productive state in which virus can be maintained at 37°C 
for several days, and virus can be reactivated by 
superinfection of monolayers with HCMV (Stow and Stow,
1989). Inl814 was employed to investigate the possibilty of 
establishing a latent infection at 37°C, the physiological 
temperature for virus growth.
HFL cells were infected with inl814 and latency was 
established at 42°C in the standard manner or directly at 
37°C (without prior heat treatment) in the presence or 
absence of Ara-C. At various time points HFL cell cultures 
were mock superinfected or superinfected with 0.1 pfu/cell 
of tsKsyn or UV tsKsyn. Irradiation prevents detectable 
viral gene expression whilst retaining functional Vmw65. 
Therefore, superinfection with UV tsKsyn provides only Vmw65 
whereas superinfection with unirradiated virus provides 
Vmw65 and the IE polypeptides, including VmwllO. Following 
incubation at 38.5°C for 2 days under EHu5 the monolayers 
were stained with giemsa and plaque numbers counted.
Throughout the time course experiment inl814 could be 
reactivated efficiently by superinfection of monolayers with 
tsKsyn (Table 4.5.). The inl814 genome could be recovered 
by superinfection with irradiated virus within the first 
24hr of the experiment (Table 4.5.), which correlates with 
independent observations that functional Vmw65 supplied in 
trans complements inl814 (Ace et al., 1989). However, 
thereafter latent inl814 could not be reactivated by 
superinfection with UV tsKsyn (Table 4.5.), implying that as 
latency is established the IE promoter regions are modified 
and become unresponsive to transactivation by Vmw65.
Despite these apparent alterations, the latent genome
Table 4.5. TIME COURSE FOR REACTIVATION OF LATENT Inl814.
Time of Superinfection
(Days)
Inl814 Pfu Reactivated 
after Superinfectiona
Latency at 42°C
Mock UV tsK tsK
<0.1
<0.1
<0.1
0.5
<0.1
715
1.5
1.3
0.4
<0.1
2500
2015
1960
2230
1350
Latency at 37°C +Ara-C
2.4
<0.1
<0.1
<0.1
<0.1
35.5
<0.1
<0.1
<0.1
<0.1
3450
1610
1650
1420
1220
Latency at 37°C -Ara-C
1
<0.1
0.5
<0.1
47
44.5
<0.1
<0.1
<0.1
57
3720
1380
1260
950
640
a HFL cells were initially infected with 106 , 105 or 104 
particles per cell of inl814. At various time points 
post infection, HFL cell cultures containing latent 
inl814 were either mock superinfected or superinfected at 
38.5°C with 0.1 pfu/cell UV tsKsyn or unirradiated virus. 
The amount of reactivated virus was determined in 
duplicate by plaque count and is expressed as pfu per 105 
in!814 particles in the initial inoculum.
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remains susceptible to transactivation by VmwllO.
After 4 days at 37°C, in the absence of Ara-C, latently 
infected monolayers showed signs of virus replication that 
probably represents spontaneous reactivation and replication 
of virus in a single plaque which is reported to occur on 
rare occasions after establishment of latency at 42°C 
(Russell and Preston, 1986).
In summary, these observations demonstrate that HFL 
cell cultures can be infected with a substantial number of 
inl814 particles at the temperature permissive for virus 
growth in analogy with observations of mutant dll403 at 37°C 
(Stow and Stow, 1989). Moreover, the latent inl814 genome 
is differentially sensitive to HSV-1 transactivators. 
Incorporation of Ara-C in the growth medium did not affect 
the amount of virus that was reactivated upon superinfection 
(Table 4.5.).
4.4.1.4. Discussion.
Infection of HFL cells with inl814 at 42°C or 37°C 
results in the establishment of latency (Tables 4.3.-4.5.). 
Therefore, the disruption of Vmw65 function does not 
preclude establishment of a latent infection in vitro. The 
ability of inl814 to establish a latent infection at high 
multiplicity implies that the absence of Vmw65 predisposes 
HSV-1 to latency in cultured cells and which compares with 
the behaviour of inl814 in an animal model system (Steiner 
et al., 1990). In contrast, infection of HFL cells at high 
moi with dll403, which has a similar growth phenotype to 
inl814 but produces wt levels of HSV-1 IE polypeptides 
except VmwllO, results in significant cell destruction. The 
differences observed between inl814 and dll403, and the 
characteristic predisposition of inl814 to latent infections 
is presumably due to a very early block to viral gene 
expression in inl814 infections in which synthesis of IE 
gene products and cytotoxicity is drastically reduced.
After latency, a 103 to 104-fold decrease in titre is 
routinely seen by 42°C treatment of HFL cells infected by 
HSV-2 (Russell, 1989). In comparison, only a 4-fold 
reduction in plaque number was observed for inl814 at 42°C
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(Table 4.4.) implying that the combined effect of mild heat 
shock of HFL cells and the mutation are not additive. 
Therefore, 42°C treatment of HFL cells and disruption of 
Vmw65 function may exert their effects through the same 
pathway involving IE gene expression. Incubation of HFL 
cells at the supraoptimal temperature of 42°C induces the 
cellular heat shock response (Notarianni, 1986; Figure 4.9.) 
which affects the transcription of several cellular genes. 
Therefore, the effect of 42°C treatment may be manifest at 
the level of OTF-1 transcription, or any of the other 
cellular transcription factors which interact with Vmw65 in 
IEC formation. Alternatively, mild heat shock may influence 
viral gene expression directly at the level of Vmw65, 
perhaps by modifying its binding affinity for cellular 
components.
It is not clear from these data if the small proportion 
of effective particles which form a plaque after the in 
vitro latency system (Table 4.4.) are produced by 
replication in a subpopulation of cells capable of 
supporting virus growth in the absence of Vmw65 function or 
represent a Poisson distribution of the actual number of 
particles received by an individual cell such that a 
threshold level is exceeded and a gene dosage effect permits 
the formation of a plaque.
The particle:pfu ratio of inl814 stocks varies with 
the cell state. Particle:pfu ratios in the order of 
approximately 2xl05 have been observed (Ace et al., 1989). 
However, inl814 routinely has a particle:pfu ratio in the 
range of 104-5xl04 on HFL cells. Therefore, by 
extrapolation, application of 5 particles/cell of inl814 to 
a confluent monolayer on a 35mm petri dish, which averages 
106 cells/plate, would routinely result in the formation of 
100-500 plaques. Incorporation of Ara-C into the growth 
medium supresses the negligible background of non-latent 
virus particles (0.05-0.5%) present amongst the majority of 
latent particles, thus producing a stable high multiplicity 
latency system at 42°C or 37°C. Indeed, results presented 
in Table 4.5. and, Section 4.4.2. and 4.4.4. indicate that 
at 37°C with or without Ara-C the virus-cell interaction is 
indistinguishable from latency at 42°C.
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Table 4.5. indicates that during latency IE promoters 
undergo rapid alterations such that they are refractory to 
stimulation by Vmw65. This contrasts with HSV productive 
infections in which the the response of IE control regions 
to Vmw65 is central to progression to full lytic phase gene 
expression. Thus, during latent infections the IE promoters 
are apparently only responsive to VmwllO, which fits with 
the observation that reactivation, in the in vitro latency 
system employed here, relies on VmwllO. The phenomena may 
be related and occur for the identical reason. For 
example, if the latent genome is packaged into chromatin 
then VmwllO may non-specifically displace bound nucleosomes, 
rendering the genome available to the cellular transcription 
machinery. Alternatively, this may reflect the presence of 
a specific inhibitor of IE transcription in HFL cells 
analogous to that claimed to exist in a mouse neuroblastoma 
cell line (Kemp et al., 1990).
4.4.2. The State of the Latent Inl814 Genome.
4.4.2.1. Introduction.
Mouse and human neurological tissues latently infected 
with HSV-1 contain DNA that lacks terminal restriction 
endonuclease fragments (Rock and Fraser, 1983; Efstathiou et 
al., 1986). Thus, latent HSV-1 genomes are in a physical 
state that differs from the characteristic unit length 
molecules found in virion DNA. The current working model is 
that the latent HSV-1 genome is probably in the form of a 
circular episome which is associated with nucleosomes in a 
chromatin-like arrangement (Rock and Fraser, 1983; Mellerick 
and Fraser, 1987; Deshmane et al., 1989). In contrast, HEL 
cells latently infected in vitro with HSV-1 have been shown 
to contain only unit length linear viral DNA (Wigdahl et 
al., 1984a).
Analysis of the physical nature of the latent inl814 
genome in the in vitro latency system was enhanced by the 
infection of HFL cells at high multiplicity (5 
particles/cell). Since the predominant form of HSV-1 
genomes during latency in vivo is non-linear, it was
- 108 -
important to investigate the molecular organization of 
inl814 DNA in the in vitro latency to facilitate comparison 
with other independent in vivo and in vitro observations.
4.4.2.2. Latent Inl814 DNA is in a Non-Linear 
Conf iguration.
The physical organization of the HSV genome was 
analyzed in HFL cell cultures infected with inl814 at 5 
particles/cell and incubated at 42°C or 37°C in the presence 
of 50/zg/ml Ara-C or 5/ig/ml aphidicolin. Nuclear DNA was 
extracted from cultures at 5hr, 2 days or 4 days post 
infection. Samples were digested with BamHI and subjected 
to density gradient centrifugation to remove the majority of 
cellular DNA sequences, thereby enriching for HSV fragments. 
DNA restriction fragments with densities ranging from 1.709 
to 1.746 were separated by gel electrophoresis and analyzed 
by Southern hybridization utilizing a HSV-1 strain 17 BamHI 
k probe labelled to high specific activity (Figure 4.5.).
In reconstruction experiments with genomic HSV-1 DNA, the 
presence of the joint spanning fragment (BamHI k) and the 
terminal fragments (BamHI q and s) were detected. In nuclei 
extracted 5hr after infection, hybridization to the BamHI 
fragments k, q and s was apparent, although BamHI q and s 
were present at reduced levels compared to BamHI k (Figures 
4.6.-4.8.). In contrast, samples extracted at 2 and 4 days 
post infection were notable for the absence of hybridization 
to BamHI q and s, but the presence of hybridization to the 
joint sequence BamHI k regardless of whether latency was 
established at 42°C or at 37°C with DNA replication 
inhibitors (Figures 4.6.-4.8.). It is unlikely that the 
lack of BamHI terminal sequences is due to the DNA 
purification protocol as it has been demonstrated that the 
terminal fragments are not lost during the processing of DNA 
samples which contain a mixture of BamHI digested mock 
infected HFL cell DNA and viral genomic DNA (Russell, 1989; 
S. Jamieson, unpublished observation).
HFL cells infected with inl814 and incubated at 42°C or 
37°C contain the HSV-1 joint fragment but do not contain 
detectable amounts of the BamHI terminal fragments. Also,
Figure 4.5. THE GENOMIC LOCATIONS OF THE HSV-1 RESTRICTION
FRAGMENTS BamHI k, q AND s.
The HSV-1 BamHI fragments illustrated in the diagram are the 
joint fragment BamHI k (k=q+s), and the terminal BamHI fragments 
q and s. The scale in mu is indicated.

Figure 4.6. DETECTION OF Inl814 DNA AT 42°C.
Lanes 1-3 contain 5, 1.5, and 0.5ng of BamHI digested HSV-1 
genomes respectively. Nuclear DNA of densities 1.709 to 1.746 
were extracted from mock infected HFL cells after 4 days at 42°C 
(lane i^) and latently infected cultures which had been incubated 
at 42°C for 5hr (lane 5) , 2 days (lane ,6 ) or 4 days (lane 7 ). 
Electrophoresed DNA restriction products were analyzed by 
Southern hybridization with a 32P-labelled BamHI k probe. 
Positions of BamHI k (joint fragment) and BamHI q and s 
(terminal fragments) are indicated.
5 1.5 0.5 M 5h 2d 4d
1 2 3 4 5 6 7
Figure 4.7. LATENT Inl814 DNA AT 37gC WITH ARA-C.
Experimental details are described in the legend to Figure 4.6. 
except that latent DNA was extracted from cells incubated at 
37°C with the inclusion of 50jiig/ml Ara-C in the growth medium.
5 1.5 0.5 M 51) 2d 4d
1 2 3 4 5 6 7
K § • »  • • •
*
Figure 4.8. LATENT Inl814 DNA AT 37°C WITH APHIDICOLIN.
Experimental details are as for Figure 4.6. with the exception 
that DNA was extracted from HFL cells that had been incubated at 
37°C in the presence of 5/xg/ml aphidicolin.
5 1.5 0.5 M 5h 2d 4d
1 2 3 4 5 6 7
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the absence of termini at 37°C is not a product of a
specific inhibitor as identical results were obtained with
\ . . .
Ara-C and aphidicolin. Therefore, during latency in vitro
inl814 DNA exists in an "endless" conformation. The DNA may
persist as a unit length molecule i n t e g r a t e d i X - h i w w c
cellular genome via the terminal repeats which would
generate novel sized terminal restriction fragments. Since
this type of fragment was not detected, the results
presented in Figures 4.6.-4.8. indicate that the predominant
form of the inl814 genome during latency in tissue culture
must be either a circular or concatemeric molecule, or
integrated into the cellular genome via regions of the viral
genome excluding the termini.
The latent genome copy number was calculated by 
comparison of the hybridization signals obtained for 
reconstruction experiments (Figure 4.6-4.8, lanes 1-3) with 
latently infected DNA samples. The control samples 
contained 5, 1.5 and 0.5ng BamHI digested viral genomes 
which is assumed to represent 2xl07 , 6xl06 and 2xl06 HSV 
genomes per 106 cells respectively. Densitometric analysis 
(Section 3.7.5.) showed that in a DNA extract derived from 
1.5xl07 HFL cells initially infected with 5 particles/cell 
inl814, the HSV-1 joint fragments were detected in the range 
of approximately 0.1-0.5 copies/cell at 37°C and 0.2-1.0 
copies/cell at 42°C in a monolayer of 106 HFL cells.
4.4.4.3. Discussion.
Infection of HFL cell monolayers with 5 particles/cell 
of inl814 and incubation at the supraoptimal temperature of 
42°C or directly at the physiological temperature 37°C 
results in the conversion of the HSV genome to an "endless" 
molecule. The proportion of termini present in the latent 
DNA samples is decreased by 5hr post infection and 
apparently undetectable 2 days later. Therefore, latent 
genomes are converted rapidly to a non-linear state.
Infectious centre assays estimate that between 13% and 
21% of cells receive a potentially active genome following 
infection of 106 HFL cells with 5xl06 inl814 particles (C.M. 
Preston, unpublished observations). Therefore, at most
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approximately 2.0xl05 pfu could be recovered from the 
initial inoculum. Densitometric analysis of hybridization 
signals obtained with reconstruction experiments relative to 
latently infected samples suggests that 0.1-1.0 joint
are present in a monolayer of 106 cells. Thus, 
each latently infected cell retains a maximum of 1-5 in!814 
genomes. Furthermore, the amount of joint DNA detected 
remained constant or decreased implying that, over the 4 day 
period examined, replication of viral DNA did not occur. 
Thus, it is unlikely that the presence of "endless" DNA is 
due to concatermeric structures formed by a rolling circle 
mechanism. In summary, the results presented in this 
section demonstrate that non-linear HSV-1 DNA is maintained 
at low abundance in an in vitro latency system. This 
correlates well with an independent study in which infection 
of HFL cells with wt HSV-2 at the supraoptimal temperature 
also resulted in the conversion of the genome to an 
"endless" molecule present at low copy number (Preston and 
Russell, 1991). Moreover, in the same study, joint 
fragments were detected at bimolar concentrations relative 
to a unique region of the genome demonstrating that the lack 
of terminal fragments was due to the covalent fusion of 
termini to form an additional joint fragment. Thus, HSV-2 
DNA during latency in vitro is predominately circular, 
concatenated or integrated via internal regions (Preston and 
Russell, 1991). By comparison with these data and other in 
vivo observations which suggest that latent HSV DNA is in a 
circular form (Mellerick and Fraser, 1987) it is postulated 
that inl814 is present as a circular episome during latency 
at 42°C or 37°C.
Despite increasing the MD\ of the in vitro
latency system, it is not clear why infection of HFL cells 
with a relatively high multiplicity of inl814 compared to wt 
HSV-2 yields an equivalent number of latent genomes per HFL 
cell (Preston and Russell, 1991). Possibly HFL cells can 
tolerate a finite level of latent HSV genomes. However, 
this is not compatible with in vivo observations which 
suggest that the HSV genome may be present in the order of 
several hundred copies per latently infected neuronal cell.
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A related in vitro latency system has been described in 
which viral replication is repressed at 37°C by treatment of 
HEL cell monolayers with the antiviral agents BVDU and IFN-a 
(Wigdahl et al., 1982b). However, in this system latent 
HSV-1 DNA is principally unit length and linear (Wigdahl et 
al., 1984b). Thus, despite obvious similarities the two 
systems must be fundamentally different at the molecular 
level. This difference may be ascribed to the existence of 
two subpopulations of latently infected cells within a HEL 
cell monolayer (Shiraki and Rapp, 1986). One subpopulation 
showed signs of spontaneous reactivation after temperature 
downshift to 37°C. In the other subpopulation, reactivation 
was dependent on superinfection of latently infected 
cultures with HCMV. The proportion of cells that reactivate 
upon temperature reduction decreased rapidly with time 
whilst the number that produced infectious virus after 
superinfection remained constant (Shiraki and Rapp, 1986). 
Thus, it is possible that the more stable form of virus 
found at 37°C may represent a minor undetectable DNA species 
that is non-linear.
In conclusion, in nuclear extracts from latently 
infected HFL cells at 42°C or 37°C inl814 DNA is in a form 
other than unit length molecules. This is the first 
evidence that HSV-1 DNA is non-linear in vitro and 
correlates with available information pertaining to the 
physical structure of the latent HSV-1 genome in mouse 
model systems(Rock and Fraser, 1983; Efstathiou et al., 
1986).
4.4.3. Viral Gene Expression During Latency.
Several approaches were adopted to examine the status 
of latent inl814 genome expression in the in vitro latency 
system. These included the use of an enzyme assay to detect 
the synthesis of products from an early HSV gene, the 
analysis of polypeptide profiles and PCR amplification of 
latently infected cellular RNAs.
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4.4.3.1. Analysis of Latently Infected Monolayers for Viral 
TK Activity.
TK is a prototype HSV early gene in terms of its 
promoter and regulatory regions. The TK assay employed 
permits the sensitive detection of viral TK enzymatic 
activity.
TK activity was assessed in HFL cells that had been 
mock infected or infected with 5 particles/cell inl814 or 
1814R. Monolayers were incubated at 42°C or 37°C and 
cytoplasmic extracts were prepared at various time points 
between 3hr and 96hr post infection. The results of TK 
assays performed on cell extracts (Table 4.6.) indicate that 
viral TK activity in cells infected with inl814 was not 
significantly different from values obtained with mock 
infected extracts at 42°C and 37°C. A similar pattern was 
observed in 1814R infected cultures at 42°C. However, TK 
enzymatic activity was increased after infection of HFL 
cells with 5 particles/cell 1814R and incubation at 37°C for 
9-48hr.
Therefore, the expression of TK and presumably other 
HSV early genes is restricted in latently infected cultures 
at 42°C implying that a functional TK polypeptide is not 
essential for maintenance of the latent state in vitro. 
Transcription of the TK gene during latency in vitro is 
investigated in Section 4.4.3.
4.4.3.2. Latent Infection Polypeptide Profiles of Inl814 
and 1814R.
To determine which, if any, virus specific polypeptides 
are synthesised during latency, HFL cell cultures were mock 
infected or infected with inl814 or 1814R at 5 
particles/cell. Cultures were pulse-labelled for lhr after 
incubation at 42°C or 37°C for varying lengths of time. 
Labelled, infected cell polypeptides were analyzed by SDS 
polyacrylamide gel electrophoresis. The results shown in 
Figure 4.9. indicate that the polypeptide profile of the 
mutant virus is similarly restricted at 42°C and 37°C.
1814R protein synthesis is likewise restricted at 42°C, but
Table 4.6. TIME COURSE OF TK GENE EXPRESSION WITH Inl814
AND 1814R DURING LATENT INFECTIONS IN VITRO,
Time at 429.C TK Activity
(hr) (cpm//xg protein)
Mock inl814 1814R
3 7.0 2.4 3.0
6 5.9 2.7 3.3
9 4.5 3.7 3.9
18 5.1 2.7 3.4
24 3.7 4.1 6.8
36 3.9 3.6 4.0
48 4.7 4.5 1.8
72 5.5 8.9 6.4
96 5.5 6.5 3.7
Time at 372c
9 5.4 4.8 19.6
24 4.9 4.4 33.9
36 4.0 2.3 65.0
HFL cells were mock infected or infected with inl814 or 
1814R at 5 particles/cell and incubated at 42°C or 37°C. 
Cultures were harvested at the time point indicated. TK 
activity was determined by assay of the cytoplasmic fraction 
from each sample.
Figure 4.9. VIRAL POLYPEPTIDES DURING LATENCY AT 42°C.
HFL cells were mock infected (lanes 1 to 5), infected with 5 
particles/cell inl814 or 1814R (lanes 6 to 10; lanes 11 to 15 
respectively). Cultures were pulse labelled after incubation at 
42°C (lanes 1 to 4, lanes 6-9 and lanes 11 to 14) or 37°C (lanes 
5, 10 and 15) for 3hr (lanes 1, 6 and 11), 6hr (lanes 2, 7 and 
12), 9hr (lanes 3, 5, 8, 10, 13 and 15) or 16hr (lanes 4, 9 and 
14). HSV-1 induced polypeptides are indicated • . A cellular 
heat shock protein is labelled □ .
□act in
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as expected during incubation at 37°C some virus specific 
polypeptides are visible.
4.4.2.3. PCR Analysis of Latent Gene Expression.
During HSV-1 latent infections gene expression is 
restricted to a family of transcripts that have been 
detected in mice, rabbits and humans (Spivack and Fraser, 
1987; Stevens et al., 1987; Rock et al., 1987a; Croen et 
al., 1987; Deatly et al., 1987,1988; Wagner et al., 1988b; 
Krause et al., 1988; Steiner et al.,1988; Weschler et al., 
1988b; Gordon et al., 1990a).
PCR is an in vitro method for the primer-directed 
enzymatic amplification of specific nucleotide sequences 
that is capable of producing large amounts of a defined 
fragment from small quantities of a target sequence (Saiki 
et al., 1988). PCR amplification of cellular RNAs has been 
adapted to study the status of gene expression from the 
latent HSV-1 genome in murine cervical ganglia (Lynas et 
al., 1989a,b). The PCR technique facilitated the detection 
of LAT gene expression in <ljLtg of RNA extracted from the 
combined ganglia of several latently infected animals which 
corresponds approximately to the estimated RNA content of an 
individual ganglion (Lynas et al., 1989b).
The production of LAT and TK mRNA was examined in HFL
cells latently infected with inl814 and incubated at 42°C or
37°C +/- Ara-C for 4 days. Total RNA extracted from
infected HFL cells was treated with RNase-free DNase to
remove contaminating DNA, and was converted to cDNA using
the appropriate antisense oligonucleotide primer (LAT 2, TK
2). The products of the cDNA synthesis reaction were then
subjected to 3 0 cycles of PCR amplification with the
addition of the sense oligonucleotide (LAT 1, TK 1) 5' end
labelled with 32P. Incorporation of an end-labelled primer
during the PCR amplification permits the specific quantitive
detection of low abundance RNAs (Arrigo et al., 1989).
Parallel analysis of samples with 5' oligonucleotide primers 
r\
in the cDNA s^thesis and 3' primers in the PCR amplification 
permits the discrimination of a DNA signal from an RNA 
signal since DNA will generate a product with either
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combination of primers whereas RNA is detected specifically 
with the mRNA complementary (3' or antisense) primer during 
the cDNA synthesis reaction.
The LAT oligonucleotide primers utilized originate from 
the 3 1 end of LAT in a region that is unique to LAT which is 
not complementary to VmwllO and does not involve the 
putative 3 1 intron detected by Wechsler et al. (1988a) 
(Figure 4.1.)• Amplification of a 132bp fragment is 
indicative of transcription from the region encoding LAT.
The TK specific primers are not identical but overlap 
the primers chosen by Lynas et al. (1989a,b) and the 3' 
oligonucleotide primer is located close to the TK 
polyadenylation signal. PCR analysis of RNA samples 
containing TK mRNA is expected to yield an amplified product 
of 104bp.
The LAT specific fragment was amplified from virion DNA 
and a BHK cell extract made at late times post infection 
(Figure 4.10). However, the LAT PCR product is not detected 
in HFL cells infected with inl814 at high multiplicity at 
42°C and 37°C or as expected in a mock infected extract made 
from cells incubated at 42°C for 4 days (Figure 4.10.). 
Likewise, the TK PCR fragment could be detected in DNA 
extracted from virus particles or in BHK cells at late times 
post infection but in HFL cells TK gene expression was not 
detectable during latent infections (Figure 4.11.). PCR 
examination of RNA extracted from HFL cells infected with 
1814R for 2 0hr at 37°C revealed the presence of PCR products 
using the HSV LAT and TK specific primers in both 
combinations implying that the positive result may be due to 
contaminating DNA (Figures 4.10. and 4.11.). This 
presumably also accounts for the presence of a positive 
signal in the mock infected extract subjected to PCR 
amplification in the presence of TK 2 (Figure 4.11. lane 5). 
These data suggest that during maintenance of latency in 
vitro expression of HSV genes, including LAT, does not 
occur.
Figure 4.10. PCR ANALYSIS OF LATENTLY INFECTED HFL CELL RNAs
USING LAT SPECIFIC PRIMERS.
HFL cells were either mock infected (lane 1), infected with 5 
particles/cell inl814 and incubated at 42°C for 4 days (lane 2), 
37°C for 4 days with 50/xg/ml Ara-C (lane 3) or 5 particles/cell 
1814R and incubated for 20hr at 37°C (lane 4). Total cell RNA 
was isolated using guanidinium thiocynate, and treated with 
RNase-free DNase. Lanes 5 and 6 contain a mock infected cell 
extract and a late extract respectively. Lane 7 is the 
amplified product from 200ng of HSV-1 DNA. Lane 8 contains no 
PCR template. RNA samples were converted to cDNA using the 5 1 
(sense) or 3' (antisense) oligonucleotide primer (Figure 4.10 A 
and 4.10 B respectively) and were subjected to PCR after 
addition of the complementary end-labelled primer. Products 
were separated on a 6% polyacrylamide gel and visualized by 
autoradiography. The position of the 132bp LAT specific 
fragment (•) is indicated relative to non-radioactive size 
markers.
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Figure 4.11. PCR ANALYSIS OF LATENTLY INFECTED HFL CELL RNAs
USING TK SPECIFIC PRIMERS.
HFL cells were either mock infected (lane 1 and 9), infected 
with 5 particles/cell inl814 and incubated at 42°C for 4 days 
(lane 2 and 10) , 37°C for 4 days with 50/zg/ml Ara-C (lane 3 and 
11) or 5 particles/cell 1814R and incubated for 20hr at 37°C 
(lane 4 and 12). Total cell RNA was isolated using guanidinium 
thiocynate, and treated with RNase-free DNase. Lanes 5, 13 and 
6 and 14 contain a mock infected cell extract and an extract 
harvested at late times post infection respectively. Lanes 7 
and 15 are the amplified product from 200ng of HSV-1 DNA. Lane 
8 and 16 contain no template. RNA samples were converted to 
cDNA using the 5' (sense) or 3 1 (antisense) TK oligonucleotide 
primer (Figure 4.11 A and 4.11 B respectively) and were 
subjected to PCR after addition of the complementary end- 
labelled primer. Products were separated on a 6% polyacrylamide 
gel and visualized by autoradiography. The position of the 
104bp TK specific fragment (•) is indicated relative to size 
markers.
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4.4.2.4. Discussion.
A characteristic of latent infections in vivo is the 
suppression of transcription from the majority of viral 
genes. Only a region encompassing the terminal repeats is 
actively expressed. Although the subject of intense 
research, the biological function(s) of the LAT gene 
products have not been determined. The analysis of 
engineered and spontaneously arising LAT mutant viruses in 
animal model systems indicate that LAT gene expression is 
not required for establishment or maintenance of latency 
(Javier et al., 1988; Steiner et al., 1988; Leib et al., 
1989a; Sedarati et al., 1989). Therefore, the importance of 
LAT is speculated to be in events that lead to reactivation. 
Indeed, a recent study has suggested that LAT may be 
required in reactivation in vivo induced by iontophoresis of 
epinephrine (Hill et al., 1990).
Examination of the status of latent gene expression 
utilizing the in vitro latency system suggests that, like 
the in vivo situation, viral gene expression is restricted. 
In contrast to observed in vivo phenomena LAT gene products 
are undetectable during inl814 latent infections at 42°C or 
at 37°C. This is presumably not a consequence of an 
inability of inl814 to synthesis^LAT since latent LAT gene 
expression has been detected by in situ hybridization 
analysis of mouse trigeminal ganglia (Vlayi-Nagi et al., 
1991) . An explanation for the absence of LAT in vitro may
reside in the apparent increase in activity of the LAT gene 
promoter in cells of neuronal origin (Batchelor and O'Hare, 
1990; Zwaagstra et al., 1990). The specificity of the LAT 
promoter in neuronal-derived cells is thought to reside in 
an element which lies between nucleotides -797 to -12 67 
relative to the LAT RNA start site. Furthermore, gel 
retardation analysis has detected a nuclear protein present 
in neuronal and non-neuronal cells that binds upstream of 
the TATA box and appears at least partly responsible for 
promoter activity in in vitro assays (Zwaagstra et al.,
1990, abstracts of the 1 5 ^  International Herpesvirus 
Workshop, Washington DC, USA). The absence of such cellular 
factors, which may include proteins capable of interaction
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with the neuronal specific control region, in HFL cells 
could prevent the expression of LAT. Alternatively, the 
lack of LAT during maintenance of the latent infection in 
vitro may be a consequence of technical failure. The 
availibilty of a positive control sample isolated from 
latently infected ganglia or amplification of an internal 
cellular control, such as actin sequences, would have 
eliminated this latter explanation.
In the context of a previous report, it is perhaps not 
surprising that TK enzymatic activity was not detected 
during inl814 latency in vitro (Russell, 1989). In this 
study it was postulated that the transcription, translation 
or processing of the enzyme may be inhibited in HFL cells 
latently infected with HSV-2, or alternatively that 
functionally important domains of TK may be altered in such 
a way as to prevent enzymatic activity in this situation.
PCR analysis of inl814 latency in HFL cells (Figure 4.11.) 
implies that the block to TK, and probably other HSV-1 
genes, gene expression is at the level of transcription 
since TK specific mRNA was not detected. Likewise, using a 
similar approach, Lynas et al., (1989b) found no evidence of
TK transcripts during latent infections in vivo.
In conclusion, during inl814 latent infections there 
appears to be very limited, if any, viral gene expression. 
Therefore, in common with other in vitro and in vivo 
observations the latent inl814 genome is rendered 
transcriptionally silent during latent infections. The 
obvious difference between the quiescent state in vivo and 
that reported here is the apparent lack of LAT. Non­
production of LAT is not a universal feature of in vitro 
latency models since LAT is readily detected in an other in 
vitro latency system based on the cultivation of primary rat 
neurones (Doerig et al. , 1990, abstracts of the 15 th 
International Herpesvirus Workshop, Washington DC, USA) 
which supports the hypothesis that the failure to detect LAT 
by PCR is most likely due to the neuronal specificity of the 
LAT promoter.
In vivo, LAT is not required for establishment or 
maintenance of latency, and its precise role in reactivation 
remains to be ascertained. The absence of LAT does not
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therefore invalidate latency studies in vitro, but future 
work may reveal subtle differences in the molecular events 
that contribute to the reactivation process.
4.4.4. Reactivation of Latent Virus.
4.4.4.1. Introduction.
It is apparent that the latent HSV genome is responsive 
to a variety of stimuli which induce reactivation in vivo 
(Section 1.3.4.). However, the molecular mechanisms 
involved in this process have not yet been elucidated.
Reactivation of latent HSV-2 from an in vitro latency 
system that depends on infection of cells in the presence of 
antiviral agents for establishment, followed by incubation 
at increased temperature (40.5°C) for maintenance, can be 
experimentally induced to reactivate by superinfection of 
monolayers with HSV ts mutants or HCMV DNA-negative ts 
mutants which synthesis^only IE and early gene products at 
the NPT (Colberg-Poley et al., 1979b,1981; Wigdahl et al., 
1982a,b).
During latency in the in vitro latency system employed 
in this thesis, the virus-cell interaction is not perturbed 
by chemical or physical manipulations of latently infected 
cultures (Russell, 1989; Section 4.3.). However, 
reactivation of HSV from its latent state can be induced by 
intertypic superinfection with wt HSV-1, HCMV or HSV mutant 
viruses that produce the IE polypeptide VmwllO (Russell et 
al., 1987; Section 4.2.). Furthermore, disruption of a 45 
amino acid domain in VmwllO is sufficient to preclude 
reactivation induced by HSV superinfection (Section 4.3.).
4.4.4.2. Reactivation of Latent HSV-2 by Inl814.
To confirm that the virion transinducing factor Vmw65 
was not required for reactivation, mutant inl814 was tested 
for its capacity to reactivate latent HSV-2 upon 
superinfection. Cultures were infected with wt HSV-2 (0.003 
pfu/cell) and incubated for 6 days at 42°C followed by 4 
days at 37°C. Latently infected monolayers were
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superinfected over a range of multiplicities (0.001-0.1 
particles/cell) with wt HSV-1, 1814R or inl814 and incubated 
at 37°C for a further 2 days. Cytoplasmic DNA, extracted 
from BHK cells infected with 100/il of the HFL cell harvest, 
was digested with Hindlll and analyzed by hybridization of a 
Southern blot with a 32P-labelled Hindlll L fragment (Figure
4.2.).
Figure 4.12. indicates that each superinfecting virus 
replicated efficiently and induced the reactivation of 
latent HSV-2 as demonstrated by the presence of the HSV-2 
specific Hindlll L band against a background of cross- 
hybridizing HSV-1 bands Hindlll b, e, g and n. However, 
reactivation was consistently reduced in latently infected 
monolayers superinfected with inl814. In BHK cells infected 
with inl814 the amount of VmwllO mRNA is reduced 4 to 5-fold 
and importantly, a 10-fold decrease in the level of VmwllO 
is observed in inl814 infected HFL cells (Ace et al., 1989). 
The importance of VmwllO in reactivation is discussed in 
Section 4.2. and it is probable that the reported reduction 
in VmwllO transcription and translation is sufficient to 
decrease the reactivation efficiency of inl814.
4.4.4.3. Reactivation of Inl814 Requires VmwllO.
Reactivation of virus in the HSV-2 latency system is 
strictly dependent on VmwllO supplied by a superinfecting 
virus (Russell et al., 1987; Harris et al., 1989). Further 
characterization of the inl814 latent infection in HFL cells 
was directed at determining whether a comparable requirement 
for VmwllO was needed for the reactivation process.
HFL cells were mock infected or infected with 0.1 
particles/cell of inl814 and incubated at 42°C for 6 days 
followed by 37°C for 4 days. Alternatively, latency was 
established at 37°C with 0.1 particles/cell inl814 in the 
presence of 50jLtg/ml Ara-C. Superinfection of monolayers was 
carried out, after removal of inhibitor where relevant, with 
0.01-0.1 pfu/cell of dll403 or wt HSV-1. Monolayers were 
harvested when cpe was evident, and progeny virus was used 
to reinfect a BHK cell monolayer. BamHI cleaved cytoplasmic 
DNA extracts were subjected to Southern blot hybridization
Figure 4.12. REACTIVATION OF HSV-2 FROM LATENTLY INFECTED
CULTURES BY SUPERINFECTION WITH Inl814.
HFL cells were mock infected (M) or infected with 0.003 pfu/cell 
of HSV-2 (L) and incubated at 42°C for 6 days followed by 37°C 
for 4 days. Cultures were super inf ected with ,inl814 (lanes 1 to 
4), wt HSV-1 (lanes 5 to 8), 1814R (lanes 9 to 12) or mock 
superinfected (lane 13). Cytoplasmic DNA was extracted, cleaved 
with Hindlll and hybridized to a labelled HSV-2 Hindlll L 
fragment. The multiplicity of infection was 0.1 pfu/cell (lanes 
2, 6 and 10), 0.001 pfu/cell (lanes 3, 7 and 11) and 0.001 
pfu/cell (lanes 4, 8 and 12). Lanes 1, 5 and 9 contain samples 
infected with 0.01 pfu/cell.
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analysis. Digestion of inl814 DNA with BamHI produces two 
novel BamHI fragments from BamHI f because of the presence 
of an additional site generated by BamHI linker insertion. 
Therefore, detection of two BamHI bands of about 5kbp and 
3kbp against an 8kbp HSV-1 or dll403 band is diagnostic of 
reactivated inl814. The Southern hybridization data (Figure 
4.13.) show that superinfection with wt HSV-1, but not 
dll403 or mock superinfection, induced the reactivation of 
latent inl814 after latency was established at 42°C or 37°C.
4.4.4.4. Discussion.
Recent experiments have demonstrated that in the mouse 
eye model for latency inl814 establishes a latent infection 
without detectable replication in the cornea or trigeminal 
ganglia and reactivates at a rate comparable to wt HSV-1 or 
1814R. This implies that Vmw65 and viral replication are 
not essential for establishment of and reactivation from the 
latent state in vivo (Steiner et al., 1990). Furthermore, 
the ability of recombinant adenoviruses, expressing VmwllO 
in the absence of other HSV proteins, to reactivate latent 
virus implies by default that Vmw65 is not a prerequisite 
for reactivation in vitro. The results described in this 
section demonstrate that, as expected, Vmw65 is not required 
for reactivation in vitro (Figure 4.12.).
Moreover, in analogy with the HSV-2 system, only a 
functional VmwllO supplied by the superinfecting virus is 
necessary for reactivation of inl814 in either the 42°C or 
37°C HSV-1 latency model system.
These results confirm the data derived from the time 
course experiment (Section 4.4.1.3.) in which Vmw65 failed 
to stimulate the latent viral genome whereas expression of 
VmwllO by the superinfecting virus was essential for 
reactivation at 42°C or 37°C.
Figure 4.13. REACTIVATION OF LATENT Inl814 REQUIRES THE
POLYPEPTIDE VmwllO.
HFL cell cultures were mock infected (lanes labelled M) or 
infected with 0.1 particles/cell inl814 (lanes labelled L). 
Latency was established in the absence of Ara-C at 37°C (lanes 2 
to 7) , at 37°C in the presence of 50/zg/ml Ara-C (lanes 8 to 14) 
or at 42°C for 6 days followed by temperature downshift to 37°C 
(lanes 16 to 23). After incubation at 37°C for 4 days, and 
removal of inhibitor where appropriate, monolayers were mock 
superinfected (lanes 14, 19 and 20), superinfected with 0.1 
pfu/cell wt HSV-1 (lanes 2-4, 8-10 and 16-18) or 0.1 pfu/cell 
d!1403 (lanes 5-7, 11-13 and 21-23). Cytoplasmic DNA was 
digested with BamHI . Lanes 1 and 15 contain 1/Ltg BamHI cleaved 
inl814 DNA. The Southern blot was probed with a 1.6kb BamHI 
fragment derived from pMC17 (Ace et al., 1988).
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4.5. The Effect of Interferon on Mutant Inl814.
4.5.1. Introduction.
The antiviral effect of IFN in susceptible cells is 
reliant upon the de novo or increased synthesis of two 
double stranded RNA-dependent cellular enzymes. These are a 
2',5'-oligoadenylate synthetase and a protein kinase which 
inactivates an initiaton factor of eukaryotic protein 
synthesis, EIF2 (Baglioni, 1979). The synthetase activity 
is induced in murine trigeminal ganglia acutely infected 
with HSV-1 (Sokowa et al., 1980), although it has been 
suggested that some DNA viruses, including HSV, may have 
developed means to overcome these cellular defense 
mechanisms (Cayley et al., 1984).
IFN inhibits different viruses at various stages of 
virus replication. The inhibition of HSV growth by IFN has 
been demonstrated in several studies but the level at which 
IFN mediates its antiviral effect remains unclear. Munoz 
and Carrasco (1984) reported that in IFN pretreated cells 
there was no significant reduction in HSV-1 protein 
synthesis or virion assembly, although the infectivity of 
progeny virus produced was substantially decreased. The 
results presented by Chatterjee et al., (1985) indicated
that virus specific protein synthesis was not affected, but 
virion morphogenesis and release of particles from IFN 
treated cells was prevented. In contrast, examination of 
the effects of IFN on the HSV-1 TK and DNA polymerase 
enzymes in mouse L-cells has shown that, at relatively high 
concentrations, IFN suppressed the specific activities of 
these early proteins (Panet and Falk, 1983). Subsequently, 
Gloger and Panet (1984) demonstrated that treatment of HeLa 
cells with IFN inhibited HSV-1 replication at or prior to IE 
protein synthesis. Similarly, an independent analysis 
indicated that pretreatment of mouse or human macrophages 
with low doses of IFN efficiently inhibited virus IE protein 
production (Domke et al., 1985; Domke-Opitz et al., 1986; 
Straub et al., 1986). Extension of both studies, using a 
nuclear runoff transcription assay, produced compatible 
results which indicated that the major target of IFN-
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mediated inhibition is HSV-1 IE gene transcription 
(Mittnacht et al., 1988; Oberman and Panet, 1988,1989).
These later reports have led to the attractive hypothesis 
that the IFN induced reduction of IE mRNA synthesis is a 
consequence of an inhibitory effect involving Vmw65 or the 
interaction of Vmw65 with cellular proteins. However, it is 
possible that more than one mechanism may be involved for 
HSV-1 or that different mechanisms can predominate in 
different cell types.
Interest in IFN and its application to latency in 
tissue culture arose from several observations. It has been 
demonstrated that IFN inhibits the growth of HSV in cell 
culture. In addition, treatment of HEL cells with IFN-a 
results in a significant increase in the proportion of cells 
in which a latent infection can be established (Wigdahl et 
al., 1982). Also, the availability of a Vmw65 mutant 
provided an opportunity to test the recent suggestion that 
inhibition of HSV-1 replication by IFN involves a specific 
effect on this polypeptide (De Stasio and Taylor, 1990).
The objective of the experiments described in this 
section was to determine if the effect of human 
lymphoblastoid IFN-a (Hu IFN-a Ly) acted additively upon 
inl814, which is already impaired for growth and gene 
expression on HFL cells, such that a high multiplicity 
latent infection could be established, thereby improving the 
sensitivity of the system.
4.5.2. Inhibition of Virus Plaque Formation on IFN-Treated 
HFL Cells.
Confluent monolayers of HFL cells were treated with 
102 , 103 IU/ml of Hu IFN-a Ly for 18hr or were untreated.
The medium was removed, monolayers were washed twice with 
medium without Hu IFN-a Ly, and then the plates were 
infected with 3-fold serial dilutions of inl814 or 1814R. 
After lhr the virus inoculum was removed and the plates were 
overlaid with EHu2 supplemented with the appropriate amounts 
of Hu IFN-a Ly. 2-3 days later the plates were stained with 
giemsa and plaque numbers determined.
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The results presented in Table 4.7. indicate that 
pretreatment of HFL cells with Hu IFN-a Ly is capable of 
reducing the titre of in!814 at least as efficiently as the 
rescued virus, and that the degree of inhibition is 
dependent on the concentration of Hu IFN-a Ly employed. The 
maximum reduction in titre, approximately 20-fold, was 
observed when HFL cells were pretreated with 103 IU/ml of Hu 
IFN-a Ly in parallel titrations of inl814 and 1814R.
4.5.3. Uptake of Viral DNA to the Nucleus in IFN-Treated 
HFL Cells.
The effect of Hu IFN-a Ly on the efficiency of DNA 
migration to the cell nucleus was determined. HFL cell 
growth medium was replaced with 5ml medium containing no Hu 
IFN-a Ly or 102 , 103 IU/ml Hu IFN-a Ly and incubation was 
continued overnight at 37°C. Prior to infection, the medium 
was aspirated and the monolayers washed twice to remove 
residual Hu IFN-a Ly. Monolayers were infected in the 
presence of 25/zg/ml cycloheximide with 300 particles of 
in!814 or 1814R per cell. Nuclei were prepared 5hr post 
infection and BamHI digested nuclear DNA was analyzed by 
Southern blot hybridization (Figure 4.14.). No significant 
differences were detected in the levels of HSV DNA showing 
that Hu IFN-a Ly does not prevent the transport of viral DNA 
to the nucleus, nor does it reduce the amounts of DNA 
reaching the nucleus.
4.5.4. Discussion.
The results described here imply that IFN mediated 
inhibition of HSV-1 growth is not at the level of 
transactivation by Vmw65, since inl814 is defective for IEC 
formation and thereby reduced for IE gene expression, and 
the mutant was not resistent to the antiviral effects of Hu 
IFN-a Ly being inhibited for growth to the same extent as wt 
virus. A complication of this experiment is that it may 
focus on the subpopulation of cells capable of supporting 
inl814 plaque formation. If a homologue of Vmw65 existed in 
these cells then the effect of Hu IFN-a Ly may be to block
Table 4.7. THE EFFECT OF PRETREATMENT OF HFL CELL
MONOLAYERS WITH HU IFN-a LY ON THE TITRE OF 
Inl814 AND 1814R.
TREATMENT3
VIRUS No IFN 102 IU/ml 103 IU/ml
1814R 1.0 x 109b 2.0 x 108 5.8 x 107
(5)c (17)
inl814 2.7 x 106 4.4 x 105 1.3 x 105
(6) (21)
a Monolayers of HFL cells were treated with medium which 
lacked IFN or with medium containing Hu IFN-a Ly as 
indicated for 18hr prior to infection in duplicate with 
3-fold serial dilutions of inl814 of 1814R.
b Titre in terms of pfu/ml.
c Figures in parentheses are the fold reduction in titre in 
comparison to the titre in the absence of Hu IFN-a Ly.
Figure 4.14 EFFECT OF Hu IFN-a Ly ON MIGRATION OF VIRAL DNA TO
THE CELL NUCLEUS.
Monolayers were treated overnight with either 102 IU/ml or 103 
IU/ml Hu IFN-a Ly or were untreated. DNA was isolated from the 
nuclei of mock infected HFL cells (lanes 1 to 3) or from those 
infected in the presence of 25 jttg/ml cycloheximide with 3 00 
particles of inl814 or 1814R per cell (lanes 4 to 6 and lanes 7 
to 9 respectively). BamHI cleaved DNA was separated on an 
agarose gel, transferred to nylon membrane and probed with pTKl. 
The position of BamHI p is indicated.
1 2 3 4 5 6 7 8 9
Bam p m
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the action of such a homologue. However, co-infection of 
HFL cells with UV irradiated virus and inl814 increased the 
titre of inl814 essentially to wt levels in normal cells and 
in Hu IFN-a Ly treated cells suggesting that transactivation 
is not affectedijjEFN treatment (C.M. Preston, unpublished 
observation). The Southern blot data (Figure 4.14.) 
demonstrate that virus migration of viral DNA to the cell 
nucleus is not affected by Hu IFN-a Ly treatment. Likewise, 
this is implied from in vitro latency experiments (S. 
Jamieson, unpublished observations) which show that the long 
term potential gene expression is not affected.
It is speculated that the inhibition of in!814/1814R 
replication by Hu IFN-a Ly involves an effect on IE 
transcription in analogy with other published data 
(Mittnacht et al., 1988; Oberman and Panet, 1988,1989). 
However, this possiblity has notAinvestigated and 
alternatively, the inhibitory mechanism of IFN could be 
effective at late stages of virus replication (Munoz and 
Carrasco, 1984; Chatterjee et al., 1985). The results 
presented in this section cannot explain why IFN 
specifically reduces IE transcription. In contrast to 
recent evidence (De Stasio and Taylor, 1990), it is clear 
that it is not achieved at the level of Vmw65.
Wigdahl et al. (1984a) detected linear genomes in their 
in vitro latency system which is reliant on the use of IFN-a 
in combination with BVDU to repress virus replication. The 
presence of these linear genomes may have arisen as a 
consequence of a block to transport of viral DNA to the 
nucleus mediated by IFN-a treatment. The results shown in 
Figure 4.14. predict that this was not the case, and in the 
context of this experiment the observation by Wigdahl et al. 
(1984a) remains unexplained.
5. FINAL DISCUSSION.
To date no specific viral gene products have been 
identified which are associated with the establishment of 
latent infections without affecting replication. However, 
it has been hypothesised that the decision between a latent 
infection or progression to lytic phase gene expression may 
be determined by the presence or absence of the tegument 
protein, Vmw65, in the nucleus of the sensory ganglia. This 
balance may be altered by a variety of factors including the 
failure of sufficient Vmw65 to be transported to the 
neuronal nucleus, perhaps as a consequence of a low 
multiplicity infection, lack of necessary cellular 
transcription factors, like OTF-1, for IE gene expression in 
certain neurones (Roizman and Sears, 1987), or functional 
alteration of Vmw65.
Use of a Vmw65 mutant, inl814, in latency studies has 
demonstrated that a functional polypeptide is not required 
for establishment or/reactivation of latency in the mouse 
eye model (Steiner et al., 1990). Moreover, in!814 
replication at the site of inoculation was not detected 
(Steiner et al., 1990). These findings imply that Vmw65 is 
not required for establishment, nor is virus replication an 
essential prerequisite for establishment of latency, and 
that inl814 is predisposed to latent infection in vivo. 
Likewise, during latency in tissue culture, in!814 behaves 
in a similar mannner to the observed in vivo situation in 
terms of its ability to establish latency, in particular the 
capacity for high multiplicity latent infections at 42°C or 
at the physiological temperature 37°C (Section 4.4.1.). The 
predisposition of inl814 to latency argues for a defect in 
IE gene expression mediated at the level of Vmw65 being the 
actual pathway through which latency occurs. Furthermore, 
results presented in Section 4.4.1.2. suggest that 
incubation of cells at the supraoptimal temperature of 42°C 
renders the HSV genome incapable of synthesising adequate 
levels of IE gene products presumably by interfering with 
Vmw65 function.
It has been shown that HSV TK mutants do not replicate 
in murine sensory ganglia but retain the ability to
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establish latency in these tissues (Coen et al. , 1989; 
Efstathiou et al.y 1989; Leist et al., 1989; Tenser et al.,
1989). In this regard, these mutant viruses have a 
phenotype similar to inl814. The pattern of viral gene 
expression in murine trigeminal ganglia of defined TK" 
viruses has been examined using in situ hybridization with 
probes for all classes of HSV gene, including LAT (Kosz- 
Vnenchak et al., 1990). During latent infections of 
trigeminal ganglia TK” mutant strains expressed nuclear LAT 
RNA but lytic gene expression, especially IE gene 
expression, was at very low or undetectable levels (Kosz- 
Vnenchak et al., 1990). It is not clear why a defective 
gene encoding TK, a prototypic early gene should result in 
decreased amounts of IE gene products. However, the results 
are consistent with observations employing inl814 which is 
also defective for IE gene expression but can establish a 
latent infection (Steiner et al., 1990; Section 4.4.1.). 
Therefore, the implication of these data is that 
preferential establishment of latency in the absence of IE 
gene expression is not unique to a Vmw65 mutant.
In an attempt to clarify the role of Vmw65 during 
establishment of latency, two recombinant viruses have been 
constructed in which Vmw65 transcription was controlled by 
the mouse metallothionine promoter (R603) or a stop codon 
was inserted into the normal Vmw65 gene (R604). Normal mice 
or transgenic mice (which constitutively expressed Vmw65) 
were infected with viruses R603 and R604, and tested for ^the 
establishment of latent infections. Both recombinants 
established latency in normal mice with equivalent frequency 
and likewise, the expression of Vmw65 in transgenic mice, 
induced by heavy metals had no effect on the capacity of 
these viruses to establish a latent infection. Therefore, 
these data from Roizman's group suggest that the postulated 
lack of Vmw65 and the consequential reduction in IE gene 
expression is not operational during the establishment of 
latent infections in mice (Roizman and Spector, 1991).
Recent evidence has suggested the presence of a 
repressor activity specifically in cells of neuronal origin 
(C1300 cells). The presence of a trans-acting repressor 
molecule was implied from several lines of experimental
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evidence including: i) co-transfection of an IE construct 
with another vector containing a single copy of the 
TAATGARAT sequence element increased expression of a 
heterologous gene, and ii) permissivity for HSV-1 infection 
in C1300 cells increased following prior transfection of a 
plasmid containing the TAATGARAT element presumably by 
sequestration of the neuronal repressor by excess TAATGARAT 
motifs (Kemp et al., 1990). Furthermore, the existence of a 
putative repressor protein specifically in C1300 cell nuclei 
was demonstrated by gel retardation assay using an 
overlapping consensus octamer/TAATGARAT oligonucleotide probe 
(Kemp et al., 1990). Therefore, these results imply that a 
failure of viral gene transcription due to the presence of 
an IE gene inhibitor in neurones may play a role in the 
establishment of latent infections.
In summary, a model for establishment of latency in a 
situation where IE gene expression is reduced or absent, due 
an aberrant Vmw65 molecule as a consequence of one or a 
combination of the situations detailed above, fits the data 
presented in this thesis and elsewhere (Steiner et al.,
1990). However, it also compares with observations using 
TK” mutants (Kosz-Vnenchak et al., 1990). Therefore, a 
virus may favour a latent infection under more diverse 
circumstances, for example, low multiplicity of infection or 
because of any non-specific defect that interferes with IE 
gene expression. Indeed, certain HSV IE genes possess the 
ability to inhibit transactivation of target genes in 
transient expresion systems (O'Hare and Hayward, 1985b; Su 
and Knipe, 1989). It is possible that these proteins may 
have a modulatory effect on the expression of viral genes 
facilitating a latent virus-cell interaction.
Models that rely on a simple loss of Vmw65 over the 
distance between the nerve endings and the neuronal nucleus 
or an IE inhibitory factor limited to cells of the nervous 
system fail to account for the evidence that HSV can exist 
in a latent form at the periphery in vivo in cells other 
than neuronal cells (Clements and Subak-Sharpe, 1988; Al- 
Saadi et al., 1988; Clements and Jamieson, 1989) and in 
vitro in non-neuronal cells (Russell and Preston, 1986; this 
thesis).
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In vivo, the presence of the latent HSV genome has been 
detected in multiple copies per neuronal cell (Puga et al., 
1978; Cabrera et al., 1980; Rock and Fraser, 1983,1985; 
Efstathiou et al., 1986). On the basis of this evidence, it 
has been suggested that the balance between maintenance of 
the latent state and viral gene expression leading to lytic 
replication may depend on the copy number of viral genomes 
per latently infected cell. Thus, any given stimulus may 
cause an indirect amplification of viral genomes such that 
eventually a tolerated level of genomes is exceeded and 
reactivation is induced. Such a model for HSV latency is 
not inconsistent with results described in Section 4.4.2. in 
which maximal input of inl814 genomes does not result in an 
incremental increase in levels of latent DNA compared with 
wt HSV-2 infections at a relatively low moi (Preston and 
Russell, 1991). Other supporting evidence suggests that 
there is a correlation between initial infection at high 
multiplicity and the level of spontaneous reactivation from 
latency in the in vitro model system (Russell, 1989).
The absolute copy number of EBV genomes varies between 
different latently infected cell lines but is generally 
stable over time within a given cell line. Several viral 
proteins are expressed in cell lines harbouring latent EBV. 
Of these, only EBNA-1 is expressed in virtually all cells 
examined which retain latent EBV genomes. EBNA-1 interacts 
with a latent phase origin of replication (oriP) which is 
distinct from the origin used during lytic infection (Lupton 
and Levine, 1985; Yates et al., 1985) and therefore, oriP 
and EBNA-1 are functionally important for the controlled 
replication and maintenance of latent EBV episomes in 
proliferating cells. OriP is composed of a 65bp region of 
dyad symmetry, which functions as the actual origin of 
replication (Wysokenski and Yates, 1989), and a family of 
tandem, imperfect repeats which act as a transcriptional 
enhancer of heterologous genes that is strictly dependent on 
the presence of EBNA-1 (Reisman et al., 1985; Reisman and 
Sudgen, 1986). Rawlins et al. (1985) have demonstrated that 
a fusion protein representing the C-terminus portion of 
EBNA-1 binds specifically to the repeat sequences in vivo. 
Recently, the enhancer region within oriP has been shown to
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increase transcription from an EBV promoter region, in 
combination with EBNA-1 supplied in trans, that is 
responsible for the expression of some of the latent phase 
proteins, including EBNA-1 (Sugden and Warren, 1989). Thus, 
EBNA-1 is important for the synthesis of latent viral DNA 
and can potentially affect transcription from the latent EBV 
genome.
Two pieces of evidence predict that the control of 
genome copy number analogous to that observed in B- 
lymphocytes latently infected with EBV is not applicable to 
HSV latent infections. First, the EBV genome is replicated 
by the cellular DNA polymerase, in the context of the viral 
requirements discussed above, concomit antly with the 
replication of the dividing B-lymphocyte (Adams, 1987). 
Clearly, since neuronal cells invariably do not divide, the 
mechanisms involved in genome amplification must differ at 
this level in these divergent cell types. Moreover, the 
finding that HSV-1 LAT or mLAT mutants are capable of 
establishment and maintenance of latency in the absence of 
viral gene expression (Javier et al., 1988; Leib et al., 
1989a; Steiner et al., 1989; Sedarati et al., 1989; Mitchell 
et al., 1990b) implies that a similar EBNA-1 function is not 
required during HSV-1 latent infections.
Alternatively, herpesvirus latency may be controlled by 
mechanisms that involve the modification of the latent 
genome. Elucidation of the role of DNA methylation has 
typically involved the use of isochizomers which share the 
same recognition site but are differentially sensitive to 
methylation at CG dinucleotides, or the use of DNA 
hypomethylating agents. At least a proportion of CpG 
residues are methylated during non-productive EBV and HVS 
infections (Desrosiers et al., 1979; Szyf et al., 1985.).
The demethylating agent 5-azacytidine has been shown to 
activate virus production in lymphoid cells containing 
latent EBV (Ben-Sasson and Klein, 1981). This agent and 
other demethylating agents increase the reactivation 
efficiency of HSV from its latent state in vivo (Whitby et 
al. , 1987;, Berrvstein and Kappes, 1988; Stephanopoulos et 
al., 1988) which suggests that, like other herpesviruses, 
methylation of latent HSV DNA and subsequent hypomethylation
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may be involved in the maintenance of latency and the switch 
to lytic gene expression. In contrast, there is conflicting 
evidence which indicates that HSV-1 DNA is not heavily 
methylated in vivo (Dressier et al., 1987) and certainly, 
the usual demethylating agents are not effective in 
stimulating reactivation of latent virus in tissue culture 
(Russell, 1989; Section 4.4.3.1.). Therefore, the 
cumulative evidence may point to a limited methylation of 
the HSV genome, perhaps including the IE promoter regions.
On the other hand, since most demethylating agents can 
affect a broad spectrum of cellular processes, analysis of 
the alterations in cellular metabolism may indicate 
interesting events that lead to the reactivation of a latent 
genome that is not significantly methylated.
In the mouse eye model system, the majority of latent 
HSV-1 DNA is arranged in a complex structure that resembles 
cellular chromatin, whilst during the acute infection most 
viral DNA is not associated with nucleosomes (Deshmane and 
Fraser, 1989). Although control of viral gene expression 
may be determined crudely at the level of chromatin 
formation, other factors must be important as the region of 
the genome encoding LAT is associated with nucleosomes 
(Deshmane and Fraser, 1989), and yet transcription is not 
inactivated.
Recent studies have defined an area of the HSV genome 
that is active during latency in latently infected 
ganglionic nuclei of the natural host and experimental 
animals (Stevens et al., 1987,1988; Rock et al., 1987a; 
Spivack et al., 1988; Krause et al., 1988). These 
transcripts are termed LAT, their properties and biological 
significance are discussed in detail in Section 1.3.5.4.
RNA with at least some of the properties of LAT have been 
demonstrated in rabbits latently infected with BHV-1 (Rock 
et al., 1987b) and PRV (Rock et al., 1988; Lokensgard et 
al., 1990; Priola et al., 1990). However, there is a 
fundamental disparity between the cellular localization of 
the PRV latency specific RNAs; in one case nuclear retention 
of RNA has been reported (Rock et al., 1988) whilst another 
group has detected cytoplasmic species (Priola et al.,
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1990) . In situ hybridization analysis of latently infected 
human trigeminal ganglia has indicated that the VZV latent 
phase transcription pattern differs from HSV-1 (Croen et 
al., 1988) . Transcripts were mapped in the opposite 
polarity to some genes expressed during lytic infection of 
tissue culture cells and were apparently not restricted to 
regions of the genome encompassing the IE genes (Croen et 
al., 1988). Thus, there are obvious similarties and 
differences in the status of latent gene expression amongst 
alphaherpesviruses which may yet involve a common mechanism, 
perhaps in analogy with the HSV-1 situation wherein some 
property of the transcriptionally active region appears to 
have a role in facilitating reactivation from the latent 
state (Leib et al., 1989a; Steiner et al., 1989; Sedarati et 
al., 1989; Hill et al., 1990).
A possible role for the involvement of the HSV-1 LAT 
region in the control of latency has been postulated based 
on observations that LAT RNA is the only species abundantly 
transcribed during latency and that it is antisense to the 
mRNA of the IE protein VmwllO (Stevens et al., 1987; Rock et 
al., 1987a; Figure 1.6.). Recent evidence suggests that
this theory may be credible since LAT has the
characteristics of a stable intron that can inhibit the 
transactivation function of VmwllO, at least in transient 
transfection assays (Farrell et al., 1991). This property 
is not without precedent as antisense RNA molecules with 
important regulatory function have been reported in Xenopus 
and differentiated murine erythroleukaemia cells (Kimelman 
and Kirschner, 1989; Khochbin and Lawrence, 1989). 
Interestingly, the specificity of LAT RNA inhibition is
apparently limited to VmwllO which is important for
reactivation of HSV from its latent state in vitro (Russell 
et al., 1987; Russell, 1989; Section 4.2.). In this context 
it is important to note that VmwllO apparently plays a role 
in the synthesis of infectious virus following transfection 
of viral DNA, a process that may mimic events occurring 
during reactivation (Cai and Schaffer, 1989). Therefore, a 
negative effect of LAT RNA on production of VmwllO mRNA or 
protein might ensure the maintenance of latency. However, 
in vivo studies have demonstrated that there is no
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requirement for VmwllO in the reactivation process (Leib et 
al., 1989b; Clements and Stow, 1989).
Preliminary evidence has suggested the existence of a 
protein product derived from the region transcribed during 
HSV latency (Doerig et al., 1990, abstracts of the 15th 
International Herpesvirus Workshop, Washington DC, USA).
The promoter region controlling HSV latent phase gene 
expression contains a functional CRE that is important for 
the cAMP-mediated acceleration of reactivation by LAT+ 
viruses but not a LAT” virus that lacks the CRE and other 
sequences specifying LAT (Leib et al., 1991). In the 
context of this recent result, it is plausible that 
reactivation stimuli act indirectly on such response 
elements and induce the synthesis of a latency specific 
polypeptide that is responsible for the disruption of the 
latent infection.
In lymphoid cells latently infected with EBV, several 
chemically unrelated agents induce lytic expression from the 
viral genome, such as butyrate, calcium ionophores, tumour 
promoters, anti-immunoglobulins and a factor present in 
serum. Some of these agents are thought to act by 
stimulation of the cellular protein kinase C. The mechanism 
by which modification of intracellular protein kinase C 
concentrations induces expression from the EBV genome has 
not been elucidated, but it probably involves the induction 
of a protein transcribed from the BamHI Z leftward ORF 
(BZLF1). BZLF1 is a sequence specific DNA-binding protein 
with homology to the product of the c-fos gene (Farrell et 
al., 1989) that has the ability to transactivate some 
cellular and viral promoters (Rooney et al., 1989;
Flemington and Speck, 1990). Transfection of a BZLF1 
construct is sufficient to induce the EBV productive cycle 
(Countryman and Miller, 1985; Takada et al., 1986; Grogan et 
al., 1987). Furthermore, the primary transcript for the 
gene encoding EBNA-1, which is expressed continuously in 
latently infected lymphocytes, extends across the BZLF1 gene 
in an antisense direction (Baichwal and Sugden, 1988).
In summary, an external stimulus such as exposure to UV 
irradiation, fever, or stress may trigger an alteration in 
the expression of neuronal genes, perhaps resulting in the
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physio logical induction of a cell protein which functions in 
a similar manner to VmwllO or BZLF1. This may explain the 
disparity between the necessity for VmwllO in the 
reactivation process in tissue culture latency systems, and 
conversely, the absence of this requirement in animal model 
systems. The putative latency specific polypeptide, 
presumably synthesised from polyadenylated mLAT, may be 
produced downstream in the reactivation pathway as a 
consequence of the activities of a cellular protein(s).
The experimental data presented in this thesis extend 
the characterization of in vitro latency in HFL cells. 
Initial experiments using wt HSV-2 demonstrated that a 
stable latent infection is established by prolonged 
incubation of infected HFL cells at the supraoptimal 
temperature, 42°C, a process that requires very little or no 
viral gene expression (Russell and Preston, 1986; Russell et 
al., 1987; Russell, 1989). Use of the Vmw65 mutant inl814, 
which is blocked at a very early stage of infection prior to 
expression of IE gene products, permits the establishment of 
a high multiplicity latent infection at 42°C, or directly at 
the physiological temperature with the caveat that an 
inhibitor of viral DNA synthesis is incorporated in the 
growth medium to repress the replication of a background 
of non-latent particles. Therefore, Vmw65 is not needed for 
the establishment of latency in vitro. Indeed, its absence 
predisposes the virus to latent infections. Mutant inl814 
has facilitated the examination of the molecular mechanisms 
underlying HSV-1 latency in vitro. In particular, analysis 
of the physical organization of the latent genome has 
indicated that the HSV-1 genome is maintained in a form that 
is predominantly non-linear. This provides confirmation of 
earlier evidence that during HSV-2 latency in tissue culture 
cells, the viral genome is converted to an "endless" 
configuration at 42°C (Preston and Russell, 1991).
Concomit antly with the conversion of inl814 DNA to a non­
linear molecule, the IE promoters undergo rapid modification 
such that they are refractory to Vmw65 but retain the 
capacity to respond to VmwllO supplied in trans. These 
alterations probably reflect the packaging of the viral
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genome into a conformation that resembles chromatin and that 
like HSV-2, reactivation of inl814 in the normal 42°C system 
or at the permissive temperature is dependent on the 
presence of functional VmwllO. Viral gene expression is 
suppressed in HFL cells latently infected with inl814 
(Section 4.4.3.). Although the absence of LAT RNA is an 
important difference from the observed in vivo situation, it 
is apparent that there is no requirement for LAT in the 
processes governing establishment and maintenance. 
Furthermore, the role of LAT and mLAT in reactivation has 
not been precisely defined.
As a consequence of the results presented in this 
thesis and by others, which are described above, it is clear 
that in many respects the virus-cell interaction observed in 
vitro closely resembles in vivo phenomena and as such will 
continue to contribute to the understanding of the molecular 
biology of HSV latency. In this regard, the most important 
areas of the virus-cell interaction in vitro that warrcurt 
further investigation encompass the following areas: i) 
analysis of the mechanism by which VmwllO stimulates 
reactivation of latent virus, ii) comprehensive 
investigation of the physical organization of the latent 
genome and, iii) examination of viral gene expression, and 
its control during latency.
A more detailed analysis of the functional domains of 
VmwllO may highlight other additional areas, distinct from 
the cysteine-rich motif (Harris et al., 1989; Section
4.2.2.), that are also important for reactivation. This 
type of analysis is amenable, as a large panel of mutant 
viruses deleted for small regions of VmwllO are available 
(Everett, 1989), and would facilitate a comparison with 
independent observations in which adenoviruses expressing 
deleted forms of VmwllO were assayed for the potential to 
recover latent HSV-2 in the 42°C latency system (Zhu et al.,
1990).
A contention between in vitro and in vivo latency 
studies is the differential requirement for VmwllO, which 
probably reflects the differences in reactivation in HFL 
cells induced by superinfection and spontaneous reactivation
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in vivo, and thereby the involvement of the neurone in the 
events that govern reactivation. Moreover, in animal 
systems, host species, virus strain and the inital moi are 
determinants of the necessity for a functional VmwllO 
(Clements and Stow, 1989; Gordon et al., 1990b). The 
identification and characterization of the putative cellular 
protein homologous to VmwllO is a very ambitious 
undertaking. An interesting starting point may be 2.5BHK 
cells, which are documented to increase the plaquing ability 
of VmwllO mutants (Everett, 1989) and therefore presumably 
synthesize a complementing polypeptide. Furthermore, HMBA 
and other demethylating agents are reported to increase the 
efficiency of reactivation at explant (Whitby et al., 1987; 
Berstein and Kappes, 1988; Stephanopoulos et al., 1988) in a 
manner that may not entail hypomethylation of latent DNA. 
Thus, examination of the mode of action of such agents may 
provide information on the nature of the proteins involved 
in the events that lead to reactivation.
Having defined that the latent inl814 genome lacks the 
terminal restriction endonuclease fragments, it is important 
that other features of latent DNA are examined. For 
example, is HSV-1 DNA in a circular form and associated with 
nucleosomes during latency in vitro, in analogy with 
observations in the mouse eye model system (Rock and Fraser, 
1985; Mellerick and Fraser, 1987; Deshmane and Fraser,
1989)? Although the methylation status of latent HSV DNA 
has been investigated using demethylating agents (Russell, 
1989; Section 4.3.1.), it will also be important to 
complement these studies with an analysis of the restriction 
profile of latent DNA using enzymes, such as Smal and Xmal, 
that are differentially sensitive to methylation at the 
target sequence.
The absence of detectable LAT RNA in vitro (Section
4.4.2.3.) dictates that the further analysis of this RNA 
must involve a modification of the existing latency system. 
Since a neuronal specific element is present in the upstream 
region of the basic LAT promoter (Batchelor and O'Hare,
1990; Zwaagstra et al., 1990), this may be achieved by use
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of primary neuronal cultures or established cell lines of 
neuronal origin, such as C1300 cells, which are more 
accessible. The other option involves the construction of a 
mutant virus, based on inl814, in which the region that 
confers high level expression of LAT in neurones is 
specifically removed and replaced with a strong enhancer to 
drive LAT gene expression in HFL cells.
Concerning the suggestion that mild heat shock of HFL 
cells and mutations in Vmw65 interfere with the same process 
(Section 4.4.1.2.), this possibility could be investigated 
using gel retardation assays of nuclei extracted from 
uninfected and infected HFL cells incubated at 42°C .
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